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10 Chapter 1
In vertebrates, the immune system is responsible for the protection against pathogens 
such as viruses, bacteria, fungi or parasites. This remarkably effective defense system 
depends upon the white blood cells or leukocytes, which mediate both innate and 
adaptive immune responses. 
 Innate immunity provides an immediate but non-specific front line of host 
defense against many pathogens and involves granulocytes (neutrophils, eosinophils 
and basophils), mast cells, macrophages and natural killer (NK) cells. Germ line-
encoded surface receptors to common pathogens constituents on innate effector cells 
trigger the elimination of pathogens by phagocytosis and the release of inflammatory 
mediators, such as cytokines and chemokines. These receptors are referred to as 
pattern recognition receptors (PRRs), which recognize a limited set of molecules that 
are broadly shared by pathogens but distinguishable from host molecules, collectively 
referred to as pathogen-associated molecular patterns (PAMPs). 
 Acquired or adaptive immunity is characterized by gradual, though highly 
specific and effective immune responses against pathogens. Three major cell types 
are involved in adaptive immunity: B-lymphocytes, T-lymphocytes and antigen 
presenting cells (APCs), the most potent of which are dendritic cells (DCs). DCs act as 
messengers between the innate and adaptive immune system. Their main function is to 
take up, process and present pathogen constituents (also called antigens) with major 
histocompatibility complex (MHC) proteins to T lymphocytes. B- and T-lymphocytes are 
considered to be the central players of the adaptive immune system. Their unique and 
virtually limitless capacity to specifically recognize antigens relies on the generation of a 
wide repertoire of antigen receptors – B-cell receptor (BCR) in B-lymphocytes and T-cell 
receptor (TCR) in T-lymphocytes – during lymphocyte development. B-lymphocytes 
respond to pathogens by producing large quantities of antibodies (secreted form of 
BCR) with pathogen neutralizing capacities, when terminally differentiated into plasma 
cells. In response to antigens, T-lymphocytes produce cytokines that direct the immune 
response (T-helper cells) or toxic granules that induce the death of pathogen infected 
cells (cytotoxic T-cells). Following pathogen elimination, lymphocytes leave a lasting 
legacy of the antigens they have encountered in the form of memory cells, which are 
able to mount faster and stronger immune responses in subsequent challenges with the 
same antigen – a process know as immunological memory.
This thesis focuses on the role of specific transcription factors during lymphocyte 
development and differentiation into functional effector subsets. 
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PART I – LYMPHOCYTE DEVELOPMENT
Models for early hematopoiesis
All blood cells, including lymphocytes, originate from a small number of self-renewing 
and pluripotent hematopoietic stem cells (HSCs) in the mouse bone marrow (BM) by 
successive expansions in cell number in concert with progressive restrictions in lineage 
potential1-4 (Fig. 1). A primary event in HSC differentiation is loss of the potential to 
self-renew, while retaining the capacity for multilineage differentiation, thereby 
generating multipotent progenitors (MPPs). The initial view was that the first and 
decisive lineage commitment step of MPPs resulted in a strict separation into two major 
lineage-restricted progenitors: common lymphoid progenitors (CLPs) and common 
myeloid progenitors (CMPs)5, 6. Progeny derived from CLPs would segregate into the 
B-lymphocyte, T-lymphocyte, NK cell or dendritic cell lineage and CMPs would give 
HSC MPP 
LMPP 
CMP 
CLP 
GMP 
MkEP 
Basophils 
Eosinophils 
Neutrophils 
Mast cells 
Macrophages 
Dendritic cells 
Erythrocytes 
Platelets 
B cells 
T cells 
NK cells 
Figure 1. Schematic overview of hematopoiesis. Hematopoietic stem cells (HSCs) can give rise 
to all blood cells while retaining the capacity for self-renewal. The main lineage restriction steps 
during HSCs differentiation are indicated. MPP, multipotent progenitor; LMPP, lymphoid-primed 
multipotent progenitor; CMP, common myeloid progenitor; CLP, common lymphoid progenitor; 
GMP, granulocyte-macrophage progenitor; MkEP, megakaryocyte-erythroid progenitor. Model is 
according to Adolfsson et al, 20057.
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rise to either granulocyte-macrophage progenitors (GMPs) or megakaryocyte-erythroid 
progenitors (MkEPs). However, the identification of lympho-myeloid restricted MPPs 
(LMPPs, initially identified as lymphoid-primed multipotent progenitors or common 
myelolymphoid progenitor), which lack megakaryocyte-erythroid potential, questioned 
CMPs as obligate intermediates in HSC lineage commitment7, 8. Genome-wide gene 
expression profile analyses have been used to identify lineage-affiliated transcriptional 
programs in HSC and early lineage-restricted progenitors9, 10. These studies have 
shown that multilineage transcriptional priming present at the MPPs stage is quickly 
resolved upon erythroid lineage restriction, with rapid extinction of both lymphoid and 
myeloid transcriptional programs. In contrast, early lymphoid and myeloid transcriptional 
programs remain associated past lymphoid and myeloid lineage restrictions, revealing 
a common transcriptional backbone utilized during the development of both the 
adaptive and innate immune systems. Therefore, both differentiation and transcriptional 
studies support a revised road map for early hematopoiesis whereby MPPs lose their 
megakaryocyte-erythroid potential (MkEPs) early in development, giving rise to LMPPs, 
which retain both granulocyte-macrophage (GMPs) and lymphoid (CLPs) potential. 
B cell development in the bone marrow
In the BM, early B-cell progenitors arise from CLPs5. Recent work led to the identification of 
the transmembrane protein Ly6D as a marker for the earliest stage of B-cell specification 
(BLPs, B-cell biased lymphoid progenitors) within the CLP compartment11. The processes 
of B-cell lineage specification (induction of a lineage-specific gene expression program) 
and commitment (repression of alternative lineages gene-expression programs) are 
dependent on the coordinate actions of signalling cascades and transcription factors 
networks12-14. Both the interleukin-7 receptor (IL-7R) and Fms-like tyrosine kinase 3 
receptor (Flt3) are critical for B-cell development15-19. Likewise, developmental control 
of early B lymphopoiesis is exerted by a regulatory network of key transcription factors 
that include PU.1, Ikaros, Bcl11a, Foxo1, basic helix-loop-helix (bHLH) E-protein E2A, 
early B cell factor-1 (Ebf1) and Pax5. 
PU.1 and Ikaros are required for further specification of LMPPs into the 
lymphoid pathway probably because both are needed for proper expression of Flt3 
and IL-7R20-25. Similarly, Bcl11a and E2A are necessary for lymphoid-lineage priming in 
early hematopoietic progenitors26, 27. Foxo1 has been linked to the expression of the IL-
7R and lymphoid lineage-specific recombination-activating gene (RAG) proteins (RAG1 
and RAG2) on early B-cells28, 29. Specification of the B-cell developmental program (pre-
pro-B cells, Fig. 2) is initiated by the induction of Ebf1, downstream of E2A and IL-
7R signalling18, 19, 30, 31. Ebf1 and E2A cooperatively regulate most B cell-specific genes 
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including those encoding B lineage commitment factor Pax5 and the precursor-B cell 
receptor (pre-BCR) components λ5, VpreB, Igα (mb-1, CD79a) and Igβ (B29, CD79b)32-34. 
Commitment to the B-lymphoid lineage (pro-B cells) depends on continuous expression 
of the transcription factor Pax5, which represses B lineage-inappropriate genes and 
activates B lineage-specific genes35-38. Striking examples of Pax5-mediated repression 
includes genes encoding essential receptors for the differentiation of progenitors into 
myeloid, DC or T cell lineages, such as MCSF-R (macrophage colony stimulating factor 
receptor), Flt3 or Notch1, respectively35, 37, 39, 40. Notably, Ebf1 can also to some extent 
restrict alternative lineage options and promote B cell fate commitment in the absence 
of Pax541. Some of the Pax5-activated genes code for many components of the pre-
BCR and associated molecules, such as CD19, Slp-65, Igα and λ5, and transcription 
factors important for B-cell differentiation, including SpiB, Aiolos, Id3, Lef1, Irf4 and Irf838. 
In a feedback loop mechanism, Pax5 also induces the expression of Ebf131 thereby 
amplifying B cell-specific gene expression while reinforcing B-cell commitment and 
subsequent B cell differentiation. Although it is clear that Pax5 acts as a determinant 
of B cell lineage commitment, recent studies have suggested that collaborative DNA-
binding of PU.1, Foxo1, E2A, Ebf1 and Pax5 on a genome-wide scale is on the basis of 
a global network of transcription factors that orchestrates B cell fate42-44.
During the initial stages of B lineage commitment, ongoing differentiation 
is additionally dependent on successful assembly of a BCR. The BCR is composed 
of identical pairs of Ig heavy (H) and light (L, κ or λ subtype) chains encoded by the 
Igh, Igκ and Igλ loci. A wide range in BCR antigen specificities is mostly achieved by 
a mechanism of gene rearrangement at the Ig loci initiated by RAG1 and RAG2, a 
process also known as V(D)J recombination (see below). During B cell development, 
sequential rearrangement of Igh and Igκ or Igλ loci is essential for the production of a 
functional BCR (Fig. 2). Rearrangement of the Igh locus occurs at the pro-B cell stage. 
Upon successful rearrangement of the Igh locus, Igμ H chain protein is deposited on 
the surface of pre-B cells together with other components of the pre-BCR complex, the 
invariant surrogate light chain (SLC) constituents λ5 and VpreB, and the transmembrane 
signal transduction proteins Igα and Igβ45. The pre-BCR acts as a key checkpoint in B cell 
development to monitor the expression of a functional IgH chain46, 47. Signalling through 
the pre-BCR and the IL-7R drives clonal expansion and survival of Igµ+ pre-B cells 
(large pre-B cells). In large pre-B cells, the expression of Rag1 and Rag2 is transiently 
downregulated to terminate further Igh rearrangements48, thus ensuring that only one 
functional Igµ is synthesized, a phenomenon referred to as allelic exclusion. In mice with 
a targeted disruption of the Igµ membrane exon, the pre-B cells cannot deposit the Igµ 
chain on cell surface and therefore proliferation and allelic exclusion are lost49. 
Claudia Thesis_2.indd   13 17/10/2010   21:17:44
14 Chapter 1
Pre-BCR signals are also required for developmental progression into small 
pre-B cells, which occurs concomitantly with cessation of proliferation (Fig. 2). Although 
pre-B cell signalling has been shown to downregulate the transcription of the genes 
encoding λ5, Vpreb and IL-7R50-54, silencing of SLC is not critical for limitation of pre-B cell 
expansion55. Small pre-B cells are characterized by the reactivation of the recombination 
machinery for the initiation of Igκ or Igλ loci rearrangement and by significant changes 
in cell-surface-marker profiles: c-Kit, CD43, SLC and IL-7R expression is terminated, 
and CD2, CD25, and MHC class II expression is induced46, 47. The observation that 
Igκ+ B cells mostly retain their Igλ locus in germline configuration whereas Igλ+ B cells 
mostly carry non-productive Igκ locus rearrangements on both alleles, indicates that the 
Igκ locus is rearranged earlier or faster than the Igλ locus56-59. In fact, the Igκ locus is 
five times more frequently rearranged than the Igλ locus in mice and, due to selection, 
Igκ+ B cells are 15-20 times more frequent in the periphery than those expressing Igλ. 
Nevertheless, successful rearrangement of the Igκ or Igλ locus results in the assembly of 
the BCR on the membrane of immature B cells, provided that the IgL chain is able to pair 
with the IgH chain. The BCR acts as a second key checkpoint in B cell development not 
only to monitor for expression of a functional IgL chain but also to prevent the formation 
of autoreactive B cells60. It is estimated that more than half of all newly generated BCRs 
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Figure 2. B-cell developmental stages. B-cells develop in the BM through five distinct stages 
identified on the basis of cell surface markers expression and the rearrangement status of Igh 
and Igκ/λ loci. Large pre B-cells are distinguished from pro B-cells by intracellular expression of 
Igμ heavy chain protein. Immature B-cells with a functional BCR migrate into the periphery where 
they further mature into naïve mature B-cells that recirculate throughout the body, including the 
BM. SLC, surrogate light chain.
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are capable of binding autoantigen61. Therefore, mechanisms to enforce self-tolerance 
have to be in place in order to prevent autoimmune disease. These include secondary 
IgL chain loci rearrangements (other alleles of the Igκ or Igλ loci) to change the specificity 
of a previously autoreactive BCR (receptor editing) or clonal deletion by apoptosis62. As 
a result of negative selection mechanisms, only 10-20% of the newly formed immature 
B cells leave the bone marrow via the bloodstream to enter the spleen63, where they 
further mature into naïve mature B cells. Despite these mechanisms of central tolerance 
in the bone marrow many self-reactive B cells escape to the spleen, where they are 
silenced by an induced state of antigen unresponsiveness known as anergy.
T cell development in the thymus
T cells are unique among blood cells, as they require a dedicated organ for their 
development, the thymus. Hematopoietic progenitors must therefore leave the BM, 
traffic through the circulation and settle the thymus before developing into the T cell 
lineage. Early T cell precursors in the thymus (lacking the cell surface markers CD4 
and CD8 and therefore termed double-negative (DN) cells) are classically subdivided 
into four distinct developmental stages (DN1–DN4) by differential expression of the cell 
surface markers CD25 and CD4464 (Fig. 3). Further examination of the DN1 population 
revealed that efficient T lineage progenitor activity resides in a c-Kit+CCR9+ subset 
termed early thymic progenitors (ETPs)65, which have very limited B cell potential and 
still retains the capacity to diverge into NK, DC and myeloid lineages. Although the 
precise origin of ETPs remains controversial, it is likely that ETPs arise from the LMPP 
compartment in the BM66.
Similarly to early B-cell pathway, the processes of T cell lineage specification 
and commitment are dependent on the coordinate actions of signalling cascades and 
transcription factors networks. However, the establishment of a T cell lineage program 
is remarkable for its dependence on a balance among multiple factors, none of which 
appears to act as a T lineage “master regulator”67, 68. Development through the “pro-T cell” 
stages – that is from the ETP to DN3 stage – is characterized by extensive proliferation, 
initiation of the T cell developmental program and restriction of alternative cell lineages. 
Coordinated migrations of pro-T cells through distinct thymic microenvironments69, 
provides changes in the combinations of receptor ligands (for example, Delta-like 
and Jagged family of Notch ligands and the c-Kit ligand stem cell factors (SCF)) and 
growth factors (such as IL-7) expressed by the thymic epithelium, which drive pro-T 
cell proliferation, survival and differentiation. Both c-Kit and IL-7R sustain most pro-T 
cell proliferation and survival15, 16, 70, 71. Notch signalling is essential for several distinct 
aspects of early T cell development72, including the onset of the T cell lineage program73, 
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74, suppression of B, NK, DC and myeloid lineages potentials74-78, survival, proliferation 
and/or differentiation of DN3 cells78. 
Although Notch signals are critical to promote T cell fate, they most likely 
act in concert with a core group of transcription factors in the T cell specification and 
commitment process including: GATA-binding protein 3 (Gata3); avian myeloblastosis 
virus oncogen homolog (Myb); runt-related transcription factor 1-core binding factor 
β (Runx1-CBFβ) complexes; bHLH E-proteins E2A and HeLa E-box binding factor 
(HEB); T-cell factor 1 (Tcf1); growth factor independent 1 (Gfi1) and Ikaros67, 68. Other 
transcription factors which expression is more dynamically regulated during T cell 
developmental stages collaborate with the core group of transcription factors to induce 
stage-specific gene expression programs. These include: 1) pre-thymically inherited 
non-T cell transcription factors (PU.1, stem cell leukemia (SCL)/Tal1, Gata2 and CCAAT-
enhancer binding protein α (C/EBPα))79 that most likely sustain the lineage plasticity 
in early stages of T cell development and which expression is downregulated before 
the DN3 stage, when T cell precursors are committed to the T cell lineage and can 
no longer develop into alternative cell types; 2) transcription factors expressed at the 
ETP to DN2 transition (Bcl11b, HEBalt (an alternative promoter isoform of HEB) and 
glioma-associated oncogene 2 (Gli2))79, 80, when most T cell identity genes (encoding 
for the precursor-TCR (pre-TCR) assembly complex - CD3ε, CD3γ and pre-TCRα chain 
(pTα), signalling components - kinases, phosphatases and adaptor proteins such as 
LCK, ζ-chain associated protein kinase of 70 kDa (Zap70) and linker of activated T cells 
(Lat), RAG proteins and IL-7Rα) begin to be upregulated79-81; 3) and transcription factors 
expressed at the DN2 to DN3 transition (Ets1, Ets2, lymphoid-enhancer-binding factor 
1 (Lef1), SpiB and Hes1)79-82, when most T cell identity genes are fully activated and 
commitment to the T cell lineage is completely and stably established. 
Further differentiation of T cells depends on successful assembly of the TCR. 
Each receptor consists of a TCRα and a TCRβ chain, encoded by Tcrα and Tcrβ loci, 
respectively (Fig. 3). Most mature T cells express a TCRαβ on their cell surface (αβ 
T-cells) and these are the T cells involved in the classic adaptive immune response. 
However, a distinct and minor subset of T cells (γδ T-cells) with largely elusive functional 
role in the immune system bears an alternative TCR made up of TCRγ and TCRδ chains, 
encoded by the Tcrγ and Tcrδ loci, respectively. Similar to the BCR, a large variety of 
TCR antigen specificities is achieved by gene rearrangement of the Tcr loci (see below). 
During T cell development, sequential rearrangement of Tcrδ, Tcrγ or Tcrβ and Tcrα loci 
is essential for the production of a functional TCR. During the DN2 to DN3 transition, 
rearrangements at the Tcrδ, Tcrγ and Tcrβ loci are initiated83. Cells that productively 
rearrange the Tcrδ and Tcrγ loci may express a functional TCRγδ on the membrane, 
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undergo a small proliferative burst and develop into γδ T-cells. Upon productive 
rearrangement of the Tcrβ locus, the TCRβ chain associates with the invariant pTα 
chain and CD3 molecules on the cell surface and forms the pre-TCR complex, which 
qualifies DN3 cells to enter the αβ T cell lineage. Recent studies suggest that stronger 
signals delivered by the TCRγδ and relatively weaker pre-TCR signals determine the 
αβ/γδ-lineage choice84-86. 
Pre-TCR signalling tests for the functionality of the TCRβ chain, a process called 
β-selection87. Cells that have passed this checkpoint are termed β-selected cells (or late 
DN3 cells, to distinguish them from early DN3 cells that are not yet selected)88. The pre-
TCR complex signals for Tcrβ locus allelic exclusion and DN3 cells survival, proliferation 
and differentiation. In particular, pre-TCR signals result in the downregulation of CD25 
expression and progression of DN3 cells into the DN4 stage83 (Fig. 3). Cells subsequently 
acquire both CD4 and CD8 coreceptors to become double-positive (DP) cells, with CD8 
usually being expressed first in most mouse strains generating immature SP (ISP) cells. 
Therefore, the late DN3, DN4 and ISP stages consist of large cycling “pre-T cells”. At 
the DP cell stage, proliferation is ceased before rearrangement at the Tcrα locus is 
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Figure 3. T-cell developmental stages. T-cells develop in the thymus towards αβ or γδ T-cell 
lineages. Eight distinct αβ thymocyte developmental stages are identified on the basis of cell 
surface markers expression and the rearrangement status of TCRβ and TCRα loci. DN, double-
negative; ISP, immature single positive; DP, double-positive; SP, single positive; pTα, pre-TCRα 
chain.
Claudia Thesis_2.indd   17 17/10/2010   21:17:45
18 Chapter 1
initiated, which leads to deletion of the Tcrδ locus located in between Vα and Jα gene 
segments. If Tcrα gene recombination is productive, TCRαβ is expressed on the cell 
surface of DP cells. TCRαβ-bearing DP cells are tested for self-MHC recognition during 
the process of positive selection89. TCRαβ receptors recognizing MHC class I or class II 
molecules will develop into CD8 single positive (SP) or CD4 SP T cells, respectively90. 
Two models have been elaborated to explain CD4/CD8 lineage commitment. In the 
stochastic/selective model, lineage commitment is determined randomly, followed by 
a selection step that eliminates thymocytes that express the inappropriate thymocytes. 
The instructive/kinetic model proposes that qualitatively distinct signals initiated upon 
TCR engagement by MHC class I or class II ligands and duration of TCR signalling, 
instruct CD8 or CD4 lineage choice, respectively. DP thymocytes that fail to recognize 
MHC molecules die “by neglect”, whereas potential self-reactive T lymphocytes are 
eliminated by apoptosis, a process called negative selection. When combined, these 
selection processes result in the generation of CD4 and CD8 SP thymocytes with 
TCRαβ receptors that can recognize non-self-antigens presented by MHC class II and I 
proteins, respectively. Mature SP cells exit the thymus and migrate via the bloodstream to 
peripheral lymphoid organs – such as the spleen, lymph nodes and mucosa associated 
lymphoid tissue (MALT; for example, Peyer’s Patches) - as naïve recirculating CD4+ T 
helper and CD8+ cytotoxic T cells.
Gata3 and thymocyte development 
Gata3 is a transcription factor which expression is confined to T- and NK-cell 
lineages among all hematopoietic cell types91-96. Initial experiments using antisense 
oligonucleotides strongly suggested that Gata3 plays an essential role in the initiation of 
the earliest steps of T cell development in the fetal thymus together with Tcf197. Analyses 
in Gata3-LacZ knock-in mice show that Gata3 expression is already detectable at the 
earliest stages of T cell development in the adult thymus91 and in the absence of Gata3 
development of T cell precursors is arrested, even before the DN1 stage91, 98. More 
recently it has been shown that Gata3 is required for ETP generation99. Importantly, 
impairment of T-lymphopoiesis in Gata3 deficient hematopoietic progenitor cells can 
only be rescued when both Notch signals and Gata3 are present but not either alone100. 
This shows that Notch signalling and Gata3 act in concert at the earliest stages of T cell 
development to promote T cell fate specification. 
Gata3 expression in thymocytes peaks during proliferation at β-selection 
checkpoint and again later in cells undergoing positive selection to the CD4 SP T 
cell fate91, 101, 102. Therefore, low Gata3 expression during the two waves of Tcr gene 
recombination are separated by a stage of high Gata3 expression (β-selection), which 
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suggests that Gata3 may function as a regulator of proliferation events associated with 
the essential coupling of Tcr loci rearrangement to the cell cycle. In agreement with this, 
enforced expression of Gata3 during T cell development induces thymic lymphoma in 
transgenic mice103.  Conditional deletion of Gata3 at the DN stage shows that Gata3 is 
needed for normal β-selection and proliferation in the DN3 to DP transition102. Gata3 
deficient DN3 cells can rearrange the Tcrβ locus and express the pre-TCR but fail to 
increase their cell size and do not downregulate CD25, although there is no evidence 
for a survival defect. These findings indicate that Gata3 functions as a key mediator 
for β-selection. Conditional deletion of Gata3 after β-selection, demonstrates that at 
the DP stage Gata3 has a prominent role during positive selection, promoting the 
development of CD4 SP cells and blocking the development of CD8 SP cells101, 102, 
104. The finding that enforced Gata3 expression results in increased cell size and TCR 
expression levels in DP cells also suggests that Gata3 may influence the kinetics of 
positive selection105. However, whether Gata3 is important for commitment to the CD4 
lineage or for survival or development of CD4 lineage committed cells still remains 
elusive101, 102. In this context, TCR signal strength and duration at the DP stage has 
been shown to affect CD4 versus CD8 lineage decision, with strong and lasting TCR 
signals directing commitment towards the CD4 lineage89. Conversely, in DP cells Gata3 
enhances the expression of TCR and reduces the expression of CD5, a negative 
regulator of TCR signalling105. Because Gata3 is induced by TCR signalling101, these 
results implicate Gata3 in a key regulatory positive feedback loop that increases TCR 
expression and signal strength/duration at the DP cell stage. Two recent studies have 
further elucidated the role of Gata3 in directing the differentiation of DP cells towards 
the CD4 lineage. Gata3 disruption blocks the differentiation into CD4 T cells before 
commitment to the CD4 lineage but acts as a critical regulator of ThPOK expression at 
this stage106. ThPOK is a transcription factor that promotes differentiation into the CD4 
lineage in a Gata3-dependent fashion, while inhibits Runx3-dependent differentiation 
towards the CD8 lineage independently of Gata3106, 107. Based on these finding it was 
proposed that Gata3 works as a specification factor for the CD4 lineage ‘upstream’ of 
the ThPOK-controlled CD4 commitment checkpoint.
Interestingly, the timing and dosage of Gata3 expression is essential in T cell 
development.  Forced expression of Gata3 in nonthymic hematopoietic precursors or 
early T lineage progenitors (DN1 and DN2 stage) does not enhance or accelerate T cell 
specification. Instead it completely aborts T cell specification, resulting in non-lymphoid 
hematopoietic cell fates108-110. In developing thymocytes, overexpression of Gata3 clearly 
has adverse effects and is associated with reduced cell survival104, 105, 109. 
Taking together, these findings indicate that Gata3 function is associated with 
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T cell lineage fate specification, β-selection and positive selection towards the CD4 
lineage.
V(D)J recombination
One of the hallmark characteristics of the adaptive immune system is its practically 
endless capacity to recognize a great variety of different antigens. This relies on the 
generation of a repertoire of antigen receptors with a wide range of antigen-binding 
specificities during B and T lymphocyte development. The Ig and TCR chains - which 
constitute the BCR and TCR, respectively - are different in nature but similar in structure, 
having both variable (V) and constant (C) regions111. The C region is mostly involved in 
membrane expression and signalling functions of the antigen receptors. In B cells, the 
IgH chain 
~195 VH  10-13 DH  4 JH  8 CH  
IgL chain (Ig ) 
~120 V  5 J  C  
mRNA mRNA 
VH 
CH 
CH 
CL 
VL 
Figure 4. Schematic representation of V(D)J recombination at Ig loci. The BCR is composed 
of identical pairs of Ig heavy (H) and light (L) chains, both with a constant (C) and a variable (V) 
region. The IgH V region (VH) is encoded in multiple variable (V), diversity (D) and joining (J) 
gene segments. First a DH gene segment is joined to a JH gene segment and, subsequently, a 
VH gene segment is coupled to the DJH joint. The VDJ exon is transcribed and spliced to the CH 
exons. The IgL V region (VL) is encoded in multiple V and J gene segments (Igκ type). Only one 
recombination event is required to join a Vκ gene segment to a Jκ gene segment. The VκJκ exon is 
transcribed and spliced to the Cκ exon.
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C region of IgH chains is additionally involved in determining the effector function of 
antibodies (secreted Ig). The V region is the part of the antigen receptor that specifically 
recognizes the antigen and consists of three hypervariable complementary determining 
regions (CDR1-3). A wide range in CDR specificities is achieved by the many possible 
different combinations of Ig or TCR chains V regions, which in turn are encoded in 
multiple V (variable), D (diversity, only for Igh, Tcrδ and Tcrβ loci) and J (joining) gene 
segments. These are assembled through a somatic DNA recombination mechanism to 
form a complete V-region exon, a process also known as gene rearrangement or V(D)
J recombination112-114 (Fig. 4). Selection of a V, (D) and J gene segment during gene 
rearrangement occurs at random and the large number of possible different combinations 
accounts for most of the diversity of the antigen receptor repertoire. The C region is in 
most antigen receptor loci encoded in a separate single gene segment that is joined to 
the V region exon by RNA splicing. In the Igh locus the C region is encoded by several 
gene segments, each of them corresponding to the different classes or isotypes of the 
IgH chain involved in distinct antibody effector functions. In naïve B cells only the first 
two of these C region gene segments, Cμ and Cδ, are expressed in conjunction with 
an assembled V region exon by alternative RNA splicing, and thus naïve B cells have 
both IgM and IgD on their surface. Further somatic DNA recombination events known 
as isotype switching or class switch recombination (CSR) occur in B cells that have 
become activated by antigen, thereby allowing a switch to downstream C region gene 
segments (see below).  
V(D)J recombination mechanism
DNA rearrangements are targeted to the Ig and Tcr loci by short, conserved, non-
coding sequences at the flanks of coding V, D and J gene segments, which are 
termed recombination signal sequences (RSS) and serve as recognition sites for the 
recombination machinery111 (Fig. 5). RSS consist of a relatively conserved heptamer 
(always contiguous with the coding sequence) and nonamer separated by a non-
conserved spacer of either 12 or 23 base pairs (bp). Gene segments of a certain type 
in a particular locus are all flanked by RSS with the same spacer length, sometimes on 
both sides (D gene segments). Efficient recombination is only permitted between gene 
segments flanked by a 12 bp- and a 23 bp-spacer RSS. This restriction, referred to as 
“12/23 rule” ensues that the appropriate gene segments are joined within a given locus. 
For example in the Igh locus, V and J gene segments are flanked by 23 bp RSS and D 
segments are flanked on both sides by 12 bp RSS. The “12/23 rule” therefore dictates 
that rearrangements involving V gene segments will contain a D gene segment placed 
between a V and a J.
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Recombination is initiated by the lymphoid-specific RAG1 and RAG2 proteins, 
which cooperate to induce double-strand breaks (DSB) precisely at the 5’ border of 
the heptamer sequence in a 12 bp- and a 23 bp-spacer RSS111. This DSB generates 
coding ends that are covalently closed DNA hairpins (in V, D and J coding sequences) 
and signal ends that are blunt and 5’ phosphorylated (in the intervening DNA between 
two gene segments). The DSB generated by the RAG endonucleases are joined by 
a ubiquitously expressed set of non-homologous end-joining (NHEJ) proteins: Ku70, 
Ku80, DNA-dependent protein kinase (DNA-PK), X-ray repair cross-complementing 
factor 4 (Xrcc4), Cernunnos (also called XLF or Xrcc4-like factor), Artemis and DNA 
ligase IV111, 115. The DNA binding proteins Ku70 and Ku80 bind as a complex to DSB 
and recruit DNA-PK, which in turn recruits Artemis, Xrcc4, Cernunnos and DNA ligase 
IV. Activated DNA-PK activates the nuclease activity of Artemis leading to imprecise 
cleavage of coding ends hairpins thus generating palindromic sequences when filled 
in the complementary strand by DNA polymerases λ and μ (P-nucleotides addition). 
Opened hairpins can be additionally modified by insertion of non-template nucleotides 
(N-nucleotides addition) by terminal deoxynucleotidyl transferase (TdT) or deletion of 
nucleotides at coding ends. Finally, Xrcc4 and Cernunnos increase the activity of DNA 
ligase IV, responsible for sealing signal and coding joints. 
Of note, the DJ or VJ junctional sequences encode the CDR3 region of Ig and 
TCR chains111 and therefore, imprecisely joined borders between recombined gene 
segments contributes considerably to the diversity of BCR and TCR antigen-binding 
DJ  V  
Rag proteins  
12 bp-spacer RSS 
23 bp-spacer RSS 
NHEJ proteins 
Coding joints Signal joints 
Coding ends 
(hairpin) 
Signal ends 
(blunt) 
Figure 5. Schematic representation of V(D)J recombination mechanism. Rag proteins bind to 
12 bp- and 23 bp-spacer recombination signal sequences (RSS) and bring together the segments 
to be joined. The DNA is cleaved to create coding (hairpin) and signal (blunt) ends, where non-
homologous end-joining (NHEJ) proteins bind. Coding ends hairpins are cleaved at random and 
sequences can additionally be modified by insertion or deletion of nucleotides. NHEJ proteins are 
responsible for joining coding and signal ends, thereby forming coding and signal joints.
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specificities. However, removal and/or addition of nucleotides often disrupt the reading 
frame of the coding sequence beyond the joint. Such frameshifts might prevent protein 
expression or expression of a non-functional protein and therefore these rearrangements 
are termed out-of-frame or non-productive. Deficiency in any of the proteins involved 
in V(D)J recombination leads to incompletion of the process and results in severe 
combined immune deficiency (SCID), characterized by complete arrest of B and T cell 
development116.
V(D)J recombination regulation
Recombination at Ig and Tcr loci is regulated at three different levels: lineage-specificity, 
temporal order within a lineage and allelic exclusion. Allelic exclusion refers to a process 
by which each individual cell only expresses one allele of each antigen receptor loci, thus 
assuring the expression of a unique antigen receptor117. Several studies have suggested 
that regulation relies on developmental-stage specific changes in the availability of 
the recombination machinery and accessibility of appropriate antigen receptor loci for 
recombination118-120.
Transcriptional regulation limits expression of RAG proteins to B- and T-lineage 
cells within the hematopoietic system121-127, which accounts for lymphoid lineage 
specificity of recombination per se. During developmental progression, RAG expression 
is restricted to nonproliferating cells undergoing active rearrangement of antigen 
receptor loci. Particularly, initial productive Igh or Tcrβ rearrangement results in the cell-
cycle dependent downregulation of RAG expression during the clonal expansion stage 
that follows128-132. RAG expression is upregulated again once cells arrest proliferation for 
rearrangement of Igκ, Igλ or Tcrα loci. In the thymus, positive selection also results in 
the loss of RAG expression in CD4 SP or CD8 SP thymocytes133. In immature B cells, 
it is likely that BCR basal signalling inhibits RAG expression134. Nevertheless, in the 
presence of self antigens surface BCR expression is downregulated, which results in 
loss of basal signal that probably allows re-induction of RAG expression and edition of 
IgL chain loci135. Cell-cycle dependent regulation of RAG expression during lymphocyte 
development might be crucial for genomic stability and allelic exclusion at productively 
rearranged loci. 
Fully rearranged Ig and Tcr loci are only generated in developing B- and 
T-lymphocytes, respectively112-114. Moreover, rearrangement is ordered in a given 
lineage and, sometimes, within the locus – in the Igh or Tcrβ locus, D-J rearrangements 
precedes V-DJ rearrangement, followed by rearrangement of Igκ/Igλ or Tcrα locus. 
Finally, each individual B- or T-cell only generates one functional allele at each locus. 
Given that all rearranging gene segments are flanked by conserved RSS and use a 
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common RAG recombinase, regulation of RAG expression by itself cannot entirely 
account for the complete regulation of the V(D)J recombination process. Based on the 
observation that rearranging gene segments are concomitantly undergoing germline 
transcription136, it was proposed that changes in locus accessibility are on the basis of 
lineage-, developmental-stage- and allelic-specific regulation of V(D)J recombination. 
Later experiments confirmed this hypothesis by showing that isolated nuclei from cells 
at different developmental stages show appropriate locus sensitivity to in vitro cleavage 
by recombinant RAG proteins137. More recently, developmentally regulated antisense 
germline transcription in the Igh locus was implicated in the regulation of chromatin 
accessibility over the VH region, further supporting the accessibility hypothesis
138. Whether 
germline transcription itself can direct V(D)J recombination targeting by increasing locus 
accessibility was elegantly demonstrated for the Tcrα locus139, 140. These studies have 
demonstrated that germline transcription can instruct positive and negative alterations 
in Jα chromatin structure and target RAG proteins to the Jα region. In combination, these 
effects target initial Vα-Jα recombination to proximal Jα gene segments, thereby promoting 
the ordered usage of the Jα array and the selection of a diverse TCRα repertoire.
The molecular basis of locus accessibility likely involves subnuclear relocation, 
histone acetylation and/or methylation, DNA demethylation and locus contraction118-120. 
Accessibility is controlled through interactions between local cis-regulatory elements, 
such as promoters and enhancers, and developmental stage-specific transcription 
factors. Target deletion of these cis-regulatory elements in vivo have shown their 
important role in Ig and Tcr loci rearrangement maybe by initiating locus specific histone 
modifications and DNA demethylation141-145. Cytokine signalling can also result in the 
activation of locus accessibility. For example, IL-7R signalling has previously been 
implicated in histone acetylation at the Tcrδ146, 147, Tcrβ148 and Igh loci149, 150, although 
the role of IL-7R signalling in the control of chromatin accessibility at the Igh locus has 
recently been questioned151. 
To become accessible for rearrangement, the antigen receptor loci must undergo 
a series of chromatin changes that is best exemplified by the behaviour of Igh and Igκ loci 
in developing B cells. In early pro-B cells, the two alleles of Igh and Igκ loci are recruited 
from the periphery to the centre of the nucleus152. At the Igh locus, stepwise activation 
of the independently regulated DH-JH and VH domains likely accounts for ordered 
rearrangement. In pro-B cells poised to undergo DH-JH rearrangement, the DH and JH 
regions exhibit active histone acetylation and methylation marks153-155. At the late pro-B 
cell stage when VH-DJH joining occurs, accessibility over the VH region is achieved by 
histone acetylation149, 150, 153 and removal of inactive histone methylation marks156. In pre-B 
cells, one Igκ allele becomes preferentially packaged into an active chromatin structure 
Claudia Thesis_2.indd   24 17/10/2010   21:17:47
General introduction 25
C
ha
pt
er
 1
characterized by histone acetylation and methylation, while the other allele is recruited 
to repressive pericentromeric heterochromatin157-159. These events may actually underlie 
the process of Igκ allelic exclusion by rendering only a single allele available to DNA 
demethylation and, consequently, susceptible to rearrangement157-159. It was proposed 
that allelic differences in the timing of DNA replication randomly established at the early 
embryo direct the initial choice of the Igκ allele for rearrangement, as rearrangement 
takes place preferentially on the early-replicating allele in B cells160. Asynchronous, 
early replication of one Igh allele is also closely correlated with rearrangement of that 
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Figure 6. Schematic representation of the mouse Igh, Igκ and Igλ loci. (A) and (B) The Igh 
and Igκ loci are composed of > 100 variable (V) gene segments that span a 2.5 and 3.1 Mbp 
region, respectively. In contrast, diversity (D), joining (J) and constant (C) gene segments only 
comprise a relatively small region, 0.2 Mbp in the Igh locus and 0.1 Mbp in Igκ locus. In the Igh 
locus, the C region is encoded by eight different gene segments, each of them corresponding 
to the different classes or isotypes of the Ig heavy chain involved in different antibody effector 
functions. iEμ, intronic μ enhancer; iEκ, intronic κ enhancer; 3’Eκ, 3’ κ enhancer; MAR, matrix 
attachment region; Sis, silencer in the intervening sequence. (C) The organization of the Igλ locus 
is quite distinct from that of the Igh and Igκ loci. Each of the four Cλ gene segments contains their 
own unique Jλ gene segment and only two Vλ region gene segments, Vλ1 and Vλ2, are frequently 
utilized. Vλ2 is located approximately 60 kbp from Jλ2, and it will generally not recombine with 
other Jλ gene segments, while Vλ1, located 22 kbp from the Jλ1, will form joints with either Jλ1 or 
Jλ3.
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allele, although the mechanistic link between the two processes remains unclear160. In 
contrast, recent studies propose that monoallelic Vβ-to-DβJβ recombination events at the 
Tcrβ locus occur due to frequent stochastic, rather than directed, interactions of Tcrβ 
alleles with repressive nuclear compartments161. 
Following central relocation in the nucleus, the Igh and Igκ loci undergo large-
scale contraction by looping of individual chromatin domains in rearranging pro-B and 
small pre-B cells, respectively152, 162-164. In the Igh locus, approximately 195 VH gene 
segments span a 2.5 Mbp region and DH, JH and CH clusters located downstream only 
comprise 0.2 Mbp (Fig. 6). Likewise, the Igκ locus (3.2 Mbp) is composed of approximately 
120 Vκ gene segments that cover 3.1 Mbp, a Jκ cluster and a single constant region. 
Therefore, locus contraction may function to ensure that the multiple V gene segments 
scattered over a vast genomic region have equal opportunities to recombine with the 
DJH or Jκ region
165. In support of this hypothesis, the transcription factors Pax5, Yy1 and 
Ikaros have been shown to play a role in Igh locus contraction and in their absence, 
only the DH proximal VH genes recombine
166-168. Successful rearrangement of a Igh allele 
ultimately leads to pre-BCR signalling which engages allelic exclusion mechanisms via 
downregulation of IL-7R signalling, such as locus decontraction162, rapid repositioning 
of the non-productive Igh allele to repressive pericentromeric heterochromatin162 and 
histone deacetylation in the VH region
149, 150. At this stage, also one Igκ allele is recruited 
to the same repressive subnuclear compartment, even before the onset of recombination 
at the euchromatic Igκ allele. Recently it was shown that interchromossomal association 
between the Igκ and Igh loci at the pre-B cell stage is required to direct pericentromeric 
recruitment and locus decontraction of the non-productive Igh allele169. At later stages of 
B cell development productively rearranged Igh and Igκ alleles remain spatially discrete 
from heterochromatin, whereas non-productively or unrearranged alleles are positioned 
in pericentromeric heterochromatin thus ensuring monoallelic expression of Ig loci and 
single BCR specificity170. Reversible long-range interactions by chromatin looping in Tcrβ 
and Tcrα/δ loci and pericentromeric heterochromatin positioning of the non-productive 
Tcrβ allele has also been observed in thymocytes171. Therefore, locus contractions and 
subnuclear repositioning constitute general mechanisms of accessibility regulation at 
antigen receptor loci.
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PART II – LYMPHOCYTE FUNCTION
B cell functional subsets
Naïve B cells are generally divided into three functionally distinct mature B cell subsets: 
marginal zone (MZ) B cells, follicular (FO) B cells and B-1 B cells172, 173. Different subsets 
vary in terms of their origins and development, their location, their ability to migrate, and 
in the likelihood that they will be activated in a T cell-dependent or T cell-independent 
fashion.
 
Marginal zone and Follicular B cells
Immature B cells migrating from the BM can further mature in the spleen, through 
transient transitional – T1 and T2 – B cell stages, into either MZ or FO B cells. Because 
MZ and FO B cells have a common pathway of development they are also referred to 
as conventional or B-2 B cells. 
MZ B cells are sessile and reside in the vicinity of the marginal sinus at the 
interface between the non-lymphoid red pulp and the lymphoid white-pulp of the spleen, 
a region known as marginal zone. These cells are especially well positioned to rapidly 
respond to blood-born pathogens by forming short-lived IgM-secreting plasma cells in 
response to T cell-independent antigens such as polysaccharides174, 175. MZ B cells have 
the ability to self-renew and therefore have an unlimited lifespan. 
FO B cells have a defined lifespan that is measured in weeks, comprise most 
mature B cells and are recirculating cells that home mainly to B cell follicles in secondary 
lymphoid organs – spleen, lymph nodes and Peyer’s Patches. Follicles are always 
adjacent to T cell zones and therefore follicular B cells are particularly well suited to 
participate in T cell-dependent immune responses to protein antigens176, 177. Upon antigen 
exposure and help from cognate CD4+ T cells, FO B cells have the ability to differentiate 
into long-lived plasma cells that secrete high-affinity and class-switched (this is, IgG, 
IgE or IgA) antibodies. This occurs in discrete structures within the B cell follicles known 
as germinal centres, where B cells undergo extensive antigen-dependent proliferation, 
class switch recombination (CSR) and somatic hypermutation (SHM). CSR refers to the 
somatic DNA recombination events between switch regions located upstream of each 
CH gene segment in the Igh locus that allow B cells to switch from expressing IgM to 
expressing a different class or isotype of IgH chain178. Cytokines secreted by T helper 
(Th) cells direct CSR to certain switch regions in the Igh locus, thereby influencing 
the antibody isotypes produced by B cells during a germinal centre reaction. In the 
mouse, IL-4 preferentially induces switching to Cγ1 and Cε (IgG1 and IgE), whereas 
transforming growth factor (TGF)-β induces switching to Cγ2b (IgG2b) and Cα (IgA). 
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Th2 cells make both of these cytokines and also IL-5, which promotes IgA secretion 
from cells that have already undergone switching. Th1 cells are relatively poor initiators 
of antibody responses and IFN-γ preferentially induces switching to Cγ2c/a (IgG2c/a) 
and Cγ3 (IgG3). Because different IgH chain isotypes confer different antibody effector 
functions, the process of CSR is important to generate functional diversity among 
antigen-specific antibodies in the course of an immune response. Additional diversity 
within the expanding clone of B cells responding to antigen is generated by SHM, a 
unique mutation mechanism that is targeted to the V regions of rearranged Ig genes179. 
Combined with the selection for B cells that produce antibodies with highest affinity for 
antigen, SHM leads to affinity maturation of B cells in germinal centres.
B-1 B cells
B-1 B cells likely arise from precursors in the fetal liver and neonatal bone marrow and 
can be found predominantly in peritoneal and pleural cavities, were they are maintained 
by self-renewal. B-1 B cells are typically subdivided in B-1a and B-1b B cells. B-1a 
B cells spontaneously secrete the so called “natural antibodies” that constitute most 
of the serum IgM present in non-immunized mice. These “natural antibodies” display 
extensive polyreactivity, with low affinity to both self-antigens and common bacterial 
polysaccharides. Previously it was shown, using a mouse model of naturally generated 
autoreactive B cells, that the presence of self-antigen promotes B1a B cell accumulation 
in the peritoneal cavity and serum autoantibody secretion180. Importantly, this study 
provides evidence for positive seletion of B1a B cells on the basis of their autoreactivity. 
Studies on the relative contributions of B1a and B2 B cells during influenza virus infection 
highlight the importance of naturally occuring IgM antibodies as crucial and nonredudant 
components of the antiviral response181-183. In contrast to B1a B cells, B1b cells confer 
long-lasting and highly protective antibody responses by specifically recognizing T cell-
independent antigens present in many pathogenic bacteria184, 185. 
Differentiation of effector T cell subsets 
Mature CD4+ or CD8+ T cells that have not yet encountered their specific antigen 
recirculate between blood and peripheral lymphoid organs as naïve T cells. At sites of 
infection DCs take up antigen and are activated as part of the innate immune response, 
through receptors that signal the presence of pathogen constituents or by cytokines 
produced during the inflammatory response186. This induces their migration to local 
lymphoid tissue and their maturation into cells that are highly effective at presenting 
antigen to naïve T cells in the form of an antigen:MHC complex. Peptide antigens from 
intracellular pathogens that multiply in the cytoplasm are carried to the cell surface of 
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DCs by MHC class I (MHCI) molecules and presented to CD8+ T cells. Peptide antigens 
from pathogens multiplying in intracellular vesicules and those derived from extracellular 
pathogens, are carried to the cell surface by MHC class II (MHCII) molecules and 
presented to CD4+ T cells. Mature DCs are distinguished by the expression of high 
levels of surface co-stimulatory molecules, such as CD80 and CD86 that bind to the 
CD28 receptor on T cells. Simultaneous delivery of two independent signals by the 
same APC - an antigen-specific TCR signal and a co-stimulatory signal – is absolutely 
required for the activation of naïve T cells. This means that only activated APCs can 
initiate T cell responses, which is important because not all potentially self-reactive T 
cells are deleted in the thymus. Naïve T cells recognizing self-antigens in the absence 
of co-stimulation are not activated and instead are induced to enter a state of non-
responsiveness or anergy.
 T cell activation is characterized by clonal expansion of antigen-specific T cells 
and differentiation of CD4+ or CD8+ T cells into functionally distinct T helper or cytotoxic 
effector subsets, respectively. It is crucially dependent on the synthesis of IL-2 along with 
the α chain of the IL-2 receptor (also known as CD25) by activated T cells. Association 
of the IL-2 receptor α chain to the constitutively expressed β and γ chains in resting 
T cells confers high affinity to IL-2 and allows activated cells to respond to very low 
concentrations of IL-2. IL-2 signals through activation of Stat5 (signal transducer and 
activator of transcription 5) proteins to promote T cell proliferation and survival187. CD4+ 
T cell differentiation into different T helper lineages is determined by the cytokine milieu 
present during the initial proliferative phase of T cell activation188, whereas CD8+ T cells 
are already predestined to become cytotoxic T cells189, 190. 
T helper cell differentiation into subsets with unique cytokine expression 
profiles 
T helper cell differentiation is classically regarded as a dichotomy between two main 
cell types, termed Th1 and Th2188, 191 Fig. 7). Th1 cells produce IFN-γ as their signature 
cytokine and are predominantly involved in cell-mediated immunity against intracellular 
pathogens, through activation of macrophages and directing the production of opsonising 
antibodies by B cells (i.e. antibodies that trigger the elimination of pathogens by 
phagocytosis). In contrast, Th2 cells fail to produce IFN-γ and their signature cytokines 
are IL-4, IL-5 and IL-13 encoded by genes clustered in a Th2 cytokine locus, also 
containing the constitutively expressed Rad50 gene (Fig. 8). Th2 cells are the most 
effective activators of B cell proliferation and antibody production, thereby mediating 
humoral immunity essential for the eradication of extracellular pathogens.
The differentiation process of naïve CD4+ T cells into distinct T helper effector 
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subsets involves both TCR- and cytokine-mediated signalling188, 191, which are critical 
for early cytokine production and induction of master transcription factor expression. 
Cytokine-mediated signalling results in the activation of Stat proteins, which collaborates 
with master transcription factors in the regulation of distinct patterns of cytokine gene 
expression, selection of differentiated lineage cells by positive feedback loops and 
active repression of alternative lineage fates. Two major signalling pathways facilitate 
Th1 development, one involving IL-12/Stat4 and the other involving IFN-γ/Stat1/T-bet. 
Activated Stat4 can directly induce IFN-γ production and expression of IL-12Rβ2 and 
the T-box transcription factor T-bet during Th1 differentiation192, 193. Activation of Stat1 by 
IFN-γ is also important for the induction of T-bet during Th1 differentiation194, 195. T-bet is 
a major transcription factor for inducing IFN-γ production and T-bet-deficient CD4+ T cell 
have severe defects in Th1 cell differentiation196, 197. T-bet induces IFN-γ and IL12Rβ2 
expression, thus promoting selective Th1 cell expansion in response to IL-12198, 199. Th2 
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Figure 7. Differentiation of effector CD4+ T-cells subsets in the mouse. During activation in 
a particular cytokine milieu, naïve CD4+ T-cells may differentiate into one of several lineages of 
T helper (Th) cells, including Th1, Th2, Th17, and inducible regulatory T-cells (iTregs). Different 
differentiation programs triggered by TCR and cytokine signalling are mainly based on the 
activation of Stat proteins and induction of master transcription factors that collaborate in the 
regulation of unique patterns of cytokine production. However, cytokine production by Th cells 
might be more flexible than previously though and recently T follicular helper (Tfh), Th9 and Th22 
cells have been described. Whether these subsets represent distinct lineages remains to be 
elucidated. See Appendix for full-color figure.
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cytokine production is dependent on the transcription factor Gata3200, 201, which is rapidly 
induced by IL-4 through Stat6202-206. During the induction phase of Th2 polarization, 
early TCR-dependent and IL-4/Stat6-independent IL-4 transcription requires induction 
of Gata3 expression by TCR-signalling and activated Stat5 in response to IL-2207. Gata3 
expression is further enhanced by IL-4/Stat6 signalling and an auto-regulatory positive 
feedback loop208. In the absence of Gata3 Th2 differentiation is totally abolished209-211. 
In contrast, deletion of Gata3 from fully differentiated Th2 cells has only a modest effect 
on IL-4 production but completely blocks the production of IL-5 and IL-13210. Importantly, 
master regulators and Stat proteins collaborate with other transcription factors (for 
example, Runx1, Runx3, IFN regulatory factor (Irf) 4, Irf1, Gfi-1, Ikaros and c-Maf) 
and signalling pathways (Ca2+/Nfat, NF-κB and Notch signalling) in the fine-tuning of T 
helper cell differentiation and function188. Of interest, different Notch ligands on APCs 
have been proposed to instruct distinct T helper cell fates212. Particularly, Notch appears 
to direct Th2 differentiation by directly regulating the expression of Gata3 and Il4212-214. 
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Figure 8. Schematic representation of the mouse Ifng and Th2 cytokine loci. The Ifng and 
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More recently, Th17 cells have been described as a distinct T helper subset 
that does not express T-bet or Gata3 and which differentiation is inhibited by IFN-γ or 
IL-4215-219 (Fig. 7). These cells are characterized by the production of IL-17A, IL-17F 
and IL-22 as signature cytokines and contribute to host defense against extracellular 
pathogens particularly at mucosal surfaces. In mice, both TGF-β and IL-6 are required 
to drive Th17 differentiation through activation Stat3 and induction of the retinoid related 
orphan receptor-γt (RORγt)220-226. The residual IL-17 production in RORγt-deficient cells 
appears to be dependent on the activity of a related nuclear receptor RORα, which 
is also upregulated in Th17 cells227. Th17 cells are also good producers of IL-21 and 
express IL-23R as part of their differentiation process224-226, 228. Similarly to IL-6, IL-21 and 
IL-23 also signal through activation of Stat3 and in Stat3-deficient mice IL-17 production 
in CD4+ T cells is abolished224-226, 228-231. IL-21 and IL-23 possibly function in a positive 
feedback loop to promote expansion and terminal differentiation of Th17 cells at later 
stages. Stat4 also mediates IL-23 signals and was also shown to direct the development 
of Th17 cells230, 232.
 Recent studies on T helper cell differentiation have revealed more flexibility 
in cytokine production than predicted by conventional models of T helper cell lineage 
commitment (Fig. 7).  One example of T helper cell phenotype plasticity is that Th2 
cells can acquire IL-9-producing capacity in the presence of TGF-β via Irf4 activation, 
being thereby reprogrammed into a “Th9” pathway233-235. Similarly, differentiation of T 
helper cells producing IL-22 (“Th22”) and not IL-17 in response to IL-6 and TGF-β has 
recently been identified and shown to depend on the transcription factors RORγt and 
aryl hydrocarbon hydrocarbon receptor (AHR)236, 237. T follicular helper (Tfh) are yet 
another CD4+ T cell population with a particular function, helping B cells make antibody 
responses to T cell-dependent antigen during a germinal center reaction (see below)238, 
239. Tfh cells express Bcl6 as their master transcription factor and may produce Th1, Th2 
or Th17 cytokines, depending on the conditions of their initial activation240-244. Whether Tfh 
cells are a distinct lineage (essentially parallel to Th1, Th2 or Th17 cells) or a particular 
phenotypic state of some or all of these effector lineages remains unresolved.
Regulation of lineage-specific patterns of cytokine gene expression: the Th1/Th2 
paradigm
During T helper cell differentiation, fully polarized T helper cells are generated through 
lineage commitment and active suppression of alternative lineage fates. The mutual 
exclusivity among master transcription factors and Stat proteins regulated at the 
transcriptional levels and through suppressive protein-protein interactions appears to be 
one of the main mechanisms for cross-regulation during T helper differentiation188, 191. For 
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example, Gata3 suppresses Th1 development by downregulation of Stat4193, 245 and T-bet 
restrains Th2 development by inhibiting Gata3 expression192 and physically interacting 
with Gata3 thereby repressing its function246. However, more precise control of gene 
expression during T helper differentiation is achieved through epigenetic processes, 
which facilitate heritable and stable programs of gene expression, while preserving the 
potential for these programs to be modified in response to environmental changes247-
249. These include chromatin remodelling (induction of DNaseI hypersensitive sites by 
altering nucleossome positioning) through histone acetylation and/or methylation and 
DNA demethylation at critical cis-regulatory elements present in cytokine loci (Fig. 8). 
Changes to high-order chromatin structure at Ifng and Th2 cytokine loci, have also been 
implicated in the coordinate regulation of cytokine gene expression.
In naïve CD4+ T cells, low-level expression of Th2 cytokines and IFN-γ can be 
detected upon activation by TCR ligation250, 251, which is supported by both permissive 
and repressive histone modifications at both loci247, 248. This bivalent epigenetic state 
may help to “poise” the Th2 cytokine and Ifng loci for either expression or complete 
silencing during T helper differentiation. In the Th2 locus, Th2 cytokine genes promoters 
and the Th2 locus control region (LCR) come into close spatial proximity to form a 
higher-order chromatin structure, further suggesting that early expression of the Th2 
cytokines in naive T cells is supported by an initial “poised” three-dimensional chromatin 
configuration252, 253 (Fig. 9). Interchromosomal interactions between the Ifng and the 
Th2 cytokine locus have also been described in naïve CD4+ T cells and are apparently 
Il13 
Rad50 
Il4 
Kif3a 
Il5 
Th2 LCR 
Fibroblasts 
Rad50 
Il13 
Il4 
Kif3a 
Il5 
+ T-cells 
Th2 LCR 
Rad50 
Il13 
Il4 
Kif3a 
Il5 
Th2 cells 
Th2 LCR 
Satb1 
Gata3 
Stat6 
Figure 9. “Poised” chromatin configuration in the Th2 cytokine loci. An initial chromatin 
configuration is detected in non T-cell lineage cells, such as fibroblasts, characterized by close 
spatial proximity between Th2 cytokine gene promoters. In naïve CD4+ T-cells, the Th2 locus 
control region (LCR) further contributes to this higher order chromatin conformation to generate a 
“poised” state. Upon Th2 differentiation, recruitment of cell-specific factors, such as Gata3, Stat6 
or Satb1, to this “poised” chromatin configuration potentiates the coordinate expression of Th2 
cytokine genes. Figure adapter from253.
Claudia Thesis_2.indd   33 17/10/2010   21:17:49
34 Chapter 1
lost upon Th1 or Th2 cell differentiation254. However, unequivocal data required to prove 
that interchromosomal cytokine gene regulation truly represents another level of control 
within the nucleus is lacking255. Upon Th2 differentiation, a substantial increase in the 
transcriptional activity of Il4, Il5 and Il13 and concomitant silencing of Ifng are observed. 
The converse pattern of gene activation and silencing is present in differentiating Th1 
cells. Several studies have demonstrated that cell type-specific transcription factors and 
Stat proteins binding to cis-regulatory elements of cytokine genes directs subsequent 
recruitment of chromatin modifying proteins, which initiate substantial and reciprocal 
alterations in the chromatin structure of the Th2 cytokine and Ifng loci247-249. Likewise, 
both Stat4 and T-bet have been implicated in permissive histone modifications 
(acetylation and/or methylation) at the Ifng locus196, 198, 256-261. Similarly, Stat6 and Gata3 
are involved in Th2 locus permissive histone modifications and DNA demethylation208, 
257, 262-268. By contrast, Stat6 and Gata3 binding to the Ifng locus when naïve CD4+ T cells 
differentiate into Th2 cells is associated with increased acquisition of repressive histone 
methylation marks269. During Th2 differentiation, increased DNA methylation at the Ifng 
locus is also observed269-271. In addition, T-bet is required for the silencing of Il4 in Th1 
cells251, 260, 272, 273. During Th1 and Th2 differentiation, chromatin looping at Ifng and Th2 
cytokine loci has also proven to be essential for cytokine gene expression. Indeed, both 
Stat6 and Gata3 are responsible for the establishment and/or maintenance of a “poised” 
chromatin configuration in the Th2 cytokine locus of developing Th2 cells252, 253. Further 
changes to this conformation occur through Th2-specific triggering of Satb1 (special AT-
rich binding protein 1, an architectural factor) expression, which promotes the formation 
of additional loops and more intimate interactions between cis-regulatory elements and 
the Il4, Il5 and Il13 promoters274. In the absence of Satb1 these changes are lost and 
Th2 cytokine expression is compromised274. In Th1 cells, T-bet has also been implicated 
in the formation of Th1-specific Ifng locus architecture that brings cis-regulatory regions 
in close proximity to the Ifng promoter275. Finally, the expression of T-bet and Gata3 
is not essential but does help to maintain the Th1- and Th2-specific gene expression 
program, respectively199, 210, 211, 265, 276. Although cytokine gene expression can be partially 
sustained through hereditable epigenetic modifications, it benefits from collaboration 
between lineage-specifying transcription factors and epigenetic processes. 
Differentiation of cytotoxic T cells
Naïve CD8+ T cells differentiate into cytotoxic T cells in response to IL-2 that drives their 
proliferation and differentiation189, 190. Cytotoxic T cells are involved in the destruction 
of cells infected with virus or other cytosolic pathogens and tumor cells. The main 
mechanism of cytotoxic T cell action is the release of specialized lytic granules upon 
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recognition of antigen:MHCI complexes on the surface of a target cell277. These granules 
contain three distinct classes of cytotoxic proteins required for effective target cell killing: 
perforin (forms transmembrane pores in target cell membranes), granzymes (induces 
apoptosis) and granulysin (induces apoptosis and also has antimicrobial action). 
Cytotoxic T cells also act by releasing cytokine such as IFN-γ, which can limit the spread 
of cytoxolic pathogens in a variety of ways278, 279. Besides being involved in the activation 
of macrophages, IFN-γ inhibits viral replication directly, induces the expression of MHCI 
molecules and other proteins involved in MHCI antigen presentation pathway, and 
interferes with tryptophan metabolism in target cells thus possibly killing intracellular 
pathogens by starvation. Two highly homologous T-box transcription factors, T-bet and 
Eomesodermin (Eomes) expressed in effector T cells act in concert to promote IFN-γ, 
granzyme and perforin production197, 280, 281.
Other T cell subsets 
Regulatory T cells
In contrast to the protective functions of T helper cells, inappropriate Th2 cell responses 
give rise to allergic diseases, whereas autoimmune diseases result from inappropriate 
Th1 and Th-17 cell responses. Regulatory T (Treg) cells restrain excessive effector T cell 
responses and thus account for the maintenance of immune homeostasis and prevention 
of immunopathology282, 283. Treg cells are naturally present in the immune system as a 
functionally distinct CD4+ T cell population generated in the thymus that express CD25 
and the forkhead transcription factor Foxp3, essential for their function284-289. In addition, 
Treg cells can also be induced to differentiate from naïve CD4+ T cells in the periphery 
when activated in the presence of TGF-β, which results in the upregulation of Foxp3. 
The differentiation of both induced Treg (iTreg) cells and Th17 cells is developmentally 
related with respect to TGF-β requirement and IL-6 critically determines the balance 
between the two subsets by downregulating Foxp3 in differentiating and differentiated 
Treg cells220-222. Treg cells exert suppression by cell-contact mechanims (for example, 
killing of APCs or effector cells by means of granzyme or perforin) as well as mechanisms 
mediated by soluble factors (for example, secretion of immunosuppressive cytokines 
such as IL-10 or TGF-β or deprivation of cytokines such as IL-2 necessary for expansion 
and/or survival of effector cells)290.
γδ T cells 
γδ T cells represent only a minor but distinct subset of peripheral T cells present in 
the spleen, lymph nodes, epithelia and mucosa291, 292. The functional role of γδ T cells 
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remains obscure, although considerable insight comes from recent studies in mouse 
models of disease. Functional development of γδ T cells begins in the thymus, where 
certain subsets already exhibit differential competence for effector cytokine production293-
299. In the periphery, most γδ T cells recirculate and temporarily reside in lymphoid 
tissues where they exert their functional effects as polyclonal unselected populations. 
Nevertheless two TCR-defined γδ T cells subsets directly colonize peripheral epithelia 
and mucosa, and exert relatively uniform and defined functions300-303. Polyclonal 
activation and functional induction of intrathymic committed γδ T cells in the periphery 
might require cytokines and also TCR-ligand interactions, although putative ligands are 
still unknown299, 301, 304-308. γδ T cells often respond faster than αβ T cells and can assume 
both an effector or a regulatory role in immune responses. They can also support and 
regulate antibody production by B cells. Recently, IL-17-producing γδ T cells have been 
implicated in host defense to Mycobacterium tuberculosis infection309. 
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PART III – CTCF
During lymphocyte development and differentiation into functional effector subsets, 
proper spatial and temporal control of gene expression is achieved through the 
coordinate binding of lineage-specific transcription factors to cis-regulatory elements. In 
many developmentally regulated gene clusters, as for example the antigen receptor and 
T helper cytokine gene loci, gene regulation is particularly complex165, 248. This involves 
cell-type-specific interactions over large genomic distances between remote enhancers, 
silencers or LCRs and the promoters of particular genes. Regulation of higher-order 
chromatin structures is mediated by protein complexes composed of lineage-specific 
transcription factors and ubiquitously expressed proteins. For instance, the erythroid 
transcription factor Gata1 has been shown to be part of a complex composed of the 
hematopoietic factors Lmo-2, Tal1 and E2A and the ubiquitous nuclear protein Ldb1310-
312, involved in long-range chromatin interactions at the mouse β-globin locus313, 314. 
The CCCTC-binding factor (CTCF) is a leading candidate for the regulation of gene 
expression at complex loci during lymphocyte development and differentiation into 
functional effector subsets.
General introduction into the biology of CTCF: a multivalent factor
CTCF is an ubiquitously expressed and highly conserved 11-zinc finger DNA-binding 
protein implicated in a variety of regulatory functions including transcriptional activation/
repression, enhancer blocking and/or barrier gene insulation, hormone-responsive 
gene silencing, genomic imprinting, X chromossome inactivation and long-range 
chromatin interactions315, 316. Recent studies have mapped genome-wide CTCF 
occupancy and distribution patterns in multiple divergent cell types by employing 
chromatin immunoprecipitation (ChIP) in combination with tilling arrays (ChIP-chip) or 
high-throughput sequencing (ChIP-Seq). In human fibroblasts 13,804 CTCF-binding 
sites were reported317 using ChIP-chip while ChIP-Seq analysis identified 20,262 CTCF-
binding sites in resting human CD4+ T cells318. ChIP-Seq analysis revealed 39,609 
CTCF-binding sites in mouse embryonic stem cells319, as well as 19,308 and 19,572 
in HeLa and Jurkat cells, respectively320. Importantly, these studies have enabled the 
identification of a ~11-15 bp core consensus sequence for CTCF-binding sites, although 
initially CTCF was shown to bind to highly divergent 50-60 bp sequences through the 
combinatorial use of different sets of its 11 zinc fingers315. In fact, it was proposed 
that “during the formation of a CTCF-DNA complex both DNA and CTCF allosterically 
customize their conformation to engage different zinc fingers either for making base 
contacts or to make a target-specific surface that determines interactions between 
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CTCF and other proteins”315. This property would be on the basis of CTCF versatility 
or multiple functional roles in gene regulation. In line with this, CTCF binding partners 
that have been identified to date are involved in multiple processes in the nucleus and 
include transcription factors (Yy1, Kaiso and YB-1)321-323, chromatin modifying proteins 
(Sin3a, CHD8, Suz12)324-326, the nucleolar protein nucleophosmin327, RNA polymerase 
II328 and poly(ADP-ribose) polymerase-1 (PARP1)329.
Genome-wide CTCF binding patterns suggest a role for CTCF distinct from 
that of canonical transcription factors316. CTCF distribution strongly correlates with gene 
density but not with transcriptional start sites and the binding pattern of CTCF does 
not appear to predict cell-specific gene expression levels319. Domains with few or no 
CTCF-binding sites tend to include clusters of transcriptionally coregulated genes or 
developmentally related genes (for example, olfactory receptor gene clusters or keratin-
associated protein gene clusters), whereby these regions are often flanked by CTCF-
binding sites317. CTCF-rich regions contain genes displaying extensive alternative 
promoter usage (for example, Tcrβ, Tcrα/δ and Igλ L chain loci)317. Prior to genome-
wide queries, many studies have suggested that CTCF is the archetypal vertebrate 
protein that binds insulator sequences. Insulators are genomic elements that affect 
gene expression by blocking the inappropriate communication between neighboring 
regulatory elements (enhancer-blocking insulators) and preventing the spread of 
repressive heterochromatin from adjacent sequences (barrier insulators)330. The first 
link between CTCF and enhancer-blocking gene insulation was proposed based on the 
discovery that CTCF binds to the 5’HS4 insulator sequence upstream of the chicken 
β-globin locus331 and another insulator sequence at the 3’end of this domain332. CTCF 
mediated insulator activity has been predicted at several other sites including the H19/
Igf2 genes imprinted control region (ICR)333-336, the DM1 locus337 and the boundaries 
of domains that escape X chromosome inactivation338. More recently, computational 
analyses have been employed to show that CTCF binds to highly conserved non-coding 
elements across 12 mammalian species, which provided evidence supporting a global 
role for CTCF as an insulator protein339. Although CTCF is generally considered to 
function via enhancer-blocking mechanisms, genome-wide data sets also uncovered a 
small proportion of CTCF-binding sites at the boundaries between active and repressive 
chromatin domains, which can reflect a role for CTCF in barrier insulation318, 320. 
General introduction into CTCF function in particular loci
CTCF-mediated gene insulation via chromatin loops
Enhancer-blocking CTCF-driven insulation may occur through the formation of long-
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range chromatin interactions or chromatin loops. A recent study has provided the 
first direct evidence that loop formation can occur via contact between two CTCF-
bound insulators in vivo340. This was shown, by inserting the human β-globin HS5 (the 
orthologue of the CTCF-dependent chicken HS4 insulator) between the mouse β-globin 
LCR and downstream genes, which results in the formation of a new chromatin loop 
with endogenous HS5 that topologically isolates the LCR and disrupt β-globin gene 
transcription. Moreover, at the imprinted H19/Igf2 locus CTCF-mediated enhancer-
blocking insulation have been demonstrated to occur via long-range chromatin 
interactions in the native genomic context341, 342 (Fig. 10). CTCF is considered to play 
a critical role in the establishment and maintenance of allele-specific DNA methylation 
imprints and parent-of-origin H19 and Igf2 gene expression patterns during development. 
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Figure 10. Schematic representation of the mouse Igf2/H19 locus. The maternally expressed 
noncoding H19 gene (A) is located approximately 90 Kbp downstream from the gene encoding 
Insulin-like growth factor 2 (Igf2) that is expressed exclusively from the paternal allele (B). The 
imprinting control region (ICR) ~2 Kbp upstream of H19 contains four CTCF binding sites and 
is essential for the regulation of the entire locus. Differentially methylated regions (DMRs) such 
as DMR1 upstream of Igf2 promoters and DMR2 within Igf2 exon 6, act in concert to regulate 
reciprocal, allele-specific expression patterns from a shared set of downstream enhancers at 8 Kbp 
(Ee, endodermal tissue enhancer) and 25 Kbp (Em, mesodermal tissue enhancer) downstream of 
the H19 gene. Allele-specific patterns of CTCF binding, DNA methylation (–CH3) and chromatin 
looping account for parent-of-origin H19 and Igf2 gene expression patterns during development. 
Figure adapter from316. See Appendix for full-color figure.
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Four methylation-sensitive CTCF-binding sites are located in the ICR, immediately 
upstream of the H19 gene. On the maternal allele CTCF binds to the unmethylated ICR 
to form a tightly coiled chromatin loop structure around the Igf2 gene, thereby making 
the Igf2 promoters inaccessible to the enhancers downstream of H19. By contrast, on 
the paternal allele the ICR is methylated, which abrogates CTCF binding and ICR-
mediated insulation resulting in functional communication between the Igf2 promoters 
and the enhancers in order to activate Igf2 expression. H19 is only expressed from the 
maternal allele, since loss of CTCF binding to the methylated ICR is thought to silence 
H19 on the paternal allele due to promoter methylation. 
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Figure 11. Schematic representation of the mouse β-globin locus. (A) Four globin genes 
are embedded within a larger olfactory receptor (OR) gene cluster. Developmentally regulated 
globin expression (εy and βh1 in primitive erythroid cells; β-major (βmaj) and β-minor (βmin) in 
definitive erythroid cells) is regulated in part by a series of cis-regulatory elements surrounding 
the locus (indicated by arrows). An upstream locus control region (LCR) containing six DNaseI 
hypersensitive sites (HS) is required for high-level transcription. Three CTCF binding sites have 
been identified upstream (5’HS85, 5’HS62/60 and 5’HS5) and one 20 Kbp downstream (3’HS1) of 
globin genes. (B) Cell type-specific CTCF-mediated intrachromosomal interactions in the mouse 
β-globin locus. Although loops are illustrated by CTCF multimerization, it is not clear whether 
CTCF binds directly to each site or through interaction with other proteins that are not represented 
for simplicity. In definitive erythroid cells full expression of, for example, the βmaj gene depends 
on stable LCR-gene contacts. Figure adapter from316. See Appendix for full-color figure.
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CTCF-based chromatin loops beyond gene insulation?
CTCF-based intrachromossomal interactions between distal regulatory elements have 
also been reported at other developmentally regulated gene clusters, such as the 
β-globin and the MCHII loci. CTCF binds to three sites upstream (5’HS85, 5’HS62/60 
and 5’HS5 in the LCR) and one downstream (3’HS1) of the mouse β-globin locus in a 
cell-type specific manner343-345 (Fig. 11). During erythroid differentiation, CTCF-bound 
regulatory sequences throughout the β-globin locus came into close spatial proximity 
to form an “active chromatin hub” where stage-specific globin genes also interact with 
the LCR resulting in looping-out of transcriptionally silent isoforms345-347. Conditional 
CTCF deletion or mutation of the 3’HS1 CTCF-binding site results in disruption of 
CTCF contacts in erythroid progenitors but surprisingly has no effects on the kinetics 
of levels of globin gene expression during erythroid differentiation345. One explantion 
could be the redundacy of chromatin contacts in the β-globin locus that may not be 
readily abrogated by mutations in one regulatory element. The functional significance of 
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Figure 12. Schematic representation of the human MHCII  locus.
In the human major histocompatibility complex class II (MHCII) locus, CTCF binds to the XL9 
enhancer element between two coregulated genes, HLA-DRB1 and HLA-DQA1, driven by 
divergent promoters. Transcription factors RFX, CREB and NF-Y bind to regulatory sequences 
within the proximal promoter of MHCII genes when they are transcriptionally inactive. Interferon-γ 
(IFN-γ) treatment induces transcription in non-expressing cell types by upregulating the non-
DNA binding coactivator CIITA, which subsequently forms an heterodimer with RFX-CREB-NF-
Y-bound promoters and the CTCF-bound enhancer in parallel with HLA-DRB1 and HLA-DQA1 
gene activation. Figure adapter from316. See Appendix for full-color figure.
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CTCF-mediated insulation at the 3’HS1 and 5’HS5 of the β-globin locus is also unclear. 
Genetic disruption of CTCF-binding to HS1 has no effect on the transcription of the 
neighbouring olfactory receptor genes345 and deletion of 3’HS1 and 5’HS5 results in 
normal globin gene expression348, 349. 
Likewise, at the human MHCII locus CTCF may not function as a canonical 
enhancer-blocking insulator either. CTCF binds to the intergenic enhancer XL9 that 
coregulates the expression of the MHCII genes HLA-DRB1 and HLA-DQA1 and shows 
enhancer-blocking activity in vitro350 (Fig. 12). In non-MHCII-expressing epithelial 
cells, stimulation with IFN-γ results in the expression of the transcriptional coactivator 
CIITA and the concurrent formation of chromatin interactions between XL9 and the 
two divergent promoters upstream of HLA-DRB1 and HLA-DQA1. Chromatin loop 
formation is required for gene expression and depends on XL9-bound CTCF, the non-
DNA-binding coactivator CIITA and the transcription factor RFX constitutively bound to 
regulatory sequences within the proximal promoter of HLA-DRB1 and HLA-DQA1 genes. 
Therefore, in the human MHCII locus CTCF is involved in the control of gene expression 
through the ability to form transcriptionally functional chromatin loops. Nevertheless, we 
cannot rule out the possibility that XL9-bound CTCF is blocking inappropriate regulatory 
elements contained outside the HLA-DRB1 and HLA-DQA1 region. 
CTCF as a genome-wide organizer of chromatin architecture
Mechanistic insight into CTCF-mediated chromatin loop formation has recently been 
uncovered by genome-wide studies showing that cohesin proteins are highly enriched 
at most CTCF-binding sites351-354. CTCF is required for cohesin recruitment to these 
sites because depletion of CTCF leads to absence of cohesin binding. Because cohesin 
proteins are though to coalesce into a ring-like structure that mediates sister chromatid 
cohesion during mitosis, it is tempting to speculate that a similar mechanism could 
facilitate the stabilization of CTCF-based chromatin loops. In support of this notion, 
cohesin proteins are required for CTCF-mediated long-range intrachromosomal 
interactions at the developmentally regulated IFNg locus355. Functional interaction 
between cohesins and CTCF is also observed at sites where CTCF was previously 
shown to have enhancer-blocking insulator activity, such as the HS4 of the chicken 
β-globin locus and H19/Igf2 locus ICR351, 352. The discovery that a high proportion of 
CTCF-binding sites are shared with cohesin provide a strong indication that cohesin and 
CTCF might act in concert at many genomic locations to facilitate the formation of long-
range chromatin interactions. Together with unique CTCF distribution patterns genome-
wide these results implicate CTCF as a genome-wide organizer of chromatin architecture, 
with insulation and/or downstream effects in transcription a secondary consequence of 
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the genomic context of the endogenous locus316. In line with this view, recent studies 
have implicated CTCF in interchromosomal interactions in the maternal (CTCF-bound) 
H19/Igf2 ICR allele356-358 or between homologous X chromosomes during the process of 
X chromosome inactivation359, 360. Although the functional significance of CTCF-mediated 
interchromosomal contacts remains to be fully elucidated, it has been suggested that, at 
least at the H19/Igf2 ICR, these may function to control epigenetic information in trans 356, 
358. CTCF has also been suggested to demarcate the boundaries of “lamina-associated 
domains” (LADs), genomic regions localized to the nuclear periphery via interaction 
with the nuclear lamina protein LaminB1 that correlate with markedly decreased gene 
expression361. One example is the CTCF-binding site located 10 Kb upstream of the 
human c-myc gene that maps to a LAD border, which has been implicated in nuclear 
organization and locus protection from DNA methylation362, 363. Genome-wide CTCF-
binding sites also reveal a high percentage of CTCF binding sites in exons, introns 
and 5’ or 3’ untranslated regions (UTRs), suggesting that intRagenic and/or single 
gene loops may also have functional roles317-320, 339. For example, in the human c-Myc 
gene one CTCF-binding site found immediately downstream of the major P2 promoter 
maps precisely within the region of RNA polymerase II pausing and release364. It is also 
plausible that intragenic and/or single gene loop formation facilitates the coordination 
of RNA processing or transcriptional reinitiation. Nevertheless, the possibility remains 
that CTCF can function in the regulation of gene expression via looping-independent 
mechanisms by simply recruiting proteins involved in transcriptional activation and/
or repression, as for example histone modifying proteins324, 326, chromatin remodeling 
factors325 or RNA polymerase II328. 
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AIM OF THE THESIS
Lymphocyte development and differentiation into functional effector subsets provide an 
excellent model system for the study of developmentally regulated gene expression. 
In particular, regulation of antigen receptor and T helper cytokine gene loci is largely 
determined by the coordinate binding of lineage-specific transcription factors to cis-
regulatory elements located over considerable genomic distances. Emerging evidence 
suggests that higher-order chromatin structure is part of the mechanism of gene regulation 
at these complex loci. CTCF is a highly conserved and ubiquitously expressed DNA-
binding protein implicated in genome-wide organization of chromatin architecture and 
non-canonical gene regulatory functions. Direct evidence for CTCF-mediated higher-
order chromatin structure has been reported at several developmentally regulated 
gene loci, including the mouse β-globin and H19/Igf2 loci and the human MHCII locus. 
Cell-type-specific regulation of chromatin looping possibly arises through cooperation 
between the ubiquitous architectural factor CTCF and lineage-specific transcription 
factors. This thesis describes studies aimed to unravel the function of CTCF throughout 
B- and T-lymphocyte development and T helper cell differentiation, while further exploring 
the role of the T-cell lineage transcription factor Gata3. 
The role of CTCF in essential cellular processes as proliferation, survival 
and differentiation during lymphocyte development, benefits from in vivo analyzes. 
Particularly, we intended to analyze CTCF function in the regulation of antigen receptor 
and T helper cytokine gene loci in the in vivo context of cellular differentiation and 
function. Therefore, a conditional Ctcf knockout was generated for B- and T-lymphocytes 
using the Cre-loxP system in Chapter 2-4. As developmental arrest was expected upon 
Ctcf deletion, differentiation was rescued by Ig trangenes (B-cell lineage, Chapter 2) or 
different Cre-expressing transgenic lines (T cell lineage, Chapter 3 and 4). This allowed 
us to investigate in vivo function of CTCF at different stages of lymphocyte development 
and in the two different lymphocyte lineages, to get a comprehensive analysis of the 
role of CTCF. Importantly, the Ctcf conditional knockout mouse model provided the 
unique and exciting opportunity to study the consequences of CTCF deletion in the 
fidelity of Igκ locus cis-regulatory elements interactions genome-wide in an in vivo 
context (Chapter 2). Furthermore, the role of CTCF in the differentiation of naïve CD4+ 
T-cells into different T helper cell subsets in vitro could be compared with in vivo immune 
responses (Chapter 4).
In Chapters 5 and 6 the molecular mechanisms underlying the role of Gata3 in 
the T-cell lineage by enforced Gata3 expression are uncovered. Chapter 5 describes 
Gata3 target genes in DP thymocytes that may underpin its role in positive selection 
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towards CD4 T cell lineage. Chapter 6 shows how Gata3, the master regulator of Th2 
differentiation, affects the differentiation of CD4 T cells towards the recently identified 
Th17 lineage. We discuss the implications of the main findings described in Chapters 
2-6 and provide directions for future research in Chapter 7.
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ABSTRACT
The 11-zinc finger protein CCCTC-binding factor (CTCF) is a highly conserved protein, 
involved in imprinting, long-range chromatin interactions and transcription. To investigate 
its function in vivo, we generated mice with a conditional Ctcf knockout allele. Consistent 
with a previous report, we find that ubiquitous ablation of the Ctcf gene results in early 
embryonic lethality. Tissue-specific inactivation of CTCF in thymocytes specifically 
hampers the differentiation of αβ T cells and causes accumulation of late double-negative 
and immature single-positive cells in the thymus of mice. These cells are normally large 
and actively cycling, and contain elevated amounts of CTCF. In Ctcf knockout animals, 
however, these cells are small and blocked in the cell cycle due to increased expression 
of the cyclin-CDK inhibitors p21 and p27. Taken together, our results show that CTCF 
is required in a dose-dependent manner and is involved in cell cycle progression of αβ 
T cells in the thymus. We propose that CTCF positively regulates cell growth in rapidly 
dividing thymocytes so that appropriate number of cells is generated before positive and 
negative selection in the thymus.
INTRODUCTION
The 11-zinc finger protein CCCTC-binding factor (CTCF) is a widely expressed and 
highly conserved transcriptional regulator implicated in many important processes in 
the nucleus (for reviews, see1, 2). In line with this view, murine CTCF is essential for 
early embryonic development3. CTCF is the archetypal vertebrate protein that binds 
insulator sequences, DNA elements that have the ability to protect a gene from outside 
influences4. Its methylation-sensitive interaction with the imprinting control region of 
the H19/insulin-like growth factor 2 (Igf2) genes indeed controls enhancer access3, 5, 6. 
CTCF-mediated insulator activity has been predicted at several other sites including the 
DM1 locus and boundaries of domains that escape X-chromosome inactivation7, 8. We 
have shown that CTCF mediates long-range chromatin interactions and regulates local 
histone modifications in the β-globin locus9. Evidence has furthermore been presented 
for a function of CTCF in inter-chromosomal interactions between Igf2 and other loci10. 
During mitosis, CTCF remains bound to mitotic chromosomes, possibly facilitating 
reformation of higher-order chromatin loops after mitosis11. Taken together, these 
data suggest that CTCF is an essential organizer of imprinting, long-range chromatin 
interactions and transcription.
Genome-wide mapping of CTCF-binding sites revealed ~14 000 sites, whose 
distribution correlates with genes but not with transcriptional start sites12. Strikingly, 
the 20-bp consensus motif found in the majority of the sites is virtually identical to 
a consensus sequence (called LM2*), which is bound by CTCF and is found in ~15 
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000 conserved non-coding elements (CNEs) in the human genome13. Thus, CTCF-
binding sites are part of CNEs, which are conserved across species and appear to 
have regulatory functions. High-resolution profiling of histone methylation in the human 
genome showed that CTCF sites mark boundaries of histone methylation domains14 
consistent with a function of CTCF as an insulator protein. Genome-wide analyses also 
revealed CTCF-binding sites near genes displaying extensive alternative promoter 
usage, including Protocadherin γ, the Immunoglobulin (IG) λ light chain and the T cell 
receptor (TCR) α/δ and β chain loci. In mice, CTCF-dependent insulators were found 
downstream of the Tcrα/δ and the Ig heavy chain loci15, 16. Moreover, in T cells, CTCF-
binding sites overlap significantly with DNAse I hypersensitive sites (HS), suggesting 
that CTCF is somehow involved in global T-cell gene expression17. These data imply 
an important function of CTCF in lymphocytes, in particular in the regulation of gene 
transcription and recombination targeting in complex loci.
T-cell progenitors differentiate in the thymus, where early precursors (lacking 
the cell surface markers CD4 and CD8 and therefore termed double-negative (DN) 
cells) develop into mature CD4 or CD8 single-positive (SP) T cells, following a regulated 
differentiation programme (see Supplementary Fig. 1 for a schematic overview; for 
review, see18). The DN precursor population is generally subdivided into four distinct 
developmental stages (DN1–DN4), which are defined by differential expression of the 
cell surface markers CD25 and CD44 (interleukin-2 receptor and phagocyte glycoprotein 
1, respectively). Further differentiation of T cells depends on rearrangement of the TCR 
gene segments of four loci, that is, α, β, γ and δ. Most mature T cells express an αβ 
TCR on their cell surface. These are the T cells involved in the classic adaptive immune 
response. γδ T cells represent only a small fraction of T cells in lymphoid organs of 
humans and mice (1–5%) and line the epithelial layer of various organs, including the 
small intestine, but their function remains somewhat enigmatic (for review, see19). The 
choice of whether the α and β TCR genes are rearranged, or the γ and δ genes, is made 
at the DN2–DN3 stage in the thymus.
Tcrβ gene rearrangement is initiated and completed at the DN3 stage. Upon 
productive (in-frame) rearrangement of the Tcrβ gene, the TCRβ chain associates with 
the invariant pTα chain on the cell surface and forms the pre-TCR complex. Cells that 
have passed this so-called ‘β-selection’ checkpoint are termed ‘β-selected’ cells. The 
pre-TCR complex signals cells to proliferate and to downregulate CD25 expression. 
Cells subsequently acquire both CD4 and CD8 coreceptors to become double-positive 
(DP) cells, with CD8 usually being expressed first in most mouse strains (immature 
SP (ISP) cells). As a result, the late DN3, DN4 and ISP stages consist of large cycling 
cells (see Supplementary Fig. 1). The DP cells then leave the cell cycle and rearrange 
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their Tcrα gene locus. If Tcrα gene recombination is productive, TCRαβ is expressed 
on the cell surface of DP cells. TCRαβ-bearing immature cells are selected for major 
histocompatibility complex (MHC) recognition during the process of positive selection. 
TCRαβ receptors with specificity for MHC class I will develop into the CD8-positive 
(CD8+) T-cell lineage, whereas receptors recognizing MHC class II will become CD4-
positive (CD4+) T cells. DP thymocytes that fail to recognize MHC class molecules die 
‘by neglect’, whereas potential self-reactive T lymphocytes are eliminated by a process 
called negative selection. When combined, these selection processes result in the 
generation of CD4 and CD8 SP thymocytes with TCRαβ receptors that can recognize 
non-self-antigens presented by MHC class II and I proteins, respectively. Mature SP 
cells exit the thymus and circulate to the periphery as naive CD4+ and CD8+ T cells.
To circumvent the problem of embryonic lethality3, we generated mice with a 
conditional Ctcf allele (Ctcff/f). We examined the potential function of CTCF in Tcr gene 
rearrangement and global T-cell gene expression by deleting Ctcff/f in thymocytes. Here, 
we show that CTCF exerts an effect as a critical regulator of cell growth and proliferation 
following β-selection in the thymus. We demonstrate that CTCF expression varies 
during normal T-cell differentiation, with the highest levels occurring in subpopulations 
of relatively large and cycling thymocytes, including ISP cells. Interestingly, knockout of 
Ctcf results in a cell cycle arrest at the ISP cell stage, owing to highly increased amounts 
of the cyclin-CDK inhibitors p21 and p27. CTCF-deleted DN4 and ISP cells are also 
significantly smaller than normal cells. We therefore propose a global function of CTCF 
as a positive regulator of cell growth in αβ T cells.
RESULTS
Conditional deletion of the Ctcf gene in developing T lymphocytes
To understand CTCF function in vivo, we generated a conditional Ctcf allele (Ctcff) 
by inserting loxP sites upstream of exon 3 and downstream of exon 12 (Fig. 1A). 
Equivalent levels of CTCF are expressed in Ctcff/f and wild-type mice (data not shown). 
Ctcf+/f mice were crossed with mice expressing Cre recombinase ubiquitously20. This 
causes removal of Ctcf exons 3–12 from Ctcff, yielding the Ctcf− allele, in which a Ctcf–
lacZ fusion transcript is expressed instead of Ctcf (Fig. 1A). Ctcf+/− mice appear normal 
and are fertile, but no homozygous knockouts are born from Ctcf+/− crosses (Table 1), 
consistent with an essential function of CTCF in early development3. Surprisingly, the 
ratio of wild-type to Ctcf+/− littermates is higher than expected on a Mendelian basis in 
crosses among Ctcf+/− mice and between wild-type and Ctcf+/− mice (Table 1). These 
data suggest that CTCF is required in a dose-dependent manner.
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Figure 1. Conditional targeting of the mouse Ctcf gene. (A) Murine Ctcf locus and gene targeting 
constructs. Exons of the Ctcf gene (solid boxes) are numbered, scale is in kilobase (Kbp). Exon 
1 is embedded in a CpG island. Exon 3 contains the start codon, and exon 12 contains the stop 
codon. Southern blot probes (5′-end and HIII) are shown above the Ctcf gene. The two targeting 
constructs, with loxP sites (small triangles), flanking a PMC1-neomycin cassette (neor) or a PGK-
puromycin cassette (puror), are shown with homologous regions. TK, thymidine kinase gene; 
SA-LacZ, Splice acceptor-LacZ cassette39. PCR primers for genotyping (p8563, p8946, p260 and 
p261, large triangles) are indicated on targeting cassettes. Underneath the targeting constructs, 
the deleted Ctcf gene is shown, which is generated after complete Cre-mediated recombination 
at the outermost loxP sites. Owing to alternative splicing, the splice acceptor (SA) site, present at 
the 5′-end of the reporter LacZ cassette, is spliced on to Ctcf exon 1 or 2, thereby generating a 
hybrid Ctcf–LacZ transcript. (B) Southern blot analysis of Lck–Cre recombinase activity. Digested 
genomic DNA from thymus and spleen of mice of the indicated genotypes was analysed by 
hybridization with the HIII probe (see panel A). The positions of the wild-type (WT), Ctcff/f (flox) and 
Ctcf−/− (del) alleles are indicated. (C) Western blot analysis of thymus. Total thymus lysates from 
Lck–Cre Ctcff/f and WT mice (+ indicates presence of Cre transgene; − indicates absence) were 
analysed for CTCF, DNMT1 and UBF protein levels. Three mice were analysed per genotype. (D) 
Flow cytometric analysis of LacZ expression in CTCF conditionally deleted mice. LacZ expression 
was analysed in conjunction with cell surface markers. The indicated cell populations were gated 
and LacZ expression data are displayed as histogram overlays of Lck–Cre Ctcff/f mice (grey) on 
top of background signals in wild-type mice (black).
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To obtain a T-cell-specific deletion of the Ctcf gene, we crossed Ctcff/f mice with 
Lck-Cre transgenic mice, in which the proximal Lck promoter drives expression of the 
Cre recombinase21, 22. Southern blot analysis shows almost complete deletion of the Ctcf 
gene in thymus, whereas in spleen, deletion is not evident (Fig. 1B). These data reflect 
the specificity of the Lck-Cre transgene; they also indicate that Ctcf knockout T cells do 
not populate the spleen in large numbers. To evaluate the onset of Ctcff gene deletion, 
we analysed lacZ expression in thymocytes by flow cytometry using fluorescein-di-β-D-
galactopyranoside (FDG) as a substrate in conjunction with cell surface markers that 
define thymocyte subpopulations. We find that deletion is almost complete from the 
DN2 stage onwards (Fig. 1D). Western blotting shows that in thymic nuclear extracts 
from Lck-Cre Ctcff/f mice, CTCF protein levels are reduced to ~8% of control (Fig. 1C). 
We conclude that ablation of the Ctcf gene results in an efficient depletion of the protein 
in vivo.
Defective TCRαβ lineage development in Lck-Cre Ctcff/f mice
To examine the effects of a Ctcf deletion, thymocyte subpopulations in 6- to 8-week-
old mice were analysed by flow cytometry. This revealed that Lck-Cre Ctcff/f mice have 
a reduced thymic cellularity (Table 2). Whereas a specific defect is observed in αβ 
T-cell development (Fig. 2), γδ T cells are not affected by Ctcf deletion (Supplementary 
results and Supplementary Fig. 2), similar to what has been reported for condtional 
deletion of DNMT121 and the RNaseIII enzyme Dicer23. Apparently, cell division, chromatin 
organization and gene regulation in γδ T cells is quite different from αβ T cells.
In αβ T cells of Lck-Cre Ctcff/f mice, a decrease in the proportion and number of 
DP and SP cells, and a concomitant increase in DN3, DN4 and ISP cells, is observed 
(Fig. 2AB, Table 2). Thus, the effect of a complete Ctcf knockout is particularly prominent 
at the ISP-to-DP transition (Fig. 2B). The fact that the absolute number of Ctcf knockout 
thymocytes increases about four-fold from ISP to DP, compared with a 90-fold increase 
in wild-type mice (Fig. 2C, Table 2), suggests that a cell cycle block rather than increased 
apoptosis underlies the accumulation of ISP cells from Lck-Cre Ctcff/f mice.
Heterozygous Lck-Cre Ctcf+/f mice also display a phenotype, which is most 
Table 1. Genotype of Ctcf+/− × Ctcf+/− and Ctcf+/− × wild type offspring.
Age Genotype and number
Wild-type Ctcf +/- Ctcf -/-
Ctcf +/-  x Ctcf +/- 
E 9.5 13 14 0
E 3.5 10 7 0
Adult 88 92 0
Ctcf +/-  x wild-type
Adult 101 74 NA
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obvious at the DP stage (Fig. 2B, Table 2). In these mice, thymic cellularity is only 
modestly reduced and no accumulation of ISP cells is detected (Table 2). These 
results show that normal CTCF levels are important for proper T-cell development. In 
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Figure 2. Defective TCRαβ lineage development in CTCF-deficient mice. (A) Representative flow 
cytometric analyses of cell populations from thymus (upper three panels) and spleen (lower panel) 
derived from wild-type (WT) and Lck–Cre Ctcff/f mice. Expression profiles of surface markers 
(indicated on the left) are shown as dot plots, and the percentages of cells within quadrants or 
gates are given. The DN1–DN4 cell populations (second panel from top) were gated on the basis of 
CD44 and/or CD25 expression, using the CD3−CD4−CD8− triple-negative fraction as a basis. The 
third panel from the top shows gating of the ISP and CD8 SP cell populations (on the basis of low 
and high expression of CD3, respectively) using the fraction of CD4−CD8+ thymocytes (indicated 
in the CD4/CD8 profile of the upper panel). Note the accumulation of ISP cells in the thymus of the 
Lck–Cre Ctcff/f mouse (95%) compared with wild type (20%). (B) Number of thymic and splenic T 
cell subpopulations. Each symbol represents one individual animal (n=12 for Lck–Cre Ctcff/f mice, 
n=7 for Lck–Cre Ctcf+/f mice, and n=14 for wild-type (WT) mice). Note that different scales are used 
in the vertical axes. Horizontal lines indicate average values (see Table 2 for actual values±SEM). 
Lck–Cre Ctcff/f mice show increased numbers of DN3 (P<0.01), DN4 (P=0.0002) and ISP cells 
(P<0.002) compared with wild type. In Lck–Cre Ctcff/f mice and heterozygous Lck–Cre Ctcff/+ mice 
DP, CD4 SP and CD8 SP subsets in the thymus were significantly reduced (P<0.0001). CD4 and 
CD8 T cells in the spleen were significantly reduced in Lck–Cre Ctcff/f mice (P<0.00001) and in 
heterozygous Lck–Cre Ctcff/+ mice (P<0.01). (C) Analysis of cell numbers. Ratios were calculated 
(DP to ISP, CD4+ to DP, and CD8+ SP to DP) in Lck–Cre Ctcff/f mice (Hom), Lck–Cre Ctcf+/f mice 
(Het) and wild-type (WT) mice. The DP/ISP ratio indicates the fold increase in cells and correlates 
with number of cell divisions. By contrast, the CD4/DP and CD8/DP ratios show a decrease in cell 
number and are a measure of selection.
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agreement with impaired thymic SP cell production, the number of mature CD4+ and 
CD8+ T cells in spleen and lymph nodes of Lck-Cre Ctcff/f and Lck-Cre Ctcf+/f mice are 
significantly reduced (Fig. 2AB and H Heath, CR de Almeida, RW Hendriks and N 
Galjart, unpublished data). Interestingly, the ratio between mature CD4+ SP and DP cells, 
and between CD8+ SP and DP thymocytes, is similar in heterozygous Lck-Cre Ctcf+/f, 
homozygous Lck-Cre Ctcff/f and wild-type mice (Fig. 2C), indicating that differentiation 
from the DP to SP stage is not severely affected by a deletion of CTCF.
The accumulation of CTCF-deficient ISP cells in Lck-Cre Ctcff/f mice could result 
from a developmental arrest at the ISP stage or alternatively reflect defective upregulation 
of CD4 expression in cells that otherwise have characteristics of DP cells, similar to 
thymocytes deficient for the chromatin remodeler Mi-2β24. To distinguish between these 
possibilities, we assessed expression of various cell surface markers in wild-type and 
Lck-Cre Ctcff/f thymocytes. Normally, surface expression of TCRβ and its associated 
signalling molecule CD3 are low in ISP cells and are induced at the DP stage. CTCF-
deficient ISP cells express low levels of CD3 and TCRβ (Fig. 3A). Furthermore, wild-type 
and CTCF-negative ISP and DP cells express similar amounts of the surface glycoprotein 
CD5, which is normally upregulated on ISP cells and somewhat further on DP cells25. 
CTCF-deficient ISP cells also express low levels of CD69, which in wild-type mice is 
induced in a subfraction of DP cells, reflecting TCR-mediated activation26. Expression 
of heat stable antigen (HSA, also called CD24, a cell adhesion molecule), which is 
normally high on DN and ISP cells and downregulated at the ISP-to-DP transition24, is 
reduced in CTCF-deficient cells throughout thymocyte differentiation (Fig. 3A). As none 
of the markers tested show a ‘DP-like’ expression pattern in CD3-CD4-CD8+ cells in Lck-
Cre Ctcff/f mice, we conclude that these accumulating cells truly represent ISP cells and 
not abberant DP cells that fail to upregulate CD4 expression. In addition to the ISP-to-
DP arrest in Lck-Cre Ctcff/f mice, we observed a significant increase in number of cells 
within the preceding DN3 and DN4 stages (Table 2), indicating that a deletion of CTCF 
causes a developmental arrest from DN3 to ISP.
Interestingly, the expression level of CD3 is not only reduced in ISP thymocytes 
from Lck-Cre Ctcff/f mice, but also in DP cells and to a lesser extent in mature CD4+ SP 
and CD8+ SP cells (Supplementary Fig. 3A, note that in CD8 SP cells, the decrease 
Genotype DN1 DN2 DN3 DN4 ISP DP CD4 SP CD8 SP Total
WT (n =14) 0.27 ± 0.02 0.37 ± 0.05 2.09 ± 0.19 1.10 ± 0.13 1.81 ± 0.21 165 ± 10.3 14.1 ± 1.08 5.56 ± 0.58 191 ± 11.7
Heterozygous (n =7) 0.32 ± 0.03 0.66 ± 0.14 3.42 ± 0.93 0.73 ± 0.16 1.92 ± 0.31 95.9 ± 7.40 7.66 ± 0.81 2.48 ± 0.35 113 ± 8.77
Homozygous (n =12) 0.39 ± 0.08 0.91 ± 0.26 4.72 ± 0.85 3.15 ± 0.40 9.14 ± 1.82 35.4 ± 1.89 2.19 ± 0.50 0.81 ± 0.20 56.7 ± 3.76
P -value (heterozygous-WT) NS NS NS NS NS <0.0001 0.0001 0.0002 <0.0001
P -value (homozygous-WT) NS NS 0.0082 0.0002 0.0014 <0.0001 <0.0001 <0.0001 <0.0001
Table 2. Average numbers of thymocyte subpopulations derived from Lck–Cre Ctcff/f mice 
(homozygous), Lck–Cre Ctcf+/f mice (heterozygous) and wild-type (WT) mice.
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Figure 3. Characterization of CTCF-deleted thymocytes. (A) Expression of ISP cell markers. Flow 
cytometric analyses of HSA, CD3, TCR, CD5 and CD69 in thymocyte subpopulations, displayed 
as overlays of wild-type mice (black histograms) and Lck–Cre Ctcff/f mice (grey histograms). 
Data shown are representative of 5–8 mice per group. (B) Intracellular TCRβ levels in wild-type 
and Lck–Cre Ctcff/f mice. Representative flow cytometric analyses of intracellular TCRβ protein 
expression in the indicated thymic subsets from a wild-type (WT) and an Lck–Cre Ctcff/f mouse. 
TCRβ/forward scatter (FSC) profiles are shown as dot plots, gating is indicated by the horizontal 
lines and the percentages of TCRβ+ cells are shown. (C) Cell size in wild-type and Lck–Cre Ctcff/f 
thymocytes. Quantification of median forward scatter values (which accurately reflects cell size) 
of the indicated thymocyte subpopulations in wild-type (white bars) and Lck–Cre Ctcff/f (black 
bars) mice. Data are average values±SEM from 5 to 8 mice per group.
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is not significant). In particular, CTCF-deficient DP cells do not contain the fraction of 
CD3high/TCRhigh cells. DP cells from heterozygous Lck-Cre Ctcf+/f mice express CD3 
levels that are in the range of those from WT mice (Supplementary Fig. 3A), showing 
that only a complete lack of CTCF affects CD3 expression at the DP cell stage. Although 
CTCF-negative DP thymocytes are affected in the expression of important molecular 
markers, including CD3 and TCR, they are still able to differentiate towards the mature 
SP stages.
Defective cell-size regulation in the TCRαβ lineage in Lck–Cre Ctcff/f mice
As our findings indicated a specific function of CTCF at the ISP-to-DP transition, we 
focussed our attention on possible mechanisms underlying the hampered differentiation 
of these cells. We first analysed Tcr rearrangement, because of the many CTCF-
binding sites that are found in the genes encoding the different receptors. Tcrβ gene 
rearrangement is generally initiated and completed in DN3. This stage consists of early 
small DN3E cells that have not yet productively rearranged the Tcrβ locus, and more 
mature large proliferating DN3L cells expressing TCRβ27. We detect a significant increase 
in the population of large DN2 cells in Lck-Cre Ctcff/f mice that contain intracellular TCRβ+ 
(Fig. 3B), 13±4% in CTCF-deficient DN2 cells (n=3), compared with 4±0.5% in wild-
type controls (n=4); P<0.01). These results raise the interesting possibility that CTCF is 
involved in inhibiting recombination early in development. The proportion of large TCRβ+ 
DN3 cells appears still elevated, but the difference between the two groups (~21 and 
~18% in CTCF-deficient and wild-type mice, respectively) is not significant. Thus, the 
Tcrβ locus can undergo functional V(D)J recombination in cells that have deleted the 
Ctcf gene. It should be noted that even though the Ctcf gene is efficiently deleted using 
the Lck-Cre transgene, residual CTCF protein might still be present at DN2 and DN3 
stages, and we cannot rule out that this is sufficient for recombination.
By comparing wild-type and Lck-Cre Ctcff/f mice, we found that CTCF-negative 
TCRβ+ DN3 cells have the capacity to increase their cell size at the developmental 
progression of TCRβ− DN3E to TCRβ+ DN3L cells (Fig. 3BC). However, from the 
DN3L-to-ISP stage, CTCF-deficient cells become much smaller than wild-type cells 
(Fig. 3BC). CTCF-deficient DP cells are again larger than wild-type cells (Fig. 3C, 
Supplementary Fig. 3B) and continue to be larger throughout subsequent differentiation 
(Supplementary Fig. 3B). These results indicate that CTCF is a critical regulator of cell 
growth of αβ T cells. Cells from heterozygous Lck-Cre Ctcf+/f mice are sized like wild 
types (Supplementary Fig. 3A), showing that only a complete lack of CTCF affects cell 
size.
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Developmental arrest of CTCF-deficient thymocytes is not due to defective Tcr 
rearrangements
The severe reduction of DP cell numbers and low-surface CD3/TCR expression on 
CTCF-deficient DP cells, together with the reported presence of CTCF-binding sites 
in the Tcrα gene locus12, 16, indicated that defective Tcrα V(D)J recombination could 
contribute to the arrest of CTCF-deficient thymocytes. We therefore crossed Lck-Cre 
Ctcff/f mice with transgenic mice expressing either the pre-rearranged OTII TCRαβ, which 
recognizes the OVA323–339 peptide in the context of C57BL/6 MHC class II, and which 
positively selects thymocytes towards the CD4 lineage28, or the MHC class I-restricted HY 
TCRαβ, which recognizes a male-specific HY antigen peptide in the C57BL/6 H-2b class 
I female background and normally drives thymocytes into the CD8 lineage29. However, 
the impaired developmental progression of CTCF-deficient cells is not rescued (Fig. 4). 
Rather, the presence of the OTII and HY Tcr transgenes results in an even more severe 
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Figure 4. Arrest of CTCF-deficient thymocytes remains despite Tcr gene rearrangement. (A) 
Representative flow cytometric analyses of cell populations from thymus (upper two panels) and 
spleen (lower panel) derived from OTII transgenic mice, which are either in a wild-type (WT) or 
in a Lck–Cre Ctcff/f background. Expression profiles of CD4/CD8 and CD3/TCRγδ markers are 
shown as dot plots, and the percentages of cells within quadrants or gates are given. Thymic 
cellularity is shown for the individual animals underneath the first panel. In the right hand panels, 
data for the OTII transgenics are displayed as histogram overlays. The expression profile of total 
surface TCRβ within the indicated cell populations is shown for Lck–Cre Ctcff/f mice (bold lines) 
on top of profiles of WT littermates (grey-filled histograms). (B) Representative flow cytometric 
analyses of cell populations from thymus (upper two panels) and spleen (lower panel) derived 
from HY transgenic mice, which are either in a wild-type (WT) or in a Lck–Cre Ctcff/f background. 
Flow cytometric profiles of CD4/CD8 and CD3/TCRγδ are shown as dot plots; percentages of 
cells within quadrants or regions and total thymic cell numbers are given. The expression profile 
of total HY idiotype-specific T3.7 TCR within the indicated cell populations is shown on the right 
as a histogram overlay of Lck–Cre Ctcff/f mice (bold lines) on top of profiles of WT littermates 
(grey-filled histograms).
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arrest of T-cell development in the thymus (Fig. 4AB), respectively). OTII Tg Lck-Cre 
Ctcff/f mice manifest a relative increase in the proportions of DN and ISP cells in the 
thymus, whereas the proportions of DP and CD4 SP cells are reduced. In addition, we 
observe an almost complete absence of mature T cells in the spleen (Fig. 4A). HY Tg 
Lck-Cre Ctcff/f mice manifest a severe block at the ISP stage and an almost complete 
lack of DP cells in the thymus. Those CD8+ cells present in CTCF-deficient HY Tg mice 
are ISP cells rather than mature CD8 SP cells, because the level of HY-specific TCR 
expression (as detected by the T3.7 antibody) in the CD8+ cell fraction is substantially 
lower, when compared with wild-type CD8 SP cells. In agreement with this, CD4 or CD8 
cells in the spleen are strongly reduced (Fig. 4B). Thus, providing Lck-Cre Ctcff/f mice 
with a pre-rearranged TCRαβ does not correct the developmental arrest of DP cells, 
indicating that the developmental block in Ctcf knockout T cells is independent of Tcr 
gene rearrangement.
We next crossed Lck-Cre Ctcff/f mice with mice deficient for the Recombination 
activating gene 2 (Rag2) gene. RAG2 mediates V(D)J recombination of Tcr and Ig 
loci. Rag2−/− mice are therefore deficient in Tcr gene rearrangement, and they normally 
do not progress beyond the DN3 stage (Fig. 5). In vivo stimulation with anti-CD3ε 
antibodies mimics pre-TCR signalling25 and thereby induces the formation of DP cells 
in the absence of rearrangement. Both in Rag2−/− and in CTCF-deficient Rag2−/− mice, 
we find that on anti-CD3ε treatment, total thymic cellularity increases from <2 × 106 to 
13±4 and 11±3 × 106, respectively (n=4 in each group) and equal numbers of DN4 cells 
are induced (Fig. 5). However, the formation of DP cells is reduced in CTCF-deficient 
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Figure 5. Arrest of CTCF-deficient thymocytes is independent of Tcrα gene rearrangement. 
Representative flow cytometric analyses of the thymus of Rag2 knockout (Rag2−/−) mice, which 
are either in a wild-type (WT) or in a Lck–Cre Ctcff/f background. Mice were either untreated or 
injected with 50 μg of rat anti-CD3 antibodies (αCD3) in vivo. The CD4 and CD8 expression 
profiles, 3 days after injection, are shown (upper part). Cell populations were gated (vertical and 
horizontal lines) and the CD4−CD8− fraction (i.e., DN cells) was analysed for CD25 and CD44 
expression (lower part). Data are shown as dot plots and the percentages of cells within the 
quadrants are given. The plots shown are representative for four mice in each group.
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Rag2−/− mice, when compared with CTCF-expressing cells (Fig. 5).
As the Tcrγ and δ loci can also undergo functional V(D)J recombination in 
the absence of CTCF, we conclude that the multiple CTCF-binding sites reported 
to be present in Tcr loci14-16 do not appear to be essential for the process of V(D)J 
recombination. Therefore, deficiency of CTCF results in a developmental block at the 
ISP-to-DP transition that is independent of Tcr gene rearrangement.
Cell cycle arrest during TCRαβ lineage development in Lck-Cre Ctcff/f mice
To further examine the underlying cause of the accumulation of CTCF-negative ISP 
cells, we sorted wild-type and CTCF-deleted cells T cells into DN, ISP and DP fractions, 
and used real-time PCR to analyse mRNA expression patterns of a selected number of 
important T-cell factors. In wild-type cells, Ctcf mRNA levels increase from the DN-to-
ISP stage and then decrease again in DP cells (Fig. 6A). These data suggest that the 
relatively large, actively cycling ISP cells require a higher amount of CTCF for normal 
functioning than DN or DP cells. In sorted cells from Lck-Cre Ctcff/f mice, Ctcf expression 
is severely reduced in the DN fraction and is absent at later stages (Fig. 6A); note 
that residual Ctcf mRNA is detected in the DN pool because the Ctcf gene is only fully 
deleted from DN2 onwards).
CTCF was reported to be a negative transcriptional regulator of c-Myc30, 31, and 
c-Myc is important for T-cell development32. In wild-type T cells, c-Myc is expressed in a 
pattern different from Ctcf (Fig. 6A). In addition, c-Myc expression is hardly affected by 
a CTCF deletion. Therefore, in T cells, CTCF does not appear to regulate expression of 
the c-Myc gene. The level of DNMT1, a maintenance methyltransferase that is essential 
for T-cell development21, is also similar in wild-type and CTCF-deleted T cells (Fig. 6A), 
see also (Fig. 1C). Two other transcription factors are Gata3, which is critically involved 
in β-selection and development of CD4 SP cells33, and Satb1, which organizes cell type-
specific nuclear architecture34. In wild-type cells, the levels of these factors are opposite 
to those of Ctcf (Fig. 6A). In CTCF-deficient cells, Gata3 and Satb1 expression is 
reduced, in particular at the DP stage. We next tested two cytoplasmic factors involved 
in T-cell signalling. Expression of PreTα (that assembles with TCRβ to initiate TCR 
signalling) is not affected in ISP cells and is up- rather than downregulated in DP cells in 
the absence of CTCF (Fig. 6A). Finally, the expression of Gimap4, which is induced by 
pre-TCR signalling and accelerates T-cell death35, is increased in CTCF-deficient DP T 
cells with a factor of ~2 (Fig. 6A). Nevertheless, we did not find evidence for increased 
apoptosis of CTCF-deficient DP cells (data not shown). Although none of the factors 
tested appears to be directly regulated by CTCF, changes in their expression level may 
contribute to the observed phenotype in CTCF-deleted cells.
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Figure 6. CTCF is important for cell cycle progression. (A) Quantitative RT–PCR analysis in 
sorted DN, ISP and DP cell fractions from wild-type (WT) and Lck–Cre Ctcff/f mice. The DP fraction 
also contained CD4 SP cells. To obtain enough material, RNA was pooled from four WT and two 
Lck–Cre Ctcff/f mice. (B) Cell cycle status of DN, ISP and DP cells isolated from WT and Lck–Cre 
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cycle defects, we tested the expression of two major cell cycle inhibitors, p21 and p27. In 
wild-type cells, the expression profile of these factors is opposite to that of Ctcf, whereas 
Ctcf knockout cells show significantly increased p21 and p27 expression (Fig. 6A). We 
subsequently analysed cell cycle profiles in wild-type and CTCF-deleted thymocytes. 
The CTCF-deficient ISP population from Lck-Cre Ctcff/f mice contains approximately 
half the number of cycling cells compared with wild type (29%±1 cells in S/G2/M phase 
in Lck-Cre Ctcff/f mice (n=3), versus 53%±8 in wild-type mice (n=3); Fig. 6B shows 
an example of analysis from individual mice). These results indicate that cell cycle 
progression in β-selected CTCF-deficient T cells is blocked due to the upregulation of 
p21 and p27.
We next tested whether a deletion of CTCF always causes upregulation of the 
p21 and p27 genes, irrespective of cell type. We treated mouse embryonic fibroblasts 
(MEFs) from Ctcff/f mice with Cre recombinase9 to efficiently remove CTCF in these 
cells. Real-time PCR experiments show that in MEFs the expression of p21, but not of 
p27, is increased in the absence of CTCF (Fig. 6C). Thus, the combined upregulation of 
p21 and p27 seen in CTCF-deficient ISP cells is not a general regulatory mechanism.
CTCF as a critical regulator of cell growth and proliferation in T cells
Genome-wide studies in human cells have shown that CTCF-binding patterns in 
fibroblasts and T cells largely overlap12, 14. Interestingly, the human p21 gene contains 
four CTCF binding sites in the vicinity of its promoter, whereas no binding sites are 
found near p27. As p21 but not p27 mRNA is upregulated in different cell types in the 
absence of CTCF, and CTCF binds near and within the human p21 gene but not near 
p27, we hypothesized that CTCF might be a negative regulator of p21 expression. This 
Ctcff/f mice. Cell cycle was analysed using 7-AAD, which measures DNA amount. A representative 
analysis is shown. Numbers indicate the percentage of cells in S/G2/M. In Lck–Cre Ctcff/f mice, 
this number is significantly reduced in ISP cells, showing that this population is hampered in the 
cell cycle. (C) Quantitative RT–PCR (left hand panel) and ChIP (right hand panel) analysis in 
WT and Ctcff/f MEFs, after treatment with Cre recombinase. mRNA expression in Cre-treated 
Ctcff/f MEFs (KO) is shown relative to WT. Although residual Ctcf mRNA is present in the MEFs, 
p21 expression is increased. ChIP analysis was performed with anti-CTCF antibodies on four 
regions in the p21 gene. Potential CTCF-binding sites in the mouse p21 gene were chosen on 
the basis of a genome-wide analysis in human cells14. An identical binding pattern was observed 
in wild-type MEFs, with relatively weak CTCF binding 2.3 kb upstream of the p21 promoter (up) 
and on the promoter (pr), and very strong binding on two adjacent regions within intron 1 (i-1a, 
i-1b). (D) Quantitative RT–PCR (left hand panels) and ChIP (right hand panel) analysis in WT 
thymocytes and T cells before (d0) and after (d3) 3 days of anti-CD3/CD28 stimulation in vitro. 
mRNA expression of p21 and Ctcf is shown relative to Hprt. ChIP analysis was performed with 
anti-CTCF antibodies on intron 1 of the p21 gene and, as positive control, on known binding sites 
in the c-Myc and Tcrα genes.
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idea is enforced by the observation that in wild-type DN, ISP and DP thymocytes, the 
p21 mRNA expression profile is exactly opposite to that of Ctcf (Fig. 6A). To test our 
assumption, we first confirmed that CTCF-binding sites (which are part of CNEs) are 
conserved between man and mouse. Chromatin immunoprecipiations (ChIPs) in MEFs 
on the corresponding regions of mouse p21 indeed reveal an identical pattern of CTCF 
binding, including the two adjacent strong sites in intron 1 (Fig. 6C).
Next, we analysed thymocytes isolated from total thymus and largely consisting 
of DP cells, and purified CD4+ T cells, either before (day 0) or after 3 days of in vitro 
activation by anti-CD3/anti-CD28 stimulation (day 3). We reasoned that in these cells, 
levels of p21 must differ and that these cells therefore represent a good model to test 
whether CTCF binding correlates to p21 expression in cells expressing normal amounts 
of CTCF. We correlated mRNA expression levels of Ctcf and p21 (as tested with real-
time PCR) with CTCF binding (as analysed by ChIP), using the strongest CTCF site in 
intron 1 of the p21 gene as a reference. mRNA expression levels were normalized to 
Hprt (a housekeeping gene), whereas CTCF binding was normalized to the Amylase 
gene, which contains no CTCF-binding sites. The data show that CTCF binds very 
strongly to the p21 intron, both in thymocytes and resting and cultured T cells (Fig. 
6D). Although there is a correlation between Ctcf mRNA levels and strength of CTCF 
binding, there is no correlation with p21 expression (Fig. 6D). Thus, despite the fact that 
deletion of CTCF results in increased expression of p21 in thymocytes and MEFs, the 
p21 gene does not appear to be a general target of CTCF in wild-type cells.
The mRNA expression data indicate that Ctcf is specifically upregulated in ISP 
cells (Fig. 6A). Furthermore, lacZ staining results show increased activity of the Ctcf 
promoter in DN2-DN4 cells (Fig. 1D) and in ISP cells (not shown). However, both the 
PCR and LacZ staining results reflect mRNA levels of CTCF. To also analyse CTCF 
protein levels in vivo, we used a Ctcfgfp knock-in allele in which GFP-CTCF is expressed 
instead of CTCF (H Heath and N Galjart, unpublished data). We used flow cytometry to 
identify GFP-CTCF in the different thymocyte subsets and in the spleen (Supplementary 
Fig. 4). During αβ T-cell differentiation, CTCF levels increase from the DN2 to the ISP 
stage and then return to DN1 values in the DP cell population (Supplementary Fig. 4A), 
consistent with the expression profile of Ctcf transcripts (Fig. 6A). In TCRαβ CD4+ and 
CD8+ T cells in the spleen, CTCF levels are identical to the levels in DN1 and SP cells in 
the thymus (Supplementary Fig. 4B). Thus, CTCF levels increase in those thymocyte 
populations (DN3, DN4 and ISP) that have a larger cell size (see Fig. 3). Interestingly, 
a lack of CTCF causes accumulation of these very same cells. Taken together, our data 
suggest that CTCF is a critical regulator of cell growth and proliferation in αβ T cells.
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DISCUSSION
CTCF is an important protein involved in chromatin organization and the epigenetic 
regulation of gene expression. Most studies on CTCF use cultured cells as a basis, and 
a plethora of results regarding CTCF function have been reported. We have generated a 
conditional Ctcf knockout allele, which has allowed us to examine the in vivo function of 
CTCF. Consistent with a previous report3, we find that deletion of Ctcf in early embryonic 
development is lethal. A novel result is that heterozygous Ctcf knockout mice, which are 
viable and fertile, are born in less than expected numbers. The development of Ctcf+/− 
thymocytes is also affected, although mildly. Taken together, these data suggest that 
CTCF is required in a dose-dependent manner.
We found no evidence for an increased tumour incidence in heterozygous Ctcf 
knockout animals, or for T lymphoid malignancies in CTCF-deficient T-cell lineages. 
This argues against a function of CTCF as a crucial tumour suppressor36. Increased 
expression of p21 (and p27) in CTCF-negative cells would explain why loss of CTCF 
does not induce tumours. Still, the potential function of CTCF in cancer merits a more 
detailed investigation. We also do not observe a more severe phenotype in CTCF-
deficient female thymocytes compared with male cells, suggesting that absence of 
CTCF does not cause deregulated expression of genes on the inactive X-chromosome. 
Moreover, the deletion of CTCF does not have an effect on the maintenance of 
methylation in the imprint control region of the Igf2/H19 and ribosomal DNA (rDNA) loci 
(see Supplementary results). Unlike other studies8, 37, our results therefore indicate 
that CTCF is not required to maintain X-inactivation and DNA methylation status of the 
Igf2/H19 locus.
Despite the presence of multiple CTCF-binding sites near the Tcrα and Tcrβ 
genes, our data indicate that CTCF is not essential for recombination at these loci. 
CTCF also does not appear to be required for the differentiation of DP cells towards 
the CD4+ and CD8+ SP cell stage, even though substantial epigenetic and regulatory 
changes accompany commitment of SP cells18. CTCF is, however, essential for the 
efficient proliferation of β-selected cells, in particular for their maturation from ISP to DP 
cells, and for TCR upregulation at the cell surface of DP cells. As T cells were directly 
isolated from mice, our data provide the first in vivo evidence for an important function 
of CTCF in cell cycle progression. In line with a proliferative block, we detect strongly 
increased expression of two major cell cycle inhibitors, p21 and p27.
Our results in T cells are completely opposite to those obtained in WEHI 231 
B lymphoma cells, where conditional expression of CTCF resulted in the up- rather 
than the downregulation of p21 and p27, whereas reduction of CTCF levels decreased 
rather than increased the expression of p21 and p2731. This could be due to the fact 
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that the properties of the ISP thymocytes and WEHI 231 B cells are entirely different. 
ISP thymocytes are highly proliferating as a result of pre-TCR stimulation, whereas 
crosslinking of the B-cell receptor on WEHI 231 immature B cells results in cell-cycle 
arrest and apoptosis (thereby providing a model for self-tolerance by clonal deletion). 
This suggests that CTCF function is context dependent, although it should be noted that 
our data were obtained in vivo, whereas the data in the WEHI 231 B lymphoma cells were 
obtained with stably transfected clones selected for high expression of CTCF sense or 
antisense mRNA31. Using our conditional Ctcff/f mice in combination with existing B cell-
specific Cre transgenes, we will be able to examine the function of CTCF in B cells.
In Ctcf knockout mice, approximately four times more DP cells are present than 
ISP cells, suggesting that the latter cells can divide, although slowly. Moreover, whereas 
CTCF-negative ISP cells are smaller than their wild-type counterparts, DP cells are 
larger. These data argue against increased apoptosis as a cause of reduction in DP cell 
numbers after Ctcf gene deletion. This is different from the situation in Dnmt1 knockout 
mice, which have similar numbers of DN thymocyte subsets as wild-type littermates, and 
in which increased apoptosis was shown to be a major cause of the severe reduction in 
DP cell number21.
T-cell activation at the DN3 stage is accompanied by an enlargement of both 
cytoplasmic and nuclear volume. In the DN4 and ISP stages, growth is coupled to 
proliferation, presumably to sustain the rapid cell divisions that are required in these 
cells. When thymocytes enter the DP stage, they exit the cell cycle and become small 
again. CTCF levels increase when cells become bigger (from DN3 to ISP) and decrease 
again when cells become small. Furthermore, CTCF-negative DN4 and ISP cells 
are smaller than wild-type cells, whereas DP cells are larger. These data uncover a 
function of CTCF as a regulator of cell growth and proliferation in thymocytes. A notable 
enrichment of CTCF-binding sites was observed near DNAse I HSs in CD4+ T cells, 
indicating that CTCF controls global T-cell expression17. Our data suggest that CTCF 
couples cell growth to the cell cycle. Strikingly, the ratio between DP cell number and 
mature CD4+ SP and CD8+ SP thymocytes is the same in wild-type, heterozygous Lck-
Cre Ctcf+/f and homozygous Lck-Cre Ctcff/f mice. Thus, the major function of CTCF in 
the thymus might be to positively regulate cell growth in rapidly dividing thymocytes so 
that appropriate numbers of cells are generated before positive and negative selection 
events at the DP stage in the thymus.
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METHODS
Modified Ctcf alleles, mouse models and embryonic fibroblasts. Human CTCF 
cDNA was used to screen a 129S6/SvevTac mouse PAC library (RPCI-21)38. PAC clones 
were used to isolate 6.7 kb (for 5′-end targeting) and 8 kb (for 3′-end targeting) EcoRI 
subclones. For 5′-end targeting, the 6.7 kb EcoRI fragment was used to amplify 1360 
bp of 5′-end homology and 5340 bp of 3′-end homology. The homologous arms were 
cloned into a vector containing the neomycin resistance gene flanked by loxP sites39. A 
viral thymidine kinase gene was inserted afterwards. For 3′-end targeting, we generated 
a SpeI–EcoRI subclone from the PAC DNA and used its unique BamHI site to insert a 
cassette containing the puromycin resistance gene flanked by loxP sites, followed by 
splice acceptor sequences and the bacterial β-galactosidase (lacZ) reporter39. Relevant 
parts of the different constructs were verified by DNA sequencing. Constructs were 
targeted into E14 embryonic stem (ES) cells as described39. DNA from resistant ES cells 
was analysed with external radiolabelled probes by Southern blotting. Confirmation of 
homologous recombination was performed using different 5′-end and 3′-end probes 
(Fig. 1A and B) and a PCR-based assay for genotyping. Ctcff/f mice were crossed back 
more than 10 times to the C57BL/6 background. MEFs were isolated from Ctcff/f mice 
using published procedures40. Fibroblasts were treated with lentiviral Cre as described9. 
Ctcff/f mice were bred to mice expressing chicken β-actin-Cre-generating Ctcf+/− animals. 
T-cell-specific deletion of Ctcf was achieved by breeding to Lck–Cre mice21, which were 
kindly provided by Dr C Wilson (University of Washington, Seattle, WA, USA). Cre-
specific primers were used for genotyping. In experiments where Ctcf knockout mice 
are compared with ‘wild type’ animals, the latter are littermates of the Lck-Cre Ctcff/f 
animals, that is, mice that express normal (‘wild type’) levels of CTCF. Thus, the ‘wild 
type’ mice may be truly wild type; they may contain the Lck–Cre transgene or the Ctcff 
allele, but never a combination of the latter two alleles. HY/Rag2−/− (C57BL/10) mice 
were purchased from Taconic Europe A/S (Denmark). OT-II mice have been described28. 
Mice were bred and maintained in the Erasmus MC animal care facility under specific 
pathogen-free conditions and analysed at 6–10 weeks of age. For anti-CD3 treatment, 
Rag2-deficient mice41 were injected i.p. with 50 μg of rat anti-CD3 antibodies (αCD3; 
clone 145-2C11) as described42. Experimental procedures were reviewed and approved 
by the Erasmus University committee of animal experiments.
DNA, RNA and protein analysis. Genomic DNA was isolated, digested and blotted 
onto Hybond N+ membranes (Amersham) and hybridized with radiolabelled probes. 
Ctcf probes are shown in Fig. 1. Total RNA was prepared using RNA-Bee RNA 
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isolation solvent (Tel-Test Inc.). RNA (0.5–1.0 μg) was reverse-transcribed (RT) with 
random and oligo-dT primers, in the presence of Superscript reverse transcriptase 
(Invitrogen). For the experiment shown in Fig. 6, RNA was isolated and pooled from 
the thymus of four wild-type mice and from two Lck-Cre Ctcff/f mice. Real-time RT–
PCR was performed as described9 with 100 ng of each primer and 0.5 U of Platinum 
Taq DNA polymerase (Invitrogen). Sybr-green (Sigma) was added to the reactions and 
PCR was performed on a DNA Engine Opticon PCR system (MJ Research Inc.) and 
Bio-Rad MyiQ iCycler single-colour real-time PCR detection system. To confirm the 
specificity of the amplification products, samples were separated by standard agarose 
gel electrophoresis. Threshold levels were set and further analysis was performed using 
the SDS v1.9 software (Applied Biosystems). The obtained Ct values were normalized 
to the Ct value of Gapdh, β-actin or Hprt. Each PCR was performed at least in triplicate, 
and at least two independent experiments were performed to examine the expression 
of individual genes. Primer sequences and PCR conditions used are available on 
request. For ChIP, nuclear extracts were prepared9. Chromatin cross-linking (2 × 107 
cells treated with 1% formaldehyde for 10 min at room temperature), sonication to 
300–800 base pair fragments and immunoprecipitation were as described (Upstate 
protocol, http://www.upstate.com). At least two independent ChIPs were carried out per 
experiment. Quantitative real-time PCR was performed as described above. Values 
were normalized to input measurements and enrichment was calculated relative to 
the Amylase gene using the comparative Ct method. PCR products were all smaller 
than 150 bp. Primer sequences and PCR conditions used are available on request. 
Western blot analysis was performed as described39. Primary antibody incubation was 
done overnight at 4°C in Tris-buffered saline, containing 5% (w/v) BSA and 0.15% (v/v) 
NP-40. Blots were incubated with secondary goat anti-rabbit or anti-mouse antibodies, 
coupled to horseradish peroxidase (GE Healthcare UK Ltd: 1:50 000). Signal detection 
was performed using ECL (Amersham). Anti-CTCF (N3) and anti-fibrillarin (no. 4118 
and 4080) antibodies were generated as described39 using GST-linked chicken CTCF 
(amino acids 2–267) and fibrillarin fusion proteins. These antisera were used in a 1:300 
dilution. DNMT1 (Abcam), and UBF (Santa Cruz Biotechnology) mAbs were used at 
1:100. Western blots were scanned and the levels of protein were quantified using the 
gel macro function in ImageJ (Rasband, WS, NIH, http://rsb.info.nih.gov/ij/). The amount 
of CTCF was normalized to DNMT1 in the same sample.
Flow cytometric analyses. Preparation of single-cell suspensions, FDG-loading, mAb 
incubations for four-color cytometry have been described43. All mAbs were purchased 
from BD Biosciences (San Diego, CA). Samples were acquired on a FACSCalibur™ 
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flow cytometer and data was analysed using CellQuest™ software (BD Bioscience). 
For cell cycle profiles of thymic subsets, cells were first stained for surface markers, 
fixed with 0.25% paraformaldehyde and permeabilized with 0.2% Tween 20. Next, 
7-AAD was added to a final concentration of 15 μg/ml in PBS. Cell cycle status of T-cell 
cultures was determined after fixing in ice-cold ethanol and subsequent staining in PBS, 
containing 0.02 mg/ml propidium iodide, 0.1% v/v Triton X-100 and 0.2 mg/ml RNAse. 
Doublet cells were excluded by measuring peak area and width. FACS sorting of DN, 
ISP and DP cells was performed with a FACSVantage VE equipped with Diva Option 
and BD FACSdiva software (BD bioscience). The purity of fractions was >98%.
Statistical analysis. Statistical evaluations were performed by standard two-tailed 
t-test.
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SUPPLEMENTARY RESULTS
CTCF deficiency in γδ T cells
LacZ expression experiments in Lck-Cre Ctcff/f mice initially suggested that the Ctcf 
gene is expressed in γδT cells (data not shown). These results are confirmed using 
GFP-CTCF as a marker (Supplementary Fig. 4B). In ocntrast to αβ T cells, deletion 
of the Ctcf gene has no adverse effect on γδ T cell development, since the number 
of CD3+TCRγδ+ thymocytes in Lck-Cre Ctcff/f mice is ~2-fold higher than in wild type 
littermates (Supplementary Fig. 2A and B). The relative proportion of γδ T cells in the 
spleens of Lck-Cre Ctcff/f mice is also markedly increased (Supplementary Fig. 2A), 
due to impaired αβ T cell production. In fact, in vitro culture of anti-CD3/CD28 antibody-
stimulated peripheral T cell fractions from Lck-Cre Ctcff/f mice results in a selective 
outgrowth of TCRγδ T cells (Supplementary Fig. 2C). We do not detect CTCF protein 
in a mixed population of in vitro activated TCRαβ and TCRγδ T cells from Lck-Cre Ctcff/f 
mice (Supplementary Fig. 2D and E). We therefore conclude that CTCF is essential 
for TCR-mediated activation and proliferative expansion of TCRαβ but not of TCRγδ T 
cells.
CTCF deficient thymocytes and the maintenance of methylation
CTCF has been proposed to be required for the maintenance of methylation at the Igf2/
H19 locus (Schoenherr et al, 2003). Aberrant methylation of this locus, or of other loci, 
might therefore cause defects in CTCF-negative T cells. As CTCF deletion is highly 
efficient in T cells from Lck-Cre Ctcff/f mice and expression of DNMT1, a maintenance 
methyltransferase with an important role in T cell development (Lee et al, 2001), is not 
significantly affected by deletion of CTCF in thymocytes (Fig. 1C and 6A), we used 
these cells to examine DNA methylation in the Igf2/H19 locus in the absence of CTCF. 
We find similar methylation of a CTCF-binding site in the Igf2/H19 imprinted locus in wild 
type and CTCF-deleted thymocytes (Supplementary Fig. 5A). We also examined the 
methylation status of the ribosomal DNA (rDNA) repeats in Ctcf knockout cells, as these 
repeats have been shown to be heavily methylated (Bird et al, 1981), and CTCF binds 
to a region of the rDNA repeat upstream of the transcription start site (Van de Nobelen 
et al, manuscript in preparation). We do not detect differences in rDNA methylation in 
the thymus (where CTCF is virtually absent) and spleen (where CTCF is not deleted) 
from Lck-Cre Ctcff/f mice (Supplementary Fig. 5B). We conclude that a deletion of 
CTCF does not lead to aberrant methylation patterns. The paralogue of CTCF, named 
CTCF-L or BORIS, can bind the same DNA sequences as CTCF (Loukinov et al, 2002). 
However, we do not detect Ctcf-l mRNA in T cells in the presence or absence of CTCF 
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(data not shown). Thus, CTCF-L neither acts in a dominant-negative fashion in T cells 
lacking CTCF, not does it compensate for loss of CTCF.
CTCF deficient thymocytes and nuclear organization
Given the important role of CTCF in chromatin organization of the rDNA repeat (Van e 
Nobelen et al, manuscript in preparation) we examined whether lack of CTCF affects 
nucleolar organization in T cells. We visualized the rDNA repeats in wild type nd 
CTCF-deficient T cells by fluorescent in situ hybridization (FISH) with an rDNA probe 
(Akhmanova et al, 2000) (Supplementary Fig. 6). Based on the FISH signals we 
counted the number of rDNA dots in CD4+ and CD8+ T cells, derived from Ctcf knockout 
(KO) and wild-type (WT) mice (Supplementary Table 1). We found a very small shift 
towards a lower number of dots in Ctcf knockout cells. Combined our data indicate 
that in naive resting T cells nuclear and nucleolar organization are not dramatically 
perturbed. The effects that we observe are therefore mainly established upon T cell 
activation, explaining the phenotype observed in ISP cells.
SUPPLEMENTARY METHODS
In vitro T cell cultures. For in vitro T cell cultures from wild-type or lck-Cre Ctcff/f mice, 
either total T cell fractions (Supplementary Fig. 2C) were purified from lymph node/
spleen by MACS depletion (using anti-B220, anti-NK1.1, anti-Ter119, anti-CD11b and 
anti-Gr-1 antibodies), TCRαβ−enriched T cell fractions (Supplementary Fig. 2D) were 
purified by MACS depletion using the same antibody mix supplemented with anti-
TCRγδ antibodies, or CD4+ T fractions (Fig. 6D) were purified by MACS depletion 
using the same antibody mix supplemented with anti-CD8 antibodies. Purity of obtained 
fractions was >98%, but the TCRαβ−enriched T cell fractions still contained TCRγδ 
low Τ cells (<2% in wild-type and ~30% in CTCF-deficient mice). T cells were cultured 
at a concentration of 1 x 106 cells/ml in Iscove’s modified Dulbecco’s medium (IMDM) 
(Bio Whittaker, Walkersville, MD) containing 10% heat-inactivated FCS, 5x10-5 M 
β-mercaptoethanol, 100 U/ml penicillin and 100 μg/ml streptomycin. Stimulation was 
with plate-bound anti-CD3 (145-2C11) and anti-CD28 (37.51) mAbs (coated at 10 μg/ml 
each) at 4 °C overnight for 7 days.
Fluorescent in situ hybridization (FISH). FACS sorted naïve CD62L+ CD4+ T cells 
from cd4-Cre Ctcff/f mice were briefly cultured (Ribeiro de Almeida et al, manuscript in 
preparation) and allowed to attach to glass slides for 30 min. Cells were fixed for 10 min 
with 4% PFA/PBS. Slides were stored in 70% EtOH until further use. For DNA-FISH 
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slides were pre-treated by two PBS wash-steps followed by a permeabilization step 
(4 min incubation in 0,1% pepsin in 0,01M HCl at 37 °C). Slides were washed once in 
PBS on ice and fixed again for 5 min in 4% PFA/PBS. Slides were washed twice in PBS 
and dehydrated. Denaturation was done for 2 min at 80 °C in denaturing solution (70% 
formamide; 2xSSC; 10 mM phosphate buffer, pH 7), after which the slides were cooled 
in 70% EtOH, dehydrated and hybridised as described (Gribnau et al, 2005). The rDNA 
probe (an 11.8 kb SalI fragment of a murine rDNA cosmid which contains non transcribed 
rDNA only (Akhmanova et al, 2000) was DIG labelled by nick translation (Roche). We 
used a Zeiss Axioplan 2 microscope for image acquisition and cell counting. Cells were 
counted without knowledge of the genotype, statistical significance was tested with the 
chi-square tool (Excel), with a P-value of 0.005.
SUPPLEMENTARY FIGURES AND TABLE
DN1 DN2 DN3 DP
CD4+
SP
CD8+
SP
DN4 ISP
pTα β α β
CD44
CD25
+ + - -
- + + -
Tcrβ Tcrα
Cell divisions ~ 3 ~ 5~ 2
Lck-Cre β-selection
Positive/negative 
selection
Migration to 
periphery
Supplementary Figure 1. Schematic overview of T cell differentiation in the thymus. T cell 
progenitors that enter the thymus are called double-negative (DN) cells. These cells differentiate 
as outlined in the figure in a series of stages towards mature thymocytes, which leave the thymus 
and migrate to the periphery. The DN1-DN4 early T cell stages are characterized by the differential 
expression of the CD25/CD44 markers. At DN2 a choice is made whether to rearrange the αβ or 
the γδ Tcr genes. The γδ T cell differentiation pathway is not depicted here. In the case of αβ T 
cells, the Tcrβ gene is rearranged first (the approximate time frame of rearrangement is indicated 
below the cells). Upon productive recombination (mediated by the RAG proteins, see main text) a 
functional β receptor is expressed at the cell surface, where it associates with pTα, a “surrogate” 
TCRα receptor, required for signalling. Cells subsequently start to grow, and they divide rapidly. 
At the double-positive (DP) stage cells cease division and start rearranging their Tcrα genes 
(approximate time frame is indicated below the cells). Productive rearrangement results in the 
expression of the αβ TCR. Positive and negative selection result in the formation of a pool of 
competent CD4 and CD8 single-positive (SP) cells. It should be realized that more than 90% of 
the DP cell population dies during the processes of selection. The approximate number of cell 
divisions in the different stages are indicated on the bottom of the scheme. The Lck-promoter 
turns on Cre expression in DN1-DN2 (indicated by downward arrow). This T cell developmental 
scheme is based on (Laurent et al, 2004; Lucas et al, 1993).
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Supplementary Figure 2. Characterization of TCRγδ cells in Lck-Cre Ctcff/f mice. (A) Flow 
cytometric analyses of total thymocytes and CD3+ splenocytes derived from wild type (WT) and 
Lck-Cre Ctcff/f mice. For the thymus, expression profiles of CD3 and TCRγδ surface markers 
are shown as dot plots. Gating is indicated by the horizontal and vertical lines in the graph. The 
percentages of CD3+TCRγδ+ cells are shown. For the spleen, data are displayed as histograms 
and the percentages represent the fractions of CD3+ cells that are TCRγδ+. Data shown are 
representative of all animals. (B) Absolute numbers of TCRγδ+ T cells in thymus and spleen of 
WT and Lck-Cre Ctcff/f mice. Each symbol represents a measurement in one animal (9 or more 
tested per group). Horizontal lines indicate averages. TCRγδ+ T cells are significantly increased 
in the thymus of Lck-Cre Ctcff/f mice (P<0.05). (C) Flow cytometric analysis of TCRγδ expression 
in T cell cultures from WT and Lck-Cre Ctcff/f mice. Lymph node fractions were stimulated by anti-
CD3/CD28 and cultured for 7 days. The percentages represent the fractions of TCRγδ+ T cells. 
The proportions of γδ+ T cells in the T-cell enriched cell suspensions before culture was <2% in 
WT and ~30% in Lck-Cre Ctcff/f mice (see also panel A). (D) Flow cytometric analysis of CD4, CD8 
and TCRγδ expression in mixed T cell cultures from WT and Lck-Cre Ctcff/f mice. Lymph node 
cell fractions were enriched for CD4 and CD8 cells and depleted for TCRγδ+ T cells, stimulated 
by anti-CD3/CD28, and cultured for 7 days. The percentages represent the fractions of different 
T cells. (E) Western blot, showing the absence of CTCF protein in mixed T cell cultures from WT 
and Lck-Cre Ctcff/f mice. Fibrillarin was used as a loading control. Molecular weight markers are 
indicated in kDa.
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Supplementary Figure 3. Comparison of CD3 expression and cell size in wild type and CTCF-
deficient thymocytes. Quantification of CD3 levels (CD3, A) and forward scatter values (FSC, B) 
in thymocyte subpopulations of wild type (WT, white bars), heterozygous Lck-Cre Ctcf+/f (grey 
bars) and homozygous Lck-Cre Ctcff/f (black bars) mice. FSC is a measure of cell size. Plotted are 
average values ± SD from 5 WT, 4 heterozygous and 3 homozygous mice. Statistically significant 
differences (t-test) are indicated (P <0.005: *, P <0.01: **, P <0.001: ***, P <0.0001: ****). DN: 
double-negative, ISP: immature single-positive, DP: double-positive, CD4: CD4 single-positive, 
CD8: CD8 single positive (see also Supplementary Figure 1).
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Supplementary Figure 4. Flow cytometric analysis of GPF-CTCF protein expression. GPF-
CTCF protein was analyzed, in conjunction with cell surface markers, in cell suspensions from 
thymus (A) and spleen (B) from mice carrying a GFP-Ctcf knock-in allele (CtcfGFP, H.H. et al., 
manuscript in preparation, for targeting strategy see (Akhmanova et al, 2005). The indicated cell 
populations were gated and expression data are displayed as histogram overlays of GFP-CTCF 
(grey) on top of background signals in wild type mice (black). Note that CTCF is also expressed 
in γδ T cells.
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Supplementary Figure 5. DNA methylation in T cells. (A) DNA methylation analysis in the 
Imprinting Control Region (ICR) of the Igf2/H19 locus. DNA was isolated from the thymus of Ctcff/f 
mice, which were either not crossed (-, lanes 2, 3 and 5) or crossed (+, lanes 4 and 6) with Lck-
Cre transgenics. Samples were digested with SacI only (lane 2) or with both SacI and ClaI (other 
lanes). ClaI cuts within CTCF binding site 1 of the Igf2/H19 ICR (Schoenherr et al, 2003). Normal 
tail DNA (lane 1) is shown as control. (B) Methylation status of ribosomal DNA (rDNA) repeats. 
Southern blot analysis of genomic DNA from thymus and spleen of the indicated mice. DNA was 
digested with EcoRI (lanes 1), EcoRI and HpaII (lanes 2), or (3) EcoRI and MspI (lanes 3). Blots 
were hybridized with the unstable 5’ external transcribed spacer probe (Akhmanova et al, 2000).
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Supplementary Figure 6. CTCF deletion does not affect nucleolar organization in resting T cells. 
FISH analysis of nucleolar organization in FACS-sorted naive CD62L+ peripheral T cells from the 
indicated mice. Slides were hybridized with a DIG-labeled rDNA probe containing non transcribed 
rDNA (Akhmanova et al, 2000). Cells were counterstained with DAPI. See Appendix for full-
color figure.
CD4+ number of rDNA dots (%)
0 1 2 3 4 5 6 7 Total
WT 0 2 17 20 32 22 5 1 100 (n =358)
KO 0 3 16 29 26 18 6 1 100 (n =368)
CD8+ number of rDNA dots (%)
0 1 2 3 4 5 6 7 Total
WT 1 5 9 27 26 21 7 3 100 (n =351)
KO 0 6 12 27 28 18 8 1 100 (n =354)
Supplementary Table 1. Number of nucleoli in wild-type (WT) and CTCF-negative (KO) T cells.
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ABSTRACT
Differentiation of naive CD4+ cells into Th2 cells is accompanied by chromatin remodeling 
at the Th2 cytokine locus allowing the expression of the IL-4, IL-5, and IL-13 genes. In 
this report, we investigated the role in Th2 differentiation of the transcription regulator 
CCCTC-binding factor (CTCF). Chromatin immunoprecipitation analysis revealed 
multiple CTCF binding sites in the Th2 cytokine locus. Conditional deletion of the Ctcf 
gene in double-positive thymocytes allowed development of peripheral T cells, but their 
activation and proliferation upon anti-CD3/anti-CD28 stimulation in vitro was severely 
impaired. Nevertheless, when TCR signalling was circumvented with phorbol ester and 
ionomycin, we observed proliferation of CTCF-deficient T cells, enabling the analysis of 
Th2 differentiation in vitro. We found that in CTCF-deficient Th2 polarization cultures, 
transcription of IL-4, IL-5, and IL-13 was strongly reduced. By contrast, CTCF deficiency 
had a moderate effect on IFN-γ production in Th1 cultures and IL-17 production in Th17 
cultures was unaffected. Consistent with a Th2 cytokine defect, CTCF-deficient mice had 
very low levels of IgG1 and IgE in their serum, but IgG2c was close to normal. In CTCF-
deficient Th2 cultures, cells were polarized toward the Th2 lineage, as substantiated by 
induction of the key transcriptional regulators Gata3 and special AT-rich binding protein 
1 (Satb1) and down-regulation of T-bet. Also, Stat4 expression was low, indicating that 
in the absence of CTCF, Gata3 still operated as a negative regulator of Stat4. Taken 
together, these findings show that CTCF is essential for Gata3- and Satb1-dependent 
regulation of Th2 cytokine gene expression.
INTRODUCTION
Protection against pathogens relies on the ability of T cells to give rise to various 
effector cell fates upon activation. Classically, naive CD4+ T cells are thought to undergo 
programmed differentiation into mainly two functionally distinct subsets, termed Th1 and 
Th2 (for review, see1, 2) Th1 cells, which produce IFN-γ, are predominantly involved 
in cellular immunity against intracellular pathogens. Two major signalling pathways 
facilitate Th1 development, one involving IL-12/Stat4 and the other involving IFN-γ/
Stat1/T-bet3-5. Th2 cells, producing IL-4, IL-5, and IL-13, mediate humoral immunity and 
are essential for the eradication of parasitic worms, but also mediate allergic responses. 
Th2 cytokine production is dependent on the transcription factor Gata3, which is rapidly 
induced by IL-4 through Stat66-10. Recently, a distinct effector T cell subset has been 
described, termed Th17. These cells produce IL-17 and control a wide range of infections 
at mucosal surfaces and are implicated in the pathogenesis of several autoimmune 
diseases first thought to be caused by deregulated Th1 function (reviewed in2). In mice, 
both TGF-β and IL-6 are required to drive Th17 differentiation through activation of the 
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orphan nuclear receptors RORγt and RORα 11, 12. Differentiation of pathogenic Th17 cells 
is developmentally related to anti-inflammatory Foxp3+ regulatory T (Treg) cells, which 
can be generated in vitro by stimulation with TGF-β in the absence of IL-613. 
Subset-specific expression of cytokine genes in T cells involves unique 
transcriptional, epigenetic, and structural mechanisms. When naive T cells are 
stimulated with Ag, they show low transcription of both IFN-γ and Th2 cytokines14, 15. 
Th2 cytokine gene promoters and the Th2 locus control region come into close spatial 
proximity to form a higher-order chromatin structure, suggesting that early expression 
of the Th2 cytokines in naive T cells is supported by an initial “poised” chromatin 
configuration16. Upon Th2 differentiation, a substantial increase in the transcriptional 
activity of IL-4, IL-5, and IL-13 and concomitant silencing of IFN-γ are observed. The 
converse pattern of gene activation and silencing is present in differentiating Th1 cells. 
Such polarized patterns of cytokine gene expression are achieved through the activation 
of cell type-specific transcription factors and chromatin remodeling proteins which bind 
to cis-regulatory elements of cytokine genes, thus initiating substantial and reciprocal 
alterations in the chromatin structure of the IFN-γ and Th2 cytokine loci (reviewed in17, 18) 
Indeed, both Stat6 and Gata3 are responsible for the establishment and/or maintenance 
of the chromatin conformation changes in the Th2 cytokine locus of developing Th2 
cells16, 19. Particularly, because Gata3 can induce chromatin-remodeling activity20, it may 
facilitate the interaction between the Th2 locus control region and the cytokine gene 
promoters and thereby coregulate IL-4, IL-5. and IL-13 expression. In addition, Th2 
cytokine expression requires special AT-rich binding protein 1 (Satb1), which mediates 
the formation of a densely looped, transcriptionally active chromatin structure at the Th2 
locus containing Gata3, Stat6, c-Maf, the chromatin-remodeling enzyme Brg1, and RNA 
polymerase II21. 
The 11-zinc finger protein CCCTC-binding factor (CTCF) is a ubiquitously 
expressed and highly conserved transcriptional regulator implicated in many key 
processes within the nucleus, including promoter activation and repression, hormone-
responsive gene silencing, and genomic imprinting (for review, see22). CTCF often binds 
in the vicinity of insulators, elements that affect gene expression by preventing the spread 
of heterochromatin (acting as “barrier”) and inhibiting inappropriate interactions between 
regulatory elements on adjacent chromatin domains (acting as “enhancer blocker”)23. It 
has been shown that CTCF is required for the enhancer-blocking activity of insulators24. 
Consistent with a role for CTCF as an insulator protein, we have shown that in the 
mouse β-globin locus, CTCF mediates long-range chromatin looping and regulates local 
histone modifications25. However, CTCF binding is not always required for chromatin 
insulation26, 27. Combined, these data establish CTCF as an important protein involved 
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in long-range DNA interactions and the regulation of active and repressive chromatin 
marks. 
Genome-wide mapping of CTCF binding sites (CBS) in the human genome 
identified ~14,000 sites, whose distribution correlated with genes but not with 
transcriptional start sites28, 29. Domains with few or no CTCF sites tend to include clusters 
of transcriptionally coregulated genes, whereby these regions are often flanked by CTCF 
binding sites28, 30. The genome-wide analyses also revealed CTCF binding sites near 
genes displaying extensive alternative promoter usage, including protocadherin γ, the 
Ig λL chain, and the TCR α/δ- and β-chain loci. In mice, CTCF binding was observed 
downstream of the TCR α/δ and the Ig H chain loci31, 32. Very recently, CTCF was 
found to control MHC class II gene expression and long-range chromatin interactions 
between MHC class II promoter regions33. These data imply an important role for CTCF 
in lymphocytes, in particular in the regulation of gene transcription in complex loci. We 
have recently found that conditional inactivation of Ctcf early in thymocyte development 
resulted in a severe arrest of early T cell development34. Our findings indicated that 
CTCF regulates cell cycle progression of αβ T cells in the thymus34. 
In this report, we investigated whether CTCF is important for Th2 cytokine 
expression. Chromatin immunoprecipitation (ChIP) assays revealed the presence of 
multiple CTCF binding sites in the Th2 cytokine locus. We show that conditional deletion 
of the Ctcf gene in the thymus, using CD4-Cre mice, allowed the generation of peripheral 
T cells, albeit with reduced numbers. In vitro polarization cultures of CTCF-deficient 
CD4+ T cells revealed a Th2 cytokine expression defect, despite normal induction of the 
transcription factors Gata3 and Satb1.
RESULTS
CTCF binding sites in the Th2 cytokine locus
CTCF binding sites in the human Th2 locus have recently been identified in CD4+ T cells30. 
Taking into account that CTCF binding sites are largely invariant between cell types28, 
we first used ChIP coupled to ultrahigh-throughput DNA sequencing data obtained in 
mouse I11 erythroid cells (S Krpic and F Grosveld, manuscript in preparation) to gain 
insight into CTCF binding in the murine Th2 cytokine locus. We identified four CTCF 
binding sites (CBS-1, CBS-3, CBS-6, and CBS-7) encompassing the 200-kb region 
containing the Il5, Rad50, Il13, Il4, and Kif3a genes (Fig. 1A). These sites, as well as 
three other CTCF binding sites (CBS-2, CBS-4, and CBS-5), have been reported to be 
occupied in mouse embryonic stem cells35. We subsequently analyzed CTCF-binding to 
CBS-1 to CBS-7 in cultured Th1 and Th2 cells by ChIP. For these experiments, MACS-
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purified CD4+ T cells from spleen and lymph nodes were stimulated with anti-CD3/
CD28 under Th1-polarizing conditions (with IL-12 and anti-IL-4 Abs) or Th2-polarizing 
conditions (with IL-4, anti-IL-12, and anti-IFN-γ Abs) for 7 days. Quantitative real-time 
PCR analyses showed that CTCF binding to CBS-1, CBS-3, CBS-6, and CBS-7 was 
significantly increased when compared with IgG control, both in Th1- and Th2-polarized 
cells (Fig. 1B). A similar enrichment at these sites was also found in PMA/ionomycin- 
activated Th1- and Th2-polarized cells (data not shown). Thus, the Il-4, Il-5, and Il-13 
genes in the Th2 locus are flanked by CBS-6 and CBS-7 upstream of the Il-5 gene 
and CBS-1 downstream of the Il-4 gene, within the Kif3a gene. Interestingly, CBS-3 is 
located in the intergenic region between the Il-13 and Il-4 genes, close to a conserved 
noncoding sequence, designated CNS-1, which has been shown to be critical for Gata3 
binding and Th2 cytokine expression36, 37. Our data indicate that the CTCF protein binds 
to CBS-1, CBS-3, CBS-6, and CBS-7, irrespectively, of Th1 or Th2 polarization.
Conditional deletion of the Ctcf gene in T lymphocytes
To study CTCF function in vivo, we generated a conditional Ctcf allele (Ctcff) by inserting 
a loxP site upstream of exon 3 and a loxP site along with a lacZ reporter downstream 
of exon 12 (Fig. 2A)34. We bred Ctcff/f mice to mice carrying a Cre-encoding transgene 
under the control of the CD4 promoter38. Southern blotting showed almost complete 
deletion of the Ctcf gene in the thymus of CD4-Cre Ctcff/f mice, whereas in the spleen Ctcf 
deletion was only partial, reflecting the presence of many non-T lineage cells (Fig. 2B)
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Figure 1. CTCF binding sites in the murine Th2 cytokine locus. (A) Schematic representation 
of the Th2 cytokine locus and CTCF binding sites (CBS-1 to CBS-7). CBS were identified by a 
bioinformatics approach in combination with ChIP assays. (B) ChIP analysis in Th1 and Th2 cells. 
Analysis was performed with CTCF (black) or IgG (white) Abs in 7-day polarized Th1 or Th2 cells. 
Mean values and SD are given for two ChIP experiments; *, P<0.05 and **, P<0.01.
Claudia Thesis_2.indd   137 17/10/2010   21:18:24
138 Chapter 4
A
H H
H H H
H H
probe
neor puror SAlacZ
SAlacZ
5’end targeting 3’end targeting
Cre-mediated
recombination
Wild-type allele
(WT)
Floxed allele
(Ctcff)
Deleted allele
(Ctcf-)
B Ctcf allele wt
CD4-Cre
+/f f/f wt +/f f/f
- + + - + +
wt*
flox
del
wt
D
CD4
CD4-Cre
CD8
- + - +
DNMT1
CTCF
UBF
DN1 DN3 DN4DN2
ISP CD4 SP CD8 SPDP
LacZ
Counts
thymus spleen
C
Figure 2. Conditional targeting of the mouse Ctcf gene. (A) Simplified map of the wild-type (WT) 
murine Ctcf locus and modified alleles. Top line, WT Ctcf allele, with exons shown as solid boxes, 
and position of HindIII sites (H) and the Southern blot probe (arrow) indicated. Middle line, Floxed 
Ctcf allele (Ctcff). Two targeting cassettes were inserted into the Ctcf gene via consecutive rounds 
of homologous recombination. The first cassette contained LoxP sites (black arrows) flanking 
a PMC1-driven neomycin resistance gene (neor), the second cassette contained LoxP sites 
flanking a PGK-driven puromycin resistance gene (puror), followed by a splice acceptor-lacZ 
cassette (SA-LacZ). Bottom line, deleted Ctcf gene (Ctcf–) generated after complete Cre-mediated 
recombination at the outermost loxP sites. For details on constructs and targeting, see34. The small 
horizontal lines underneath each allele represent HindIII fragments recognized by the probe in the 
Southern blot analysis of B below. (B) Southern blot analysis of CD4-Cre recombinase activity. 
HindIII-digested genomic DNA from thymus and spleen of mice of the indicated genotypes was 
analyzed by hybridization with a CTCF locus-specific probe (see A). The positions of the WT, 
Ctcff/f (flox), and Ctcf–/– (del) alleles are indicated (asterisk indicates a polymorphic WT allele 
from the FVB background). (C) Western blot analysis of sorted naive CD62L+CD4+ and CD8+ 
T cell fractions from nontransgenic (–) or CD4-Cre-transgenic (+) Ctcff/f mice were analyzed for 
CTCF. DNMT1 and UBF were used as loading controls. (D) Flow cytometric analysis of LacZ 
expression in CTCF conditionally deleted mice. LacZ expression was analyzed in conjunction 
with cell surface markers. The indicated cell populations were gated and lacZ expression data are 
displayed as histogram overlays of CD4-Cre Ctcff/f mice (grey) on top of the background signals 
in WT mice (black). ISP, Immature SP.
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To evaluate the onset of Ctcff gene deletion, we analyzed thymocyte subpopulations for 
expression of the Ctcf-lacZ fusion transcript, using fluorescein-di-β-D-galactopyranoside 
as a substrate in conjunction with cell surface markers. Consistent with the reported 
CD4-Cre activity at the double-negative (DN) stage39, Ctcf deletion was initiated in DN 
cells (DN2 to DN4) and completed from the immature single-positive (ISP) cell stage 
onward (Fig. 2D). Despite efficient deletion of the Ctcf gene in the thymus, residual 
CTCF protein was still detectable in purified fractions of peripheral naive CD62L+CD4+ 
and CD8+ T cells (~25% of control; Fig. 2C), indicating that CTCF is a remarkably stable 
protein in resting naive T cells. 
To examine the effects of Ctcf deletion on T cell development, thymocyte 
subpopulations from 6- to 8-wk-old CD4-Cre Ctcff/f mice and wild-type (WT) littermates 
were analyzed by flow cytometry. CD4-Cre Ctcff/f mice displayed low thymic cellularity, 
with reduced numbers of double-positive (DP), CD4, and CD8 single-positive (SP) 
Figure 3. Defective TCRαβ lineage development in CTCF-deficient mice. (A) Flow cytometric 
analyses of the indicated cell populations in thymus or spleen from wild-type (WT) and CD4-Cre 
Ctcff/f mice. Expression profiles of surface markers are shown as dot plots and the percentages 
of cells within the quadrants or gates are given. (B) and (C) Absolute numbers of the indicated 
thymic and splenic T cell subpopulations. Each symbol represents one individual animal and lines 
indicate average values. Values of P of significant differences between WT and CD4-Cre Ctcff/f 
mice are indicated.
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cells, when compared with WT controls (Fig. 3A,B). The CD4–CD8+ thymocyte fraction 
had a relative increase of CD3lowCD69low ISP cells and a decrease of CD3+CD8+ SP 
cells. Consistent with impaired thymic SP cell production, the numbers of mature CD4+ 
and CD8+ T cells in spleen and lymph nodes of CD4-Cre Ctcff/f mice were significantly 
reduced (Fig. 3A,C and data not shown). Furthermore, the numbers of γδ T cells in the 
spleens of CD4-Cre Ctcff/f mice were increased (Fig. 3C).
In summary, in CD4-Cre Ctcff/f mice, αβ T cell development is partially arrested 
at the DP stage, resulting in a significant reduction of the numbers of peripheral CD4+ 
and CD8+ T cells.
Defective TCR/CD3-mediated proliferation of CTCF-deficient CD4+ and CD8+ T 
cells
To investigate cellular activation of CTCF-deficient T cells, we performed in vitro 
stimulation experiments with highly purified naive CD62L+CD4+ and CD8+ peripheral T 
cells. We evaluated their ability to go through sequential cell divisions by CFSE labeling 
and observed severely reduced proliferation of anti-CD3/CD28-activated CTCF-deficient 
CD4+ T cells at day 3 (Fig. 4A). Proliferation was not only defective when standard 
conditions of 10 µg/ml anti-CD3/anti-CD28 were used, but also when we increased either 
of the two (or both) Ab concentrations to 50 µg/ml (data not shown). Next, the capacity 
of CTCF-deficient CD4+ T cells to proliferate upon a more physiological, Ag-specific 
stimulation was investigated by crossing CD4-Cre-Ctcff/f mice with OT-II-transgenic 
mice, which harbor a TCR specific for OVA peptide. Upon activation by OVA peptide323–
339-pulsed APC, survival of nondividing
 (WT and CTCF-deficient OT-II-transgenic CD4+ 
T cells was similar, but we noticed a severe proliferation defect in the absence of CTCF 
(Fig. 4A). Although anti-CD3/CD28-activated CTCF-deficient CD8+ T cells were able to 
undergo cell division, they lagged behind WT cells by approximately one cell cycle, and 
cell recovery was reduced when compared with WT CD8+ T cells (Fig. 4A). 
PMA bypasses proximal TCR signalling events and directly activates protein 
kinase C signalling40. Under conditions where PMA was added as a costimulatory signal 
with anti-CD3, CTCF-deficient cells showed defective proliferation. However, when T 
cells were stimulated by PMA and the calcium ionophore ionomycin (which raises the 
intracellular level of Ca2+), we observed significant proliferation of CTCF-deficient CD4+ 
and CD8+ T cells (Fig. 4A).
Consistent with limited cell division observed in the CFSE experiments, anti-
CD3/CD28-stimulated CTCF-deficient CD4+ T cell cultures showed diminished cell 
recovery and an almost complete lack of cells in the S-G2-M phase of the cell cycle (Fig. 
4B). Although CTCF-deficient PMA/ionomycin-stimulated CD4+ or CD8+ T cell cultures 
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exhibited lower expansion rates, their cell cycle profiles at day 3 were similar to those 
from WT cells (Fig. 4B). In vitro proliferation of CD4-Cre Ctcff/f T cells did not reflect 
a specific expansion of rare cells that have escaped CTCF deletion, as CTCF protein 
levels were severely reduced both in CD8+ (Fig. 4C) and in CD4+ T cell cultures (see 
Fig. 9C). 
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Figure 4. Impaired anti-CD3ε-mediated proliferation of CTCF-deficient T cells. (A) CFSE profiles 
of T cell cultures of sorted CD62L+CD4+ and CD8+ T cell populations from wild-type (WT) mice 
(gray histograms) in comparison to cultures from CD4-Cre Ctcff/f mice (black line). Cells were 
activated by the indicated stimuli and cultured for 3 days (or 4 days for OTII CD4 T cells). Dotted 
lines indicate the fluorescence intensity of unstimulated cells. (B) Cellular expansion in 3-day 
cultures upon anti-CD3/CD28 or PMA/ionomycin stimulation (upper part). Symbols represent the 
expansion values of cultures from individual mice, whereby cell numbers at the start of the culture 
were set to one; lines indicate average values. Values of P of significant differences between 
WT and CD4-Cre Ctcff/f mice are indicated; n.s., not significant. The lower part shows the cell 
cycle status of the indicated cultures, whereby DNA content was examined by propidium iodide 
(PI) staining. The percentages of cycling cells (S-G2-M phase) are shown. (C) Western blotting 
analysis of naive CD62L+CD8+ T cells from WT or CD4-Cre-transgenic Ctcff/f mice cultured for 5 
days and examined for CTCF levels. Fibrillarin was used as a loading control.
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Taken together, these findings demonstrate that conditional deletion of the Ctcf 
gene in DP thymocytes allows development of peripheral T cells, but their activation 
and proliferation upon anti-CD3/anti-CD28 stimulation in vitro is severely impaired. 
Nevertheless, when TCR signalling is circumvented with phorbol ester and ionomycin, 
CTCF-deficient T cells have the capacity to proliferate, indicating that in this context loss 
of CTCF can be compensated for by signalling molecules or nuclear factors induced by 
PMA/ionomycin. These results therefore indicate that CTCF is not absolutely required 
for cell proliferation. 
Defective TCR/CD3-mediated activation of CTCF-deficient CD4+ and CD8+ T cells 
Next, we investigated whether defective proliferation of CTCF-deficient T cells was 
caused by impaired cellular activation. Binding of IL-2 to its receptor is a critical event 
in the initiation of T cell proliferation, since it regulates transition of the cell cycle from 
G1 into S phase
41. Therefore, we investigated whether CTCF-deficient T cells had an 
IL-2 production defect or impaired IL-2R induction. We found that upon stimulation with 
anti-CD3/CD28 or PMA/ionomycin, the absence of CTCF did not affect IL-2 production 
in CD4+ or CD8+ T cells, as analyzed by intracellular cytokine staining at day 3 (Fig. 5A). 
By contrast, induction of the IL-2 receptor CD25 on CTCF-deficient CD4+ and CD8+ T 
cells was severely impaired, when activated by plate-bound anti-CD3/CD28 (Fig. 5B). 
When activated by PMA/ionomycin, CTCF-deficient CD4+ T cells displayed a partial 
defect in CD25 up-regulation, while in CD8+ T cells CD25 induction was normal. 
Expression of CD69, an ~30-kDa glycoprotein induced in activated T cells, was 
hampered in CTCF-deficient CD4+ T cells upon TCR stimulation, but was normal in 
CD8+ T cells or in PMA/ionomycin-stimulated CTCF-deficient T cells. Finally, analyses 
of forward scatter values of stimulated cells showed that cell size increases in CTCF-
deficient cells were limited, particularly upon anti-CD3/CD28 stimulation, whereby CD4+ 
cells were more affected than CD8+ cells (Fig. 5B). 
From these findings, we conclude that anti-CD3/CD28 treatment does not elicit 
proper activation of CTCF-deficient peripheral T cells, in terms of induction of CD25, 
CD69, and cell size increase, whereby CD4+ T cells are somewhat more affected than 
CD8+ T cells. However, when T cells are stimulated by PMA/ionomycin, expression 
levels of CD25 and CD69 are largely in the normal ranges. 
CD4-Cre Ctcff/f mice have severely reduced serum levels of IgG1 and IgE 
Concentrations of Ig subclasses in the serum of CD4-Cre Ctcff/f mice were reduced, 
except for IgM and IgG3, which are T cell independent and IgA which requires TGF-β 
expression (Fig. 6A). This does not necessarily mean that CTCF-deficient CD4+ T cells 
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produce normal levels of TGF-β, since this cytokine is secreted by many cell types. 
Interestingly, serum levels of the IL-4-dependent isotype IgG1 were more affected 
than those of the IFN-γ-dependent isotype IgG2c (~10 and ~60% of WT, respectively). 
Serum concentrations of the IL-4-dependent isotype IgE were also lower in the absence 
of CTCF (Fig. 6B). Moreover, when Th2-mediated responses were tested in vivo by 
injection of a low dose of TNP-KLH in alum (10 µg), we observed an increase in the 
concentration of total IgE in WT mice at day 10, but not in CD4-Cre Ctcff/f animals (Fig. 
6B). Thus, the absence of CTCF resulted in a severe deficiency for the Th2-dependent 
subclasses IgG1 and IgE in the serum, whereas the Th1-dependent subclass IgG2c 
was only moderately affected. CD4-Cre Ctcff/f mice also had very low levels of IgG2b 
in the serum. Because class switch recombination to IgG2b is thought to be regulated 
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Figure 5. Impaired cellular activation of CTCF-deficient T cells. (A) Analysis of IL-2 expression in 
anti-CD3/CD28 and PMA/ionomycin-stimulated cultures of sorted CD62L+CD4+ and CD8+ T cell 
fractions from wild-type (WT) and CD4-Cre Ctcff/f mice. At day 3, cells were restimulated for 4h 
before intracellular flow cytometric analysis. Total living cells were gated and CD4/IL-2 and CD8/
IL-2 profiles are displayed as dot plots and the percentages of cells within the quadrants are given. 
Data shown are representative of four mice per group. (A) Phenotypic characteristics of anti-CD3/
CD28 or PMA/ionomycin-stimulated CD4+ and CD8+ T cells. CD25, CD69, and forward scatter 
profiles are displayed as histogram overlays of WT (gray histograms) and CD4-Cre Ctcff/f cultures 
(bold lines). The percentages shown represent the fractions of the cells within the indicated 
marker in WT (grey) or CD4-Cre Ctcff/f (black, bold) cultures. Data shown are representative of 
four to six mice per group.
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by various cytokines including IFN-γ and TGF-β, but not by Th2 cytokines, the IgG2b 
deficiency cannot be explained by a selective Th2 defect.
Th2 cytokine defect in CD4-Cre Ctcff/f mice 
Next, we performed in vitro polarization cultures to investigate whether CTCF is 
specifically required for differentiation of Th2 effector cells. Sorted naive CD62L+CD4+ 
T cells from spleen and lymph nodes were stimulated with anti-CD3/CD28 or PMA/
ionomycin under Th0 conditions (without additional cytokines or Abs), Th1-polarizing 
conditions (with IL-12 and anti-IL-4), or Th2-polarizing conditions (with IL-4, anti-IL-12, 
and anti-IFN-γ) for 7 days. Under these conditions, anti-CD3/CD28-stimulated WT CD4+ 
T cell fractions manifested a 10- to 100-fold expansion in 7 days (Fig. 7A). Consistent 
with the observed severely defective proliferation of anti-CD3/CD28-stimulated 
CTCF-deficient CD4+ T cells, we found that the expansion of these cells at day 7 was 
negligible. Importantly, replacing anti-CD3/CD28 by PMA/ionomycin stimulation resulted 
in significant expansion of CTCF-deficient T cell cultures (~2–10 times at day 7; Fig. 
7A), enabling the analysis of Th1 and Th2 development in vitro. Under these conditions, 
WT Th cultures showed an ~10- to 30-fold expansion (Fig. 7A).
In Th1-polarized cultures, CTCF-deficient T cells produced moderately reduced 
levels of IFN-γ when compared with WT T cells, as determined by intracellular flow 
cytometry (Fig. 7B). The proportions of IFN-γ+ cells were 55 ± 15% (n = 7) and 23 ± 6% 
(n = 4; P < 0.005) in WT and CTCF-deficient Th1 cultures, respectively. Remarkably, 
CTCF-deficient T cells showed a more severe IL-4 production defect in Th2-polarized 
cultures. Both the frequency of IL-4+ T cells (51 ± 11% (n = 7) in WT and 9 ± 4% (n = 
4; P < 0.00005) in CTCF-deficient cultures) and intracellular IL-4 signals per cell were 
significantly reduced in the absence of CTCF (Fig. 7B). Additional intracellular flow 
cytometry analyses showed that in CTCF-deficient Th2 cell cultures IL-5 production was 
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Figure 6. Serum Ig analysis in CTCF-deficient mice. (A) Serum concentrations of Ig isotypes 
displayed as average values plus SD. Mice were 2 mo of age. (B) Total IgE serum concentrations 
in nonimmunized mice (left) and in immunized mice 7 days after i.p. injection with 10 µg TNP-KLH 
(right).
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Figure 7. CTCF regulates Th2 cytokine expression. (A) Expansion of Th0, Th1, and Th2 
cultures 7 days after stimulation with anti-CD3/CD28 or PMA/ionomycin. Symbols represent the 
expansion values of cultures from individual mice, whereby cell numbers at the start of the culture 
were set to 1. Lines indicate average values. Values of P of significant differences between wild-
type (WT, white) and CD4-Cre Ctcff/f (black) mice are indicated. (B) Flow cytometric analysis for 
intracellular expression of IFN-γ and IL-4 in the indicated T cell cultures after stimulation with 
PMA/ionomycin. CD4+ T cells were gated and expression profiles are displayed as dot plots. The 
percentages of cells within the quadrants are given. Mean fluorescence values for IL-4 were 138 
and 75 for WT and CD4-Cre Ctcff/f IL-4+ Th2 cells, respectively. (C) Flow cytometric analysis for 
intracellular expression of the indicated cytokines after stimulation with PMA/ionomycin. Total 
cells and CD4+ T cells were gated and expression profiles are displayed as CD4/IL-5 and IL-10/
IL-13 dot plots, respectively. (D) Cytokine levels of WT (white) and CD4-Cre Ctcff/f (black) Th2 
cultures supernatant after stimulation with PMA/ionomycin. Mean values and SD are given for 
two seven mice analyzed per group; *, P<0.05 and **, P<0.01. (E) Quantitative RT-PCR analysis of 
expression of the indicated cytokines in different T cell cultures (WT, white; CD4-Cre Ctcff/f, black). 
Expression levels were normalized for Gapdh and are expressed as arbitrary units, whereby the 
values in WT Th2 cells were set to 1. Mean values and SD are given for four mice analyzed per 
group; *, P<0.05 and **, P<0.01.
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not detectable and IL-10 and IL-13 were severely reduced (Fig. 7C). Consistent with 
these findings, in the supernatants of Th2-polarized cultures, production of IL-4, IL-5, 
and IL-13 was significantly reduced in the absence of CTCF, as determined by ELISA 
(Fig. 7D). Finally, quantitative RT-PCR analysis of day 7 cultures showed that in CTCF-
deficient Th2 cultures transcription of the IL-4, IL-5, and IL-13 cytokines was strongly 
reduced (Fig. 7E). We also analyzed transcription of the Il-10 gene, which is not located 
within the Th2 locus, and found that in the absence of CTCF IL-10 expression was very 
low, both in Th1 and Th2 cultures. 
Thus, in CTCF-deficient Th2 polarization cultures in vitro, transcription of IL-4, 
IL-5, and IL-13 was strongly reduced. By contrast, CTCF deficiency had a moderate 
effect on IFN-γ production in Th1 cultures. 
Th17 and Treg differentiation in CD4-Cre Ctcff/f mice 
The observed Th2 cytokine defect in CTCF-deficient Th2 cells prompted us to investigate 
whether differentiation toward alternative CD4 T cell fates, including Th17 and Treg 
cells, was possible in the absence of CTCF. We activated sorted naive CD62L+CD4+ 
T cells with PMA/ionomycin and cultured them under Th17 conditions (in the presence 
of TGF-β, IL-6, anti-IFN-γ, and anti-IL-4) or Treg conditions (with TGF-β, anti-IFN-γ, 
and anti-IL-4). As examined in CSFE experiments, we observed significant proliferation 
of CTCF-deficient CD4+ T cells under Th17 and Treg conditions at day 3 (Fig. 8A). 
When Th17 cultures were analyzed for intracellular cytokines at day 5, we found that the 
expression of IL-17 in CTCF-deficient T cells reached values that were similar to those 
found in WT T cells (~8%, n = 6; Fig. 8B). In addition, we noticed a small but consistent 
population of IFN-γ+ cells in CTCF-deficient Th17 cultures, which was not detected in 
WT Th17 cultures. 
When naive WT CD62L+CD4+ T cells were cultured under Treg conditions for 3 
days, a large majority of cells (85 ± 2%, n = 3; Fig. 8C) expressed Foxp3, the transcription 
factor associated with Treg differentiation42. Such Foxp3+ cells were also present in Treg 
cultures of CTCF-deficient T cells, albeit that the proportions were slightly lower (62 ± 
2%; n = 3). Furthermore, the proportions of naturally occurring CD25+Foxp3+CD4+ Treg 
cells in spleen and lymph nodes in vivo were not different between WT and CTCF-
deficient mice (Fig. 8D).
As a control, we also evaluated IFN-γ and granzyme B expression in day 7 
cultures of anti-CD3/CD28- or PMA/ionomycin-stimulated CD62L+CD8+ T cells. We 
found that production of IFN-γ and granzyme B was only moderately affected (data not 
shown). 
Collectively, these findings show that differentiation of CTCF-deficient T cells into 
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IL-17-producing Th17 cells is apparently normal and lack of CTCF has limited effects 
on differentiation of Treg and CD8+ T cells. We therefore conclude that the absence of 
CTCF does not result in a global defect in effector T cell differentiation. 
Gata3 and Satb1 expression in CD4-Cre Ctcff/f Th2 cells 
Because Th2 cytokine production depends on the transcription factor Gata36-10 we 
evaluated its expression in the T cell cultures. As determined by intracellular flow 
cytometry, Gata3 expression appeared unaffected in CTCF-deficient Th2 cultures (Fig. 
9A), excluding the possibility that Th2 cytokine production was impaired due to defective 
Gata3 induction. Furthermore, the CTCF-deficient Th2 cultures displayed clear features 
of Th2- polarized cells, including low mRNA levels of T-bet and Stat4 (Fig. 9B). Since 
Gata3 has the capacity to inhibit Stat4 transcription43, the finding of low Stat4 expression 
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Figure 8. CTCF is not essential for Th17 or Treg differentiation. (A) CFSE profiles of Th0, 
Th17, and Treg cultures of sorted CD62L+CD4+ T cell populations from wild-type (WT) mice 
(gray histogram) in comparison to cultures from CD4-Cre Ctcff/f mice (black line). Cells were 
activated with PMA/ionomycin and cultured for 3 days. Dotted lines indicate the fluorescence 
intensity of unstimulated cells. (B) Flow cytometric analysis for intracellular expression of IFN-γ 
and IL-17 in Th0 and Th17 cultures after stimulation with PMA/ionomycin. CD4+ T cells were 
gated and expression profiles are displayed as dot plots. The percentages of cells within the 
quadrants are given. (C) Flow cytometric analysis for intracellular Foxp3 and IL-17 expression 
in PMA/ionomycin-stimulated Treg cultures. CD4+ T cells were gated and expression profiles are 
displayed as dot plots. (D) Flow cytometric analysis for intracellular Foxp3 and membrane CD25 
with quantification of CD25+Foxp3+ Treg cells in spleen and mesenteric lymph nodes in vivo. Data 
shown are representative of four to six mice per group.
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levels suggest that in the absence of CTCF Gata3 still operated as a negative regulator 
of Stat4. In CTCF-deficient Th1 cultures, T-bet expression was reduced when compared 
with WT (Fig. 9B), which is consistent with the observed reduction in IFN-γ expression. 
Next to Gata3, Satb1 has also been implicated in Th2 locus expression21. Satb1 was 
specifically induced, both in WT and CTCF-deficient Th2 cultures (Fig. 9C). 
Taken together, these data indicate that differentiating CTCF-deficient Th2 cells 
show impaired expression of Th2 cytokines IL-4, IL-5, and IL-13, but nevertheless up-
regulate the Th2-specific factors Gata3 and Satb1 and down-regulate T-bet and Stat4.
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Figure 9. Gata3 and Satb1 are induced in CTCF-deficient Th2 cultures. (A) Flow cytometric 
analysis for intracellular Gata3 protein expression in PMA/ionomycin-stimulated T cell cultures. 
CD4+ T cells were gated and for the indicated mice expression profiles are displayed as histograms 
overlays of Th1 (gray histograms) and Th2 cultures (bold lines). (B) Quantitative RT-PCR analysis 
of Gata3, T-bet, and Stat4 expression in different T cell cultures from WT (white) or CD4-Cre Ctcff/f 
mice (black). Expression levels were normalized for Gapdh and are expressed as arbitrary units, 
whereby expression in WT Th1 cells (T-bet, Stat4) or Th2 cells (Gata3) was set to 1. Mean values 
and SD are given for four mice analyzed per group. (C) Western blotting analysis of Satb1 and 
CTCF protein levels in PMA/ionomycin-stimulated T effector cell cultures at day 7. Fibrillarin was 
used as a loading control.
Claudia Thesis_2.indd   148 17/10/2010   21:18:31
CTCF controls Th2 cytokine expression 149
C
ha
pt
er
 4
DISCUSSION
The differentiation process of naive CD4+ T cells to Th1 or Th2 cells is critically dependent 
on coordinated transcriptional regulation of cytokine gene loci18. To investigate whether 
CTCF regulates transcription of cytokine-encoding genes, we studied mice in which 
CTCF was conditionally deleted in the T cell lineage. Our data indicate that CTCF 
deficiency affects differentiation of Th2 effector cells by impairing T cell activation as well 
as Th2 cytokine production. Activation and proliferation of CTCF-deficient CD4 and CD8 
cells upon anti-CD3/anti-CD28 stimulation in vitro was severely hampered. However, 
when TCR signalling was circumvented with phorbol ester and ionomycin, we observed 
proliferation of CTCF-deficient T cells, enabling the analysis of Th cell differentiation. 
We found that in CTCF-deficient Th2 polarization cultures, transcription of IL-4, IL-5, 
and IL-13 was strongly reduced. By contrast, CTCF deficiency had only a modest effect 
on IFN-γ production in Th1 cultures and did not appear to affect Th17 differentiation 
and IL-17 production. In CTCF-deficient Th2 cultures, cells were polarized toward the 
Th2 lineage, as the key transcriptional regulators Gata3 and Satb1 were induced and 
T-bet and Stat4 were down-regulated. Nevertheless, expression of IL-4, IL-5, and IL-
13 remained strongly inhibited in these otherwise Th2-polarized cells. We therefore 
propose that CTCF plays a major role in the Gata3- and Satb1-dependent regulation of 
the expression of genes within the Th2 cytokine locus. 
We found that CTCF-deficient CD4+ and CD8+ T cells have severely defective 
activation and proliferation in response to anti-CD3/CD28 stimulation. Nevertheless, 
one of the most important downstream events, production of IL-2, was not noticeably 
affected, ruling out global defects in TCR clustering, actin polymerization, or activation 
of Nfat, NF-κB, and Jnk cascades44, 45. The finding that PMA/ionomycin stimulation 
bypassed the CD3/CD28-signalling defect suggests that the presence of CTCF is 
important for signalling events downstream of the TCR which are necessary for full T 
cell activation. In this context, we found that PMA/ionomycin partially (in CD4+ T cells) 
or completely (in CD8+ T cells) rescued the defective induction of IL-2R expression in 
CTCF-deficient T cells observed upon anti-CD3/CD28 stimulation (Fig. 5B). Additional 
experiments are required to clarify whether CTCF controls gene expression of specific 
proteins involved in proximal signalling events (induced upon TCR stimulation) that 
regulate IL-2R induction. 
The in vitro Th1 polarization cultures showed that CTCF-deficient Th1 effector 
cells produced significant amounts of IFN-γ, but expression was reduced when 
compared with WT. Also, in anti-CD3/CD28-stimulated CTCF-deficient CD8+ T cells, 
we found that the proportion of IFN-γ+ cells was ~60% of that in WT cells (C Ribeiro 
de Almeida, unpublished data). In contrast, we observed a small cloud of IFN-γ+ cells 
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in Th17 cultures from CTCF-deficient T cells, which was not detectable in WT Th17 
cultures, indicating that IFN-γ expression is not reduced under all culture conditions. 
Therefore, we conclude that the observed reduction of IFN-γ production in CTCF-
deficient Th1 cells does not necessarily implicate CTCF in transcriptional regulation of 
the Ifng locus, as decreased IFN-γ production may well result form reduced expression 
of essential transcription factors such as T-bet and Stat4 (Fig. 9B). 
Our analysis of CTCF binding in the Th2 cytokine locus revealed four CBS: 
three sites flanking the Th2 locus (CBS-6 and CBS-7 upstream of the Il-5 gene, CBS-1 
downstream of Il-4, within the Kif3a gene) and one site in the intergenic region between 
Il-13 and Il-4 (CBS-3), irrespective of Th1 or Th2 polarization. CBS-3 is located near the 
conserved noncoding sequence CNS-1, which is critical for Th2 cytokine expression 
and binds the C-terminal zinc finger of Gata336, 37. However, because the distance 
between CNS-1 and CBS-3 is ~1 kb, it is not very likely that CTCF binding to CBS-3 
influences Th2 cytokine expression by direct interaction with nuclear proteins recruited 
to the CNS-1 region. 
Interestingly, CBS-3 is located at the constitutive hypersensitive site HSS-3, 
which has been shown to be present both in naive CD4+ cells and Th1 and Th2 cells36. 
Although nine Satb1 sites were identified in the mouse Th2 locus21, none of these is 
located near the CNS-1 region. Thus, Satb1 and CTCF binding sites in the Th2 locus 
are interspersed. One of the possible explanations for defective Th2 cytokine expression 
in the absence of CTCF would be that CTCF is involved in chromatin organization of the 
Th2 locus. In such a model, loss of CTCF would affect Satb1-mediated looping of the 
Th2 locus and, consequently, Th2 cytokine expression. Indeed, studies in the chicken 
β-globin locus have led to a model of CTCF-dependent enhancer-blocking function 
based on the interaction between CTCF and the nucleolar protein nucleophosmin, 
whereby tethering of the insulator to a nuclear structure prevents enhancer-promoter 
communication46. Moreover, Satb1 was originally identified as a matrix attachment region 
DNA-binding protein47, which possibly contributes to chromatin loop organization48. It 
would be interesting to investigate whether CTCF binding sites at the Th2 cytokine locus 
are involved in the tethering of this 200-kb DNA region to subnuclear sites, thereby 
allowing coordinated expression of Th2 cytokine genes from a Satb1-dependent, 
transcriptionally active chromatin structure. 
However, mechanisms other than formation of chromatin loops can also 
account for CTCF function and explain the defective Th2 cytokine expression observed 
in the absence of CTCF. Similar to its role in the mouse β-globin locus25, CTCF could 
function to direct local histone modifications at the Th2 cytokine locus. Indeed, high-
resolution profiling of histone methylation in the human genome showed that CTCF 
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marks boundaries of histone methylation domains30 and CTCF interaction with histones 
or histone-modifying proteins have been reported30, 46, 49, 50. Additionally, CTCF has also 
been shown to interact with the large subunit of RNA polymerase II51, shown to be 
recruited to the Th2 cytokine locus upon Th2 cell activation21. Finally, it remains possible 
that the effect of CTCF on Th2 cytokine expression is indirect. For example, CTCF could 
be an essential regulator of the expression 1) of nuclear regulators other than Gata3 
or Satb1 that are required for Th2 cytokine transcription or 2) of enzymes involved in 
posttranslational modifications of Th2-specific transcription factors. 
The role for CTCF in the Gata3/Satb1-mediated regulation of the Th2 cytokine 
locus may well parallel its recently described role in the control of MHC class II gene 
expression and the formation of long-distance chromatin interactions involving the 
CIITA33. In contrast, we reported that deletion of one CTCF binding site in the mouse 
β-globin locus did not affect expression of the β-globin genes25. Thus, it is clear that 
CTCF has cell type-specific functions. It was proposed that CTCF remains bound to its 
~14,000 cognate binding sites irrespective of cell type28. It will be interesting to determine 
how CTCF performs cell type-specific roles while remaining bound to its cognate sites. 
Equally interesting are the questions how and which chromosomal interactions, both in 
cis-and in trans, persist in the absence of CTCF. Importantly, our experiments in mature 
CTCF-negative T cells show they can proliferate and differentiate under appropriate 
conditions and it is therefore feasible to address these issues using CTCF knockdown 
or conditional targeting approaches.
METHODS
Mice. T cell-specific deletion of Ctcf was achieved by breeding Ctcff/f mice34, which were 
crossed on the C57BL/6 background for >10 generations to CD4-Cre mice38, which were 
provided by Dr. C. Wilson (University of Washington, Seattle, WA). OT-II-transgenic 
mice have been described previously52. Mice were genotyped by Southern blotting or 
by PCR using Cre-specific primers. Mice were bred and maintained in the Erasmus MC 
animal care facility under specific pathogen-free conditions and analyzed at 6–10 wk of 
age. Experimental procedures were reviewed and approved by the Erasmus University 
committee of animal experiments.
RNA and protein analyses. Total RNA was extracted using the GeneElute mammalian 
total RNA miniprep system (Sigma-Aldrich). Primers spanning at least one intron-exon 
junction were designed either manually or using the ProbeFinder software (Roche Applied 
Science). Probes were chosen from the universal probe library (Roche Applied Science) 
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or designed manually (Gata3, Gapdh) and purchased from Eurogentec. Quantitative real-
time PCR was performed using an Applied Biosystems Prism 7700 sequence detection 
system. To confirm the specificity of the amplified products, samples were separated by 
standard agarose gel electrophoresis. Threshold levels were set and further analysis 
was performed using the SDS version 1.9 software (Applied Biosystems). Obtained 
cycle threshold values were normalized to cycle threshold values of Gapdh or β-actin. 
Each PCR was performed at least in triplicate. Primer sequences and PCR conditions 
used are available on request. Nuclear extracts were prepared and analyzed by Western 
blot53. Abs specific for CTCF (N3) and fibrillarin have been previously described34. 
Alternatively, anti-CTCF antiserum was purchased from Millipore. Anti-Dnmt1 was from 
Abcam and anti-Ubf, anti-Satb1, and anti-fibrillarin were from Santa Cruz Biotechnology. 
Primary Ab incubation was done overnight at 4°C in TBS containing 5% (w/v) BSA and 
0.15% (v/v) Nonidet P-40. Blots were incubated with secondary goat anti-rabbit or 
mouse Abs coupled to HRP (GE Healthcare). Signal detection was performed using 
ECL (Amersham Biosciences). Western blots were scanned and quantified using the gel 
macro function in ImageJ (W. S. Rasband, National Institutes of Health, Bethesda, MD; 
http://rsb.info.nih.gov/ij/). 
ChIP assay. ChIP followed by ultrahigh-throughput DNA sequencing on I11 erythroid 
cells was performed using a Solexa 1G Genome Analyser54. ChIP analysis of CTCF 
binding in the Th2 cytokine locus was performed as described in the ChIP Assay Kit 
protocol (UpState Biotechnology) using the anti-CTCF Abs listed above or IgG as 
control. Quantitative real-time PCR (Bio-Rad IQ5) on immunoprecipitated DNA was 
performed using SYBR Green (Sigma-Aldrich) and Platinum Taq DNA Polymerase 
(Invitrogen). Enrichment was calculated relative to Necdin and values were normalized 
to input measurements. The sequences of the primers used were as follows: CBS-1F, 5’-
GGTCTTAGCAGGTTCCCAA-3’; CBS-1R, 5’-CGTTCGGTAAGACAAGCAC-3’; CBS-2F, 
5’-CACTCAGCACCTTACCTG-3’; CBS-2R, 5’-CCTGGGCTAAATGAATCAGT-3’; CBS-
3F, 5’-AGGCACAGTGTAGAAGTGT-3’; CBS-3R, 5’-GTCTCTCTTCCAGTCCAGTT-3’; 
CBS-4F, 5’-GGCACTTGTAACGCTCTAA-3’; CBS-4R, 5’-
CCCTGACCAACATCTCCAA-3’; CBS-5F, 5’-ATTGTGGAGGCTGGCAAG-3’; CBS-5R, 
5’-GGTGACAGCCCAAATAAGT-3’; CBS-6F, 5’-CCACATCCACCTGTCACTT-3’; CBS-
6R, 5’-CTGTTTCACATCCATCGCA-3’; CBS-7F, 5’-CAGGCTTGTATCATCACCA-3’ and 
CBS-7R, 5’-TTCTTGAGGGACAGCACT-3’. 
Flow cytometric analyses. Preparation of single-cell suspensions and mAb incubations 
for four-color cytometry has been previously described55. All mAbs were purchased from 
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BD Biosciences except for PE-conjugated anti-granzyme B (GB12; Caltag Laboratories), 
anti-GATA3 (Hg-3-31; Santa Cruz Biotechnology), allophycocyanin-conjugated 
anti-Foxp3 (FJK-16s; eBioscience), biotinylated anti-IL-13 (R&D Systems), and 
allophycocyanin-conjugated IL-10 (JES5-16E3; eBioscience). For intracellular detection 
of cytokines, cells were restimulated with plate-bound anti-CD3 (10 µg/ml in PBS; 145-
2C11) or PMA (50 ng/ml; Sigma-Aldrich) plus ionomycin (500 ng/ml; Sigma-Aldrich) in 
the presence of GolgiStop (BD Pharmingen) for 4 h. Cells were harvested and stained 
extracellularly, followed by standard intracellular staining using paraformaldehyde and 
saponin. Foxp3 expression was evaluated by intracellular staining using a Foxp3 buffer 
set (eBioscience). Cell cycle Status of T cell cultures was determined after fixing in ice-
cold ethanol and subsequent staining in PBS containing 0.02 mg/ml propidium iodide, 
0.1% v/v Triton X-100, and 0.2 mg/ml RNase. Doublet cells were excluded by measuring 
peak area and width. CFSE labeling of cells was performed as described elsewhere56. 
Samples were acquired on a FACSCalibur or FACS LSRII flow cytometer and analyzed 
using CellQuest (BD Biosciences) or FlowJo (Tree Star) research software. 
In vitro T cell cultures. For in vitro T cell stimulations and Th1/Th2 polarization cultures, 
naive CD62L+CD4+ or CD8+ T cells were purified by cell sorting using a FACSVantage 
VE equipped with Diva Option and BD FACSDiva software (BD Biosciences). The purity 
of obtained fractions was >98%. For ChIP experiments, CD4+ T cells from C57BL/6 mice 
were obtained through incubation with biotinylated mAbs (BD Pharmingen) specific 
for CD11b (M1/70), Gr-1 (RB6-8C5), Ter119 (Ly-76), TCRγδ (GL3), B220 (RA3-6B2), 
NK1.1 (PK136), and CD8 (53-6.7), followed by streptavidin-conjugated microbeads and 
autoMACS purification according to the manufacturer’s instruction (Miltenyi Biotec). The 
purity of CD4+ T cell fractions was confirmed by FACS to be >95%. T cell fractions were 
cultured at a concentration of 1 x 106 cells/ml in IMDM (BioWhittaker) containing 10% 
heat-inactivated FCS, 5 x 10–5 M 2-ME, 100 U/ml penicillin, and 100 µg/ml streptomycin. 
Stimulation was with plate-bound anti-CD3 (145-2C11) and anti-CD28 (37.51) mAbs 
(coated at 10 µg/ml each at 4°C overnight) or PMA (50 ng/ml) plus ionomycin (300 ng/
ml). For Th1-polarizing conditions, anti-IL-4 (10 µg/ml; 11B11) and IL-12 (10 ng/ml) were 
added to the medium. Th2-polarizing cultures included anti-IFN-γ (5 µg/ml; R4-6A2,), 
anti-IL-12 (5 µg/ml; C17.8), and IL-4 (10 ng/ml). Treg- and Th17-polarizing conditions 
included TGF-β (3 ng/ml), anti-IL-4, and anti-IFN-γ. Th17-polarizing conditions 
additionally contained IL-6 (20 ng/ml). For Th0 conditions, no cytokines or mAbs were 
added. For differentiation of CD8+ effector T cells, only rIL-2 (5 ng/ml) was added to the 
medium. For Th0, Th1, and Th2 cultures, cells were supplemented with IL-2 (5 ng/ml) on 
day 3 after activation and expanded up to day 7 under the same cytokine conditions as 
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the primary cultures. In Th17 cultures, cells were restimulated with PMA plus ionomycin 
at day 3, supplemented with TGF-β and IL-6 and expanded up to day 5. All cytokines 
were from R&D Systems. Stimulation of OT-II-transgenic CD4+ T cells was conducted 
in the presence of bone marrow-derived dendritic cells (BM-DC). Briefly, BM single-cell 
suspensions were prepared from C57BL/6 femurs and seeded at 2 x 106 per petri dish 
in complete IMDM and 200 ng/ml murine GM-CSF (BioSource International). On days 
3 and 6, 200 ng/ml murine GM-CSF was added in 10 ml of fresh IMDM. On day 8, the 
nonadherent cells consisting of immature and mature BM-DC were harvested. For in 
vitro T cell proliferation studies, 0.2 x 106 CFSE-labeled OT-II-transgenic naive CD4+ 
T cells were cocultured with 0.2 x 106 BM-DC previously pulsed with OVA peptide323–339 
(50 µg/ml) in complete IMDM. At day 4, cultured T cells were harvested for proliferation 
analysis. 
ELISA. In vitro-polarized Th2 cells were harvested after 7 days in culture and washed 
twice with culture medium. Cells were resuspended (1.5 x 106 cells/ml) in fresh 
culture medium containing PMA (50 ng/ml) plus ionomycin (300 ng/ml). Three days 
later, supernatants were harvested and analyzed for the presence of cytokines using 
eBioscience (IL-4 and IL-5) and R&D (IL-13) ELISA systems. Total serum Ig levels were 
determined by subclass-specific sandwich ELISA, as described; IgE was induced by 
i.p. injection of 10 µg of 2,4,6-trinitrophenyl-keyhole limpet hemocyanin (TNP-KLH) 
precipitated on alum57. 
Statistical evaluations. All Statistical evaluations were done with Student’s t test. 
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ABSTRACT
The zinc-finger transcription factors Gata3 and ThPOK have both been implicated in 
positive selection of double positive (DP) thymocytes towards the CD4 lineage. As in the 
absence of Gata3, expression of ThPOK is lacking, Gata3 may directly regulate ThPOK 
expression. As ThPOK failed to promote CD4+ lineage differentiation of Gata3-defcient 
cells, ThPOK cannot be the only Gata3 target gene essential for the induction of the CD4+ 
lineage program. Therefore, it is conceivable that Gata3 is essential for selected DP T 
cells to reach the developmental stage at which ThPOK expression is induced. Here, 
we show that Gata3 overexpression does not affect ThPOK expression levels in DP or 
CD4+ thymocytes, providing evidence that Gata3 does not directly regulate ThPOK. To 
identify additional target genes that clarify Gata3 function at the DP thymocyte stage, 
we performed gene expression profiling assays in wild-type mice and transgenice mice 
with enforced expression of Gata3, in the presence or absence of the MHC class II-
restricted DO11.10 TCR. We found that Gata3 expression in DP cells undergoing positive 
selection was associated with downregulation of the V(D)J-recombination machinery 
genes Rag1, Rag2 and Dntt. Moreover, Gata3 overexpression was associated with 
downregulation of many signalling molecules and the induction of modulators of TCR 
signalling, including Ctla-4 and thrombospondin 2. Together with our previous finding 
that Gata3 reduces expression of CD5, a negative regulator of TCR signalling, and 
upregulates TCR expression, these findings indicate that Gata3 in DP cells mainly 
functions to (i) terminate Tcrα gene rearrangement, and (ii) regulate TCR signal intensity 
or duration in cells undergoing positive selection towards the CD4 lineage.
INTRODUCTION
Gata3 is a member of a family of transcription factors that bind to a consensus GATA 
site through a highly conserved zinc-finger domain1, 2. Within the hematopoetic system 
Gata3 is essential for T cell development from the earliest stages and is involved in NK 
and invariant NKT cell differentiation3, 4. In addition, Gata3 acts as master regulator of 
Th2 differentiation in mature CD4+ T cells, where it is crucial for transcription of the T 
helper 2 cytokines IL-4, IL-5 and IL-13, as well as for the inhibition of Th1 and regulatory 
T cells5-7. Gata3 is also expressed in non-hematopoietic tissues, including kidney, 
central nervous system, skin and mammary gland8. Gata3-deficient mice die at day 11 
of gestation due to noradrenaline deficiency of the sympathetic nervous system9, 10. 
The essential function of Gata3 in T cell development was demonstrated by 
the inability of Gata3-deficient ES cells to give rise to early CD4−CD8− double negative 
(DN) T cell progenitors in the thymus11, 12. In this context, Gata3 function for T cell 
specification is dependent on Notch signalling13. In DN thymocytes gene segments 
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encoding the T cell receptor β (TCRβ) chain undergo V(D)J recombination and only 
cells with a functional Tcrβ rearrangement are selected for further maturation. This 
process, termed β-selection, is associated with an increase in cell size and induction 
of proliferation14. Analysis of Gata3-lacZ reporter mice showed that Gata3 expression 
is upregulated in cells that have undergone β-selection11. Furthermore, conditional 
deletion experiments demonstrated that Gata3-deficient DN cells failed to undergo 
β-selection, indicating the essential role for Gata3 in this process15. After β-selection, 
cells upregulate expression of CD4 and CD8 and Tcrα gene segments are recombined, 
resulting in surface expression of TCRαβ at the CD4+CD8+ double positive (DP) stage. 
Upon engagement by self major histocompatibility complex (MHC) peptide complexes, 
low- to intermediate-avidity interactions rescue DP thymocytes from death by neglect, 
resulting in positive selection to either CD8 single positive (SP) cells in the context of 
MHC class I or CD4 SP cells in the context of MHC class II16, 17. In DP thymocytes TCR 
stimulation in the context of MHC class II results in the induction of Gata3 expression, 
which is maintained in CD4 SP thymocytes and downreglated in CD8 SP cells11, 18, 19. 
An absolute requirement for Gata3 for CD4 positive selection became evident from the 
finding that conditional deletion of the Gata3 gene at the DP stage resulted in a failure 
of CD4 SP generation15. We recently found that during CD4 positive selection Gata3 
has the capacity to downregulate expression of CD5, which is a negative regulator of 
TCR signalling, and to upregulate TCR expression19. Based on the observed induction 
of Gata3 by TCR stimulation in the context of MHC class II18, we concluded that Gata3 
probably acts in a positive feedback loop to upregulate TCR expression in developing 
CD4 SP thymocytes19.
Accurate regulation of Gata3 expression levels is essential for correct T cell 
development. Early overexpression of Gata3 rapidly induced respecification of early 
T cell precursors to the mast cell lineage20. CD2-Gata3 transgenic mice, with enforced 
expression of Gata3 driven by the CD2 promoter, display impaired CD8 T cell maturation 
and develop thymic lymphoma21. These lymphomas appear to arise at the DP cell stage, 
where Gata3 overexpression induces a dramatic cell size increase and increased 
expression of the c-Myc oncogene22.
The CD4/CD8-cell fate choice of double positive (DP) thymocytes is mainly 
determined through differences in TCR signal strength and duration23. Both Gata3 and 
the zinc-finger transcription factor ThPOK have been implicated in positive selection of 
DP thymocytes towards the CD4 lineage. The finding that forced expression of ThPOK 
in thymocytes can redirect cells that should become CD8 cells into the CD4 lineage, 
indicated that ThPOK is a master regulator that is necessary and sufficient for the CD4 
T cell fate24, 25. Because ThPOK is not expressed in the absence of Gata3 and Gata3-
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binding sites are present in the ThPOK locus, it has been hypothesized that Gata3 directly 
regulates ThPOK expression26. However, transgenic expression of ThPOK failed to 
promote CD4+ lineage differentiation of Gata3-defcient cells26. Therefore, Gata3 acts via 
additional targets to initiate the CD4+ lineage program and thus Gata3 expression may 
be required to reach a developmental stage at which ThPOK expression is induced.
In this report, we aimed to identify putative Gata3 targets in DP thymocytes. 
We compared gene expression profiles of sorted DP thymocytes from wild-type mice 
and from CD2-Gata3 transgenic mice. To specifically identify Gata3 target genes in the 
context of positive selection towards the CD4 lineage, we also investigated wild-type 
and CD2-Gata3 transgenic DP cells harboring the DO11.10 transgenic MHC class II-
restricted TCRαβ specific for ovalbumine27. We found that Gata3 overexpression did not 
affect ThPOK expression levels. Instead, our findings implicate Gata3 in the termination 
of Tcrα gene rearrangement and in the regulation of TCR signal strength.
RESULTS AND DISCUSSION
Enforced Gata3 expression results in increased occupancy of Gata3-binding 
sites in the Tcrα enhancer region
To be able to identify Gata3 target genes in DP thymocytes in the context of positive 
selection towards the CD4 lineage, we took advantage of our CD2-Gata3 transgenic 
mouse model, which we crossed with DO11.10 transgenic mice carrying a transgene 
encoding an ovalbumin peptide-specific TCRαβ that is MHC class II restricted27. As 
previously shown11, 18, 19, the presence of the CD2-Gata3 transgene did not affect 
DO11.10 CD4 lineage restriction (Fig. 1A). The presence of the DO11.10 transgene 
is associated with an upregulation of TCR expression levels, which was clearly more 
pronounced in CD2-Gata3 DO11.10 double transgenic mice (Fig. 1B). Gata3 has been 
shown to bind to GATA sites present in the Tcrα transcriptional enhancer located just 
3′ to the Tcr Cα gene segment28. ChIP experiments on total thymocyte fractions from 
wild-type and CD2-Gata3 transgenic mice showed that transgenic overexpression of 
Gata3 resulted in increased binding of Gata3 protein to its recognition sites in the Tcrα 
enhancer region (Fig. 1C).
Thus, overexpression of Gata3 leads to enhanced TCR expression and 
increased occupancy of Gata3-binding sites in the Tcrα enhancer region. In this context, 
Gata3 may indirectly specify the CD4 lineage, because divergence between CD4 and 
CD8 cell fates is thought to be mainly determined by a greater intensity or a longer 
duration of TCR signalling in MHC class II-restricted than in MHC class I-restricted 
thymocytes23.
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Furthermore, this finding indicates that enforced expression of Gata3 is 
an informative tool and does not lead to unphysiological levels of Gata3 reaching a 
functionally saturated point. Analyses of Gata3 protein, both by Western blotting and 
intracellular flow cytometry, previously showed that Gata3 expression in DP cells 
was increased to levels that were only slightly higher than those in CD4 SP cells21. In 
agreement with this, we have reported that the presence of the CD2-Gata3 transgene 
resulted in reduced expression of CD5 and increased TCR expression in DP cells 
and observed the converse in a conditional Gata3 knock-out model: increased CD5 
and reduced TCR expression19. Taken together, this finding indicates that enforced 
expression of Gata3 is a reliable tool to identify genes controlled by Gata3.
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Figure 1. Enforced Gata3 expression results in increased Gata3-binding in the Tcrα enhancer 
region. (A) The presence of the CD2-Gata3 transgene does not affect DO11.10 CD4 lineage 
restriction. Flow cytometric CD4/CD8 dot plots of total thymocytes of from wild-type (WT), 
CD2-Gata3 transgenic (G3), DO11.10 TCR transgenic (DO) and CD2-Gata3: DO11.10 double 
transgenic (G3:DO) mice. Numbers indicate the proportions of cells in each quadrant. The 
plots shown are representative for 6–10 mice per group. (B) Surface TCRβ chain expression 
on gated CD4+CD8+ DP thymocytes from the indicated mouse groups. Numbers indicate mean 
fluorescence intensities. Histograms shown are representative for 6–10 mice per group. (C) ChIP 
analysis in total thymocyte fractions in WT and CD2-Gata3 transgenic thymocytes, performed 
with (+) or without (−) Gata3-specific antibodies. Mean values and SEM are given for two RT-PCR 
runs on one ChIP experiment. 
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Enforced Gata3 expression does not enhance ThPOK expression in DP or CD4 
SP thymocytes
To investigate whether enforced expression of Gata3 was associated with increased 
ThPOK expression, we performed quantitative RT-PCR analyses. Whereas in DP cells 
the presence of the CD2-Gata3 transgene, either on the wild-type or the DO11.10 
background, resulted in a ~4-fold increase in Gata3 transcription, we did not detect any 
effect on ThPOK transcription (Fig. 2A). We found that in CD4 SP thymocytes enforced 
Gata3 expression was even associated with reduced ThPOK transcription (Fig. 2B). 
Finally, we analyzed ThPOK transcription in our previously reported complex crosses 
of CD2-Gata3 transgenic mice with conditionally deleted CD4-Cre Gata3f/f mice. In 
these mice, the endogenous floxed Gata3 gene is deleted and developing CD4 SP 
and CD8 SP thymocytes express the same level of Gata3 transcription, contributed 
exclusively by the CD2-Gata3 transgene, irrespective of their developmental choice11, 
18, 19.Quantitative RT-PCR experiments showed that in the CD2-Gata3 transgenic CD4-
Cre Gata3f/f mice ThPOK was exclusively expressed in CD4 cells and not in CD8 cells 
(Fig. 2C). Therefore, Gata3 expression in CD8 SP cells is not sufficient to induce the 
expression of ThPOK.
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Figure 2. Enforced Gata3 expression does not enhance ThPOK expression in DP or CD4 SP 
thymocytes. (A) and (B) Quantitative RT-PCR analysis of Gata3 and ThPOK expression in 
sorted DP thymocytes (A) or CD4 SP thymocytes (B) from wild-type (WT, white bars), CD2-
Gata3 transgenic (G3, black bars), DO11.10 TCR transgenic (DO, white bars) and CD2-Gata3: 
DO11.10 double transgenic (G3:DO, black bars) mice. Expression was normalized to Gapdh and 
expression levels of Gata3 or ThPOK in wild-type DP (A) or CD4 SP (B) thymocytes were set to 
one. Average values and SEM are given for 4–10 mice per group (*P<0.05; **P<0.01; ***P<0.001; 
t-test). (C) Quantitative RT-PCR analysis of ThPOK expression in the indicated sorted CD4 SP 
or CD8 SP thymocyte subpopulations from CD2-Gata3 transgenic (G3, white bar) and CD2-
Gata3 transgenic Lck-Cre Gata3f/f mice (G3: Gata3−/−). Expression was normalized to Gapdh and 
ThPOK expression levels in WT DP were set to one. 
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Taken together, these findings show that Gata3 overexpression did not affect 
ThPOK expression levels in DP, CD4 SP or CD8 SP cells. Therefore, Gata3 does 
not directly act as a CD4 specification factor by promoting the expression of ThPOK. 
Instead we conclude that, in the absence of Gata3, DP thymocytes do not reach the 
developmental stage at which ThPOK expression is induced.
Identification of differentially expressed genes as a result of enforced Gata3 
expression
The DP compartment in the thymus is heterogeneous and contains (i) cells that are 
positively selected towards the CD4 or (ii) the CD8 lineage, (iii) cells that are negatively 
selected, and (iv) a major proportion of cells that are not selected and die by neglect. 
Because Gata3 expression is specifically induced in DP cells by TCR signalling in the 
context of MHC class II and maintained during positive selection towards the CD4 SP cell 
lineage, we considered two different expression profile comparisons. First, we compared 
wild-type and CD2-Gata3 transgenic DP thymocytes, allowing the identification of genes 
induced or repressed by Gata3 in a heterogeneous DP cell population containing many 
cells in which Gata3 is normally not induced. We also compared DP thymocytes from 
DO11.10 single transgenic and DO11.10:CD2-Gata3 double transgenic mice. Hereby, 
we investigated the effects of premature and enhanced Gata3 expression in DP cells 
in which Gata3 would normally be induced because DO11.10 transgenic DP cells are 
efficiently positively selected towards the CD4 lineage.
FACS-sorted DP thymocyte fractions were obtained from three individual 
11-week-old mice from the following four groups: wild-type, CD2-Gata3 transgenic, 
DO11.10 transgenic and CD2-Gata3:DO11.10 double transgenic mice. Oligonucleotide 
arrays were co-hybridized with RNA from these DP cell fractions and RNA from a control 
pool of sorted DP T cells from 12 wild-type mice. After performing a non-supervised 
hierarchical clustering of individual mice and genes, we were able to identify differential 
gene expression profiles for the four different groups of mice. The gene expression 
profiles of the three individual mice present in each group clustered together, indicating 
that enforced expression of Gata3 and the presence of the DO11.10 TCR transgene 
resulted in unique gene expression signatures (Fig. 3A). The almost complete absence 
of differentially expressed genes in the individual wild-type mice, when compared to 
the control pool, provided a good quality control indicating that the observed differential 
gene expression profiles represent specific effects of enforced Gata3 expression.
To be able to identify genes, which are affected by enforced Gata3 expression 
at the DP T cell stage, the expression profiles of the individual mice were grouped per 
genotype, and a non-supervised clustering of all four groups and genes was performed 
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(Fig. 3B). In this analysis 3751 differently expressed genes were identified within the four 
groups of mice. To further identify the most relevant differentially expressed genes, the 
following selection criteria were used: (i) only genes which were >1.4-fold upregulated 
or <1.4-fold down-regulated with a P value <0.0001 were allowed, and (ii) genes which 
were differently expressed in wild-type DP T cells or genes with unknown function 
were excluded. This resulted in a total number of 1126 genes that were differentially 
expressed in CD2-Gata3 or DO11.10 single transgenic or CD2-Gata3:DO11.10 double 
transgenic DP thymocytes.
Clustering of differentially expressed genes into three groups of genes
Next, a Venn diagram was composed, allowing for the identification of differentially 
expressed genes that are common or unique for the four DP genotypes. Our expression 
profiling revealed 276 (85 + 114 + 26 + 51, clusters A–D, Fig. 3C) differentially expressed 
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Figure 3. Identification of specific gene expression signatures in DP cells as a result of enforced 
Gata3 expression. Gene expression profiles were generated from FACS-sorted DP cells from wild-
type (WT), CD2-Gata3 transgenic (G3), DO11.10 TCR transgenic (DO) and CD2-Gata3:DO11.10 
double transgenic (G3:DO) mice. (A) Non-supervised hierarchical clustering of both genes (rows) 
and individual mice (columns). Gene expression profiles were analyzed for 3 individual mice 
per group. (B) Non-supervised hierarchical clustering of both genes (rows) and grouped (n=3) 
mice of the indicated genotype. Dendograms above and on the left side of the matrixes indicate 
the average linkage clustering of respectively individual mice and genes. Green and red colors 
indicate the level of downregulation or upregulation of genes, when compared with a pool of 
DP cells obtained from WT mice (n=6). The color scale above the matrix correlates with gene 
expression and the given value numbers represent 2log values. (C) Differentially expressed genes 
in DP thymocytes from CD2-Gata3 and DO11.10 single transgenic and CD2-Gata3:DO11.10 
double transgenic mice, displayed in a Venn diagram. Genes are either up- or downregulated 
1.4-fold (P<0.0001) and are not differentially expressed in WT mice. Numbers of differentially 
expressed genes per cluster are given. See Appendix for full-color figure.
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genes in CD2-Gata3 transgenic DP thymocytes, when compared with wild-type DP 
cells. The comparison of DO11.10 single transgenic and wild-type DP thymocytes 
revealed differential expression of many more genes: 711 genes (114 + 26 + 173 + 408, 
clusters B, C, F and G), suggesting that the introduction of the DO11.10 TCR transgene, 
which induces positive selection towards the CD4 lineage, has a larger impact on gene 
expression in DP cells than the presence of the CD2-Gata3 transgene.
276 genes of clusters A–D represent genes that were induced or repressed 
by Gata3 in total DP cells, apparently irrespective of their cell fate (positive selection, 
negative selection, or death by neglect). From these 276 genes 136 genes (clusters A 
and D) were not differentially expressed in DO11.10 DP cells. The A/D cluster therefore 
represents genes that were upregulated or downregulated by transgenic Gata3 
expression but were not involved in positive selection towards the CD4 lineage. Likewise, 
the 140 genes in the B/C cluster represent genes that were not only upregulated or 
downregulated by transgenic Gata3 expression in total DP cells but also in DO11.10 
transgenic DP cells undergoing positive selection towards the CD4 lineage.
Finally, we found that enforced Gata3 expression in DO11.10 transgenic DP cells 
undergoing positive selection towards the CD4 lineage was associated with differential 
expression of 336 genes (85 + 251, clusters A and E), when compared with DO11.10 
single transgenic DP cells. Importantly, only cluster E contained genes that were 
upregulated or downregulated by transgenic Gata3 expression in DP cells exclusively in 
the context of positive selection towards the CD4 lineage, but not in the heterogeneous 
total DP cell fractions. Therefore, cluster E is expected to contain putative Gata3 target 
genes associated with the crucial function of Gata3 in CD4 SP cell development.
Taken together, we have now identified three gene clusters of putative Gata3 
targets: target genes in total DP cells that are (cluster B/C) or are not implicated in 
positive selection (cluster A/D), and target genes that are differentially expressed 
exclusively in the presence of a MHC class II-restricted positively selecting TCR signal 
(cluster E).
Putative Gata3 target genes that are not specifically implicated in positive 
selection
First, we focused on cluster A/D, which containss 136 genes that were induced or 
repressed by Gata3 in DP cells, irrespective of their cell fate, but were not implicated in 
positive selection (Table 1 and Supplementary Table 1). We found a striking ~18.5-fold 
upregulation of very low density lipoprotein receptor (Vldl-R), which is like apolipoprotein 
E (~2.7-fold upregulated) involved in lipoprotein metabolism29. Together with the 
upregulation of multiple genes associated with structural cellular organization, including 
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α-actinin 2, collagen alpha 2 (I) chain and myosin IF, this might be linked to the observed 
increased cell size of CD2-Gata3 DP thymocytes. We also found increased expression 
of c-Myc and its target cyclin D2, which we recently described as a putative Gata3 
target in lymphomagenesis and cell size regulation22. In addition, we found induction 
of Ctla-4, which is a negative regulator of TCR-proximal signalling proteins, and the IL-
18 receptor. Gata3 also induced significant expression of thrombospondin-2 (Thbs2), 
 Upregulated genes G3 DO G3: Downregulated genes G3 DO G3:
DO DO
Cluster A and D:*
Very low-density lipoprotein receptor (VldlR) 18.5 0.5 9.0 Matrix metalloproteinase 14 2.3 1.1 1.8
Thrombospondin 2 (Thbs2) 13.9 0.8 8.6 Sodium/nucleoside cotransproter 2 2.3 0.9 2.1
Alpha-actinin 2 10.8 2.3 7.7 Calcitonin receptor-like 2.1 1.6 2.3
Collagen alpha 2(I) chain 6.1 1.6 6.6 Lymphoid enhancere binding factor 1 (Lef1) 2.0 1.5 1.4
Interleukin 18 receptor 1 5.0 1.6 9.2 T-cell surface glycoprotein CD5 2.0 0.7 1.2
Cytotoxic T-lymphocte protein 4 (Ctla-4) 4.7 0.9 2.8 T-cell specific transcription factor (Tcf1) 1.9 1.6 2.0
Transferrin 4.1 0.8 3.7 T cell transduction molecule SAP 1.8 1.2 1.7
MYC proto-oncogene (c-Myc) 3.8 1.1 3.9 C-X-C chemokine receptor type 4 (Cxcr4) 1.7 1.3 2.2
Trans acting T-cell specific transcription factor GATA3 3.6 1.0 3.1 C-ETS-2 protein 1.7 1.4 3.2
Myosin IF 2.8 1.0 1.9 Interleukin 16 (IL-16) 1.7 1.3 1.6
Apolipoprotein E (Apo-E) 2.7 1.6 6.1
Cyclin D2 2.6 0.8 3.3
Spermidine synthase 2.0 0.9 2.1
Clusters B and C:*
Granzyme A 5.0 1.6 5.2 Death associated protein kinase 1 2.5 2.6 6.9
Nuclear receptor Ror-alpha 4.8 1.7 6.6 Interleukin-10 receptor alpha chain 2.0 1.6 1.6
FLT3 ligand 4.4 2.4 6.8 Transcription factor Sp3 1.9 1.8 1.9
CD44 3.3 2.6 3.9 Neurogenic locus notch homolog protein 1 (Notch1) 1.7 1.4 1.5
LIM domian transcription factor Lmo4 1.8 2.4 2.9 DNA-binding protein inhibiter Id3 1.6 0.6 1.3
Signal and transducer and activator of transcription 4 1.8 3.0 3.0
Interleukin-12 recepeptor beta-1 chain 1.5 1.9 2.3
Cluster E:**
Max-interacting transcriptional repressor Mad4 3.8 1.3 8.9 Secreted modular calcium-binding protein 1 1.9 2.2 9.1
T-lymphocyte activated protein 2.1 1.6 2.2 H-2 class I histocompatibility antigen (H-2K(B)) 1.8 2.4 3.4
L-selectin (CD62L) 1.9 1.3 2.9 DNA nucleotidylexotransferase (Tdt) 1.8 1.4 3.2
Thy1 membrane glycoprotein 1.4 1.7 2.1 Tyrosine protein kinase Tec 1.6 1.4 3.1
Guanine nucleotide-binding protein, aplha-13 (Galpha13) 1.3 2.3 2.8 V(D)J recombination activating protein 2 (Rag2) 1.4 1.7 2.9
Cop9 signalosome complex subunit 2 1.1 2.5 2.9 T cell surface glycoprotein CD4 1.6 2.0 2.5
V(D)J recombination activating protein 1 (Rag1) 1.4 2.2 2.3
Mitogen activated protein kinase4-2 (Mapk4-2) 2.2 1.7 2.3
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 1.9 1.6 2.2
Signal transducer and activator of transcription (Stat5b) 1.6 1.5 2.0
Phosphatidylinositol-4-phosphate 5-kinase type1 (PI4P5K-I) 0.6 1.6 2.0
Ccr4-not transcription complex, subunit 7 (Caf1) 1.3 1.4 1.8
B Cell translocation gene 1 (Btg1) 1.5 1.4 1.8
Interleukin 21 receptor (IL-21R) 0.9 1.4 1.8
Calpain L3 1.4 1.8 2.1
Nuclear factor of activated T cells, cytoplasmic 1 (Nfat-c1) 1.1 1.4 1.8
Tyrosine protein kinase Itk/Tsk 1.2 1.3 1.8
Nuclear factor of activated T cells 5 (NFAT5) 1.3 1.5 1.7
MHC class II transactivator CIITA 1.2 1.3 1.7
Mitogen activated protein kinase 6 (Erk3) 1.7 1.5 1.7
P300/Cbp associated factor 1.3 1.3 1.6
Table 1. Selection of putative GATA3 target genes.
G3 = CD2-GATA3, DO = DO11.10, G3:DO = CD2-GATA3:DO11.10. a Genes sorted by G3, 
b Genes sorted by G3:DO. 
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a member of the thrombospondin family of extracellular matrix proteins that regulate 
cell adhesion, growth, survival, differentiation and motility. Although Thbs receptors can 
elicit co-stimulating signals, Thbs1 has been shown to inhibit TCR signalling and CD69 
induction30. Thbs receptor ligation on human T cells induced the expression of Ctla-4, 
OX40, GITR, and Foxp3, associated with regulatory T cell function31. Thbs receptors 
include various integrins, CD36, CD47, low density lipoprotein receptor-related protein 
and heparan sulfate proteoglycans, some of which are also expressed on DP cells. 
Therefore, the induction of Ctla-4 and TSP2 on DP thymocytes would allow the formation 
of cell-autonomous regulatory loops that dampen cellular activation of DP thymocytes 
by TCR-mediated signalling. As quantitative RT-PCR showed that enforced Gata3 
expression is also associated with high Thbs2 transcript levels in DO11.10 Tg mice (Fig. 
4D), we conclude that Thbs2 is also induced during CD4 lineage differentiation.
Interestingly, we noticed a ~2-fold down-regulation of the transcription factors 
Tcf1 and Lef1 (Table 1 and Supplementary Table 1), both of which are regulated by the 
Wnt/β-catenin signalling pathway and have been implicated in a subset of peripheral T 
cell lymphomas32, 33. A ~2-fold down-regulation was also observed for Cd5, a negative 
regulator of TCR signalling, which we recently reported as a putative direct or indirect 
Gata3 target gene19. Furthermore, Gata3 expression downregulated ~1.8-fold the 
SLAM-associated protein SAP, which is involved in TCR signalling.
Taken together, this cluster of putative Gata3 targets mainly consists of genes 
implicated in lipoprotein metabolism, cell size regulation and lymphomagenesis, including 
Vldl-R, c-Myc and cyclin D2. In addition, we identified target genes that affect TCR-
mediated signalling, including Ctla-4, Thbs2, Cd5 and SAP. RT-PCR analyses for Thbs2 
and flow cytometric studies for CD519 showed that Gata3 regulates expression of these 
genes also in thymocytes that are positively selected for CD4 lineage differentiation.
Putative Gata3 target genes that are implicated in positive selection
Cluster B/C contained 140 genes that were differentially expressed in DP cells in the 
presence of CD2-Gata3 transgene, irrespective of their cell fate, that were also induced 
or repressed in DO11.10 TCR transgenic DP cells (Table 1 and Supplementary Table 
2). In this group, we surprisingly found upregulation of granzyme A, which is expressed 
in CD8+ T cells and NK cells and Rorα, which was recently implicated in Th17 cell 
differentiation34. Differential expression of granzyme A and Rorα was confirmed by semi-
quantitative PCR, by which also upregulation of the cluster A/D genes Vldl-R and IL-
18R could be verified (Fig. 4A and B). The relevance of Rorα upregulation is not clear, 
because lymphocyte-specific Rorα-deficient mice do not display defects in thymocyte 
development35.
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In addition, IL-12Rβ1 and Stat4 involved in cytokine signalling, and Cd44, 
Lmo4, and Flt3-ligand, were induced (Table 1 and Supplementary Table 2). Using 
quantitative RT-PCR, we could confirm that Flt3-ligand expression is induced in DP 
cells overexpressing Gata3 (Fig. 4D). Transcriptional regulators, such as Sp3 and Id3 
were ~2-fold down-regulated (Table 1 and Supplementary Table 2). The transcription 
factor Id3 has been shown to be an important regulator for thymocyte selection, via 
the regulation of E2A36. This in combination with our finding in CD2-Gata3 transgenic 
DP cells of increased expression of E2A and reduced expression of CD511, 18, 19, might 
indicate a role of Gata3 in downregulating CD5 via Id3 during thymocyte selection. 
Finally, we observed that Gata3 overexpression was associated with downregulation 
of Notch1 transcription. This would suggest a negative feedback mechanism regulating 
Notch1 expression, given the fact that Gata3 was recently shown to be a direct target of 
Notch1 during T helper cell differentiation37, 38.
We conclude that the B/C cluster consists of a very diverse set of genes most 
of which cannot obviously be linked to induction of positive selection towards the CD4 
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Figure 4. Expression analysis of genes upregulated as a result of enforced Gata3 expression in 
DP thymocytes. (A) Quantitative RT-PCR analysis of Gata3, c-Myc and Ctla-4 expression in sorted 
DP cells from wild-type (WT), CD2-Gata3 (G3), DO11.10 (DO) and CD2-Gata3:DO11.10 double 
transgenic (G3:DO) mice. Expression was normalized to Gapdh and expression levels of c-Myc 
and Ctla-4 in WT DP thymocytes were set to one. For statistical analysis a t-test was performed 
(**P<0.01 and ***P<0.001; t-test). Data are from 4 to 10 mice per group. (B) Semi-quantitative 
PCR analysis for IL-18R, Granzyme A, Rorα, VldlR and β-actin on serial 3-fold cDNA dilutions 
prepared from sorted DP cells of the indicated mice. Data are representative for 4 mice analyzed 
per group. (C) and (D) Quantitative RT-PCR analysis of the indicated transcripts in sorted DP 
cells from DO11.10 (DO) and CD2-Gata3:DO11.10 (G3:DO) transgenic mice. Expression was 
normalized to Gapdh and expression levels in WT DP thymocytes were set to one. Average 
values ± SEM are displayed for 5–8 mice per group (*P<0.05; **P<0.01; ***P<0.001; t-test). 
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lineage, except for Id3 or Notch1. These findings may be consistent with the notion 
that Gata3 expression is insufficient to induce positive selection towards the CD4 cell 
lineage15, 21.
Putative Gata3 target genes in the presence of a MHC class II-restricted TCR 
signal
Cluster E contained genes that were upregulated or downregulated by transgenic 
Gata3 expression in DP cells exclusively in the context of positive selection towards the 
CD4 lineage, but not in total DP cell fractions. Importantly, transgenic Gata3 expression 
induces enhanced differentiation of DP cells, as evidenced by high surface TCR and 
CD69 expression levels of CD2-Gata3 transgenic DP cells, which were close to those 
normally reached only at the CD4 SP stage19. Therefore, cluster E was expected to 
contain natural Gata3 targets associated with its crucial function in CD4 SP cell 
development.
Within cluster E, 118 genes were upregulated and 133 were downregulated as 
a result of enforced Gata3 expression (Table 1 and Supplementary Table 3). Among 
the upregulated genes, Mad4 a suppressor of c-Myc39, G protein G-alpha13 and Cd62L 
were present. Upregulation of Cd62L transcription would be in agreement with the 
previously reported increased surface expression of CD62L on CD2-Gata3 transgenic 
CD4 SP cells40.
Enforced Gata3 expression was associated with reduced activity of the V(D)
J recombination machinery, as recombination activating gene-1 (Rag1), Rag2 and 
terminal deoxynucleotidyltransferase (Dntt) were ~2–3-fold downregulated (Table 1 
and Supplementary Table 3). Reduced gene expression of Rag1, Rag2 and Dntt was 
verified by quantitative RT-PCR analysis (Fig. 4C). In the promoter of the Rag2 gene 
a Gata3 binding site has been identified, mutation of which resulted in the reduction 
of promoter activity in T cells, indicating a direct regulation of V(D)J recombination by 
Gata341. Thus, our findings indicate that the induction of Gata3 upon TCR signalling in DP 
cells results in termination of V(D)J recombination activity, precluding further Tcrα gene 
rearrangement. Interestingly, overexpression of Gata3 in early DN fetal thymocytes also 
caused downregulation of Rag1 and Rag242. Because Gata3 expression is upregulated 
in DN3 cells that have undergone β-selection11, in the context of downregulation of the 
V(D)J recombinase system Gata3 has parallel functions in DN3 cells where it is induced 
by pre-TCR signalling and in DP cells where it is induced by TCR signalling.
Enforced Gata3 expression resulted in reduced expression of B cell translocation 
gene 1 (Btg1) and CCR4-associated factor 1 (Caf1). Btg1 and Caf1 have been reported 
to act together in negative regulation of the gene for estrogen receptor α (ERα)43. Using 
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quantitative RT-PCR, we could confirm that Btg1 expression is reduced in DP cells 
overexpressing Gata3 (Fig. 4D). This is particularly interesting, since Gata3 has been 
shown to positively regulate the expression of estrogen receptor alpha in breast cancer, 
by binding to the ERα gene itself44. These data suggest that Gata3 can regulate ERα in 
a direct manner, but as well indirectly via Btg1.
Gata3 expression resulted in downregulation of genes involved in cellular 
signalling pathways such as, mitogen activated protein kinase4-2 (Mapk4-2), signal 
transducer and activator of transcription 5b (Stat5b), phosphatidylinositol-4-phospate 
5-kinase (PI4P5K-I), and extracellular signal regulated kinase-3 (Erk3). In addition, the 
tyrosine protein kinases Tec and Itk, which are involved in proximal TCR signalling, 
were ~2–3-fold downregulated. Also secreted modular calcium-binding protein-1, 
sarcoplasmic/endoplasmic reticulum calcium ATPase-3 and calpain L3, which are 
related to calcium signalling, were reduced. Secreted modular calcium-binding protein-1 
was even reduced by a factor ~9.
Enforced Gata3 expression also resulted in downregulated expression of genes 
encoding for cell surface molecules, such as MHC class I, IL-21R and Cd4. Reduction of 
CD4 expression is of particular interest, because DP cells downregulate the expression 
of the CD4 and CD8 to become “double dull” thymocytes co-receptors when positive 
selection is initiated45. Although we did not detect a significant reduction in cell surface 
protein expression of CD4 by flow cytometric analysis of Gata3 transgenic DP cells, 
we did observe reduced CD4 expression in in vitro cultured CD2-Gata3 transgenic T 
helper-2 (Th2) cells, when compared to wild-type Th2 cells (data not shown). At the 
level of transcription, enforced Gata3 expression resulted in reduced expression of the 
nucleus class II transactivator (CIITA), p300/CBP and nuclear factor of activated T cells 
cytoplasmic 1 (Nfat-c1).
Overlapping gene expression signature of CD2-Gata3 DP cells and lymphomas
When comparing the gene expression profiles of non-transformed CD2-Gata3 
transgenic DP cells with those from thymic lymphoma samples obtained from CD2-
Gata3 transgenic mice22, we noticed striking parallels. Also in the DP T cell lymphomas 
we observed downregulation of Rag1 and Rag2, the cell surface molecules Cd4, Cd5 
and IL-21R, TCR signalling molecules Itk, Tec and Sap, as well as the transcription 
regulators Stat5b and Nfat5. Moreover Ets2, Tcf1, IL-16, Cxcr4, were found to be 
downregulated in both non-malignant DP thymocytes as in Gata3-induced lymphoma 
cells. Among the upregulated genes a similar expression profile in non-malignant DP 
cells and lymphoma cells was found of c-Myc, cyclin D2, transferrin, Apo-E, spermidine 
synthase and granzyme A.
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CONCLUSIONS
In this report, we have shown that Gata3 overexpression does not affect ThPOK 
expression levels in DP or CD4+ thymocytes, providing evidence that Gata3 does not 
directly regulate ThPOK. Therefore, we propose that Gata3 is required during CD4+ 
lineage specification to reach the developmental stage at which expression of the CD4 
commitment factor ThPOK is induced. Our gene expression profiling studies allowed 
the identification of novel putative Gata3 target genes in DP thymocytes undergoing 
positive selection towards the CD4 lineage: Gata3 expression was associated with 
downregulation of the V(D)J-recombination machinery genes Rag1, Rag2 and Dntt, as 
well as various signalling molecules implicated in the transmission of TCR-mediated 
signals in DP thymocytes, including Tec, Itk, Sap, PI4P5K-I, Mapk4-2, Erk3 and various 
molecules involved in calcium signalling. Gata3 overexpression was also associated 
with the induction of Ctla-4 and thrombospondin-2, which may act as modulators of 
TCR signalling in DP thymocytes. Together with our previous finding that Gata3 
reduces expression of CD5, a negative regulator of TCR signalling, and upregulates 
TCR expression in a positive feedback loop19, these findings indicate that Gata3 in 
DP cells mainly functions to (i) terminate Tcrα gene rearrangement and (ii) regulate 
TCR signal intensity or duration in cells undergoing positive selection towards the CD4 
lineage. Validation of the identified targets in combination with functional experiments 
will provide improved insight into the essential physiological function of Gata3 during 
the developmental progression of DP cells that have received TCR-mediated positive 
selection signals into CD4 SP cells.
METHODS
Mice. The generation and genotyping of CD2-Gata3 (FVB)21, CD2-Gata3:DO11.10 
(BALB/c)19 and Lck-Cre Tg Gata3f/f 19 have been described. Mice were kept under 
pathogen-free conditions in the Erasmus MC animal care facility. All experiments were 
approved by the Erasmus MC Animal Ethics Committee (DEC).
Flow cytometry, antibodies and cell sorting. The generation of single-cell suspensions 
and cell labeling for flow cytometry have been described previously21. Antibodies were 
purchased from BD Bioscience (San Diego, CA). FACS sorting of CD4+CD8+7AAD− 
thymocytes was performed with a FACSVantage VE, equipped with Diva Option and BD 
FACSdiva software (BD, San Diego, CA). Purity of fractions was >99%.
Chromatin immunoprecipitation (ChIP). ChIP analysis of Gata3 binding in the TCRα 
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enhancer28 was performed as described previously46 using anti-Gata3 antibodies (HG3-
31 AC, Santa Cruz, CA). Quantitative real-time PCR on immunoprecipitated DNA 
was performed using SYBR Green qPCR Master Mix (Fermentas). Enrichment was 
calculated relative to Necdin (Necdin-F: GGTCCTGCTCTGATCCGAAG and Necdin-R: 
GGGTCGCTCAGGTCCTTACTT) and values were normalized to input measurements.
Preparation of probes, microarray hybridization and data analysis. Oligonucleotide 
arrays printed with the Operon Mouse Genome Oligo Set version 3.0 (32K mouse) were 
obtained from The Netherlands Cancer Institute central microarray facility (NKI-CMF, 
Amsterdam, The Netherlands). Protocols for sample preparation and array hybridization 
were supplied by NKI-CMF (http://microarrays.nki.nl). In brief, total RNA was isolated 
using the GeneElute mammalian total RNA miniprep system (Sigma–Aldrich, St. 
Louis, MO). The quantity and quality of RNA were determined using a NanoDrop 
spectrometer (NanoDrop Technologies, Wilmington, DE). Samples with a 260/280 nm 
optical density ratio >1.8 were used. Two micrograms of total RNA was used for 
amplification using T7 MEGAscript Kit (Ambion, Austin, TX), whereby aminoallyl-UTP 
(Ambion) was incorporated into amplified RNA (aRNA). Subsequently, Cy5- or Cy3-dye 
(Amersham, GE Healthcare, Piscataway, NJ) was coupled to the aminoallyl-modified 
aRNA. Labeled aRNA was purified and concentrated using Microcon YM30 columns 
(Millipore, Billerica, MA). Oligonucleotide arrays were co-hybridized with purified probes 
derived from DP thymocytes from individual mice and control probes derived from 
pooled wild-type DP thymocytes thymocytes (n = 6) and scanned with a Scanarray 
Express HT scanner (PerkinElmer, Boston, MA). Data were extracted using Imagene 
software 6.0 (Biodiscovery, CA, USA). Each experiment consisted of 2 oligonucleotide 
arrays, whereby dyes were reversed between aRNA from sorted DP cells of CD2-
Gata3, CD2-Gata3:DO11.10 or DO11.10 transgenic mice and the control wild-type DP 
T cells pool. Obtained array data were uploaded in the NKI-CMF database, analyzed 
using NKI-CMF software (http://dexter.nki.nl) and normalized per subarray using the 
Lowess normalization method. Normalized data from dye-reversed hybridizations were 
combined by means of a weighted average. Experiments were combined and data 
were filtered for genes that were differentially expressed in experiments. Hierarchical 
clustering of genes and experiments was performed using Genesis 1.5.047.
Semi-quantitative and quantitative PCR analysis. Total RNA was extracted using the 
GeneElute mammalian total RNA miniprep system (Sigma). One microgram of total RNA 
was used as a template for cDNA synthesis, using Superscript II reverse transcriptase 
(Invitrogen, Carlsbad, CA) and random hexamer primers. Semi-quantitative PCR analysis 
Claudia Thesis_2.indd   174 17/10/2010   21:18:37
Identification of Gata3 targets in DP thymocytes 175
C
ha
pt
er
 5
was performed on samples serially diluted 3-fold before amplification. Quantitative real-
time PCR was performed using the ABI Prism 7700 sequence detection system (Applied 
Biosystems, Foster City, CA). PCR primers and probes are listed in Supplementary 
Table 4. To confirm the specificity of amplified products, samples were analyzed by 
standard agarose gel electrophoresis. Threshold levels were set and analysis was 
performed using the SDS v1.9 software (Applied Biosystems). Obtained Ct values of 
the genes of interest were normalized to the Ct value of glycereraldehyde-3-phosphate 
dehydrogenase (Gapdh).
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Supplementary Table 4. Primers and probes used for RT-PCR analysis for expression of the indicated genes.
Gene Forward primer Reverse primer Probe
B-Actin TACCACTGGCATCGTGATGGACT TTTCTGCATCCTGTCGGCAAT
Btg1 CAA GTT CTC CGC ACC AA GCT TTT CTG GGA ACC AGT GA AGG AGC TG
c-Myc GCAGCTGTTTGAAGGCTGGAT GTCGCAGATGAAATAGGGCTGT CACGACGATGCCCCTCAACGTGA
Ctla4 CTTGGCCTTTTGTAGCCCTG CACATGGAAAGCTGGCGACA AGCCATACAGGTGACCCAACCTTCAGTG
Flt3L TGACCCTGAACTCAAAGCAA CAGCAGGGTGGAGGAGTCT CTCCTGCC
Gapdh TTCACCACCATGGAGAAGGC GGCATGGACTGTGGTCATGA TGCATCCTGCACCACCAACTG
Gata3 CATTACCACCTATCCGCCCTATG CACACACTCCCTGCCTTCTGT CGAGGCCCAAGGCACGATCCAG
Granzyme A TTGGACTAAACATGATTTGTGCAG AGGTGATGCCTCGCAAAATAC
IL-18R ATCCAGGACACATGGCTGTATAAG CGCAGGAGTAGTAGCCCTCATC
Rag1 AGGCCTGTGGAGCAAGGTA GCTCAGGGTAGACGGCAAG ATGGCTGC
Rag2 TGCCAAAATAAGAAAGAGTATTTCAC GGGACATTTTTGATTGTGAATAGG GCAGGAAG
Rora CTGGCTTCTTCCCCTACTGTTC TTTCCAGGTGGGATTTGGATAT
Tcf1 CAGCTCCCCCATACTGTGAG GGCAGGGAAGTGCTGTCTAT CTTCCTGC
TdT GTTCAGGGTGGAAAATGAGC CAGGACGTCTGACCCTGAGT TGGCAGAG
Thbs2 CCAACCCATCTTTTGTGGAA GACCAGCCCTCATCACTGTC TGCTGTCC
Thpok CTT TGC CTG TGA GGT CTG C CAG TGG GGG CAC GAG TAG CAGGAGAA
VldlR AGCAGGCAATGCAATGGC TGCACTTGAACTTTCCAGGGC
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differentiation of IL-17-producing cells, but 
constrains Th17-mediated pathology
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ABSTRACT
The zinc-finger transcription factor Gata3 serves as a master regulator of T helper 
2 (Th2) differentiation by inducing expression of the Th2 cytokines IL-4, IL-5 and IL-
13 and by suppressing Th1 development. Here, we investigated how Gata3 affects 
Th17 differentiation, using transgenic mice with enforced Gata3 expression. We 
activated naïve primary T cells in vitro in the presence of transforming growth factor-β 
and IL-6, and found that enforced Gata3 expression induced co-expression of Th2 
cytokines in IL-17-producing T cells. Although the presence of IL-4 hampered Th17 
differentiation, transforming growth factor-β/IL-6 cultures from Gata3 transgenic mice 
contained substantial numbers of IL-17+ cells, partially because Gata3 supported Th17 
differentiation by limiting IL-2 and IFN-γ production. Gata3 additionally constrained Th17 
differentiation in vitro through IL-4-independent mechanisms, involving downregulating 
transcription of Stat3, Stat4, Nfatc2 and the nuclear factor RORγt, which is crucial 
for Th17 differentiation. Remarkably, upon myelin oligodendrocyte glycoprotein 
immunization in vivo, Gata3 transgenic mice contained similar numbers of IL-17-
producing T cells in their lymph nodes as wild-type mice, but were not susceptible to 
autoimmune encephalomyelitis, possibly due to concomitant production of IL-4 and IL-
10 induction. We therefore conclude that although Gata3 allows Th17 differentiation, 
it acts as an inhibitor of Th17-mediated pathology, through IL-4-dependent and IL-4-
independent pathways.
INTRODUCTION
T helper cells are classically divided into two functionally distinct subsets, termed T helper 
1 (Th1) and Th21, 2. Th1 cells, producing IFN-γ and lymphotoxin-α, are associated with 
the elimination of intracellular pathogens. Two major signalling pathways facilitate Th1 
development, one involving IL-12/Stat4 and the other involving IFN-γ/Stat1/T-bet. Th2 
cells, producing IL-4, IL-5 and IL-13, are not only critically important for the eradication 
of parasitic worms, but are also implicated in allergic responses. Th2 differentiation is 
dependent on IL-4-induced activation of Stat6, leading to expression of the zinc-finger 
transcriptional regulator Gata33, 4. Gata3 auto-activates its own expression and increases 
the accessibility of the Th2 cytokine cluster containing the genes coding for IL-4, IL-5 
and IL-135-7. Furthermore, Gata3 suppresses Th1 development by downregulating 
Stat4 and IL-12Rβ2 chain expression8-10. Only if T-bet is sufficiently induced in naïve 
cells, such Gata3 suppression is counteracted, permitting Th1 differentiation to occur. 
Conditional gene targeting experiments showed that Gata3 deficiency was sufficient to 
induce Th1 differentiation in the absence of IL-12 and IFN-γ, demonstrating that Gata3 
serves as a principal Th1/Th2 switch11.
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In differentiating CD4+ effector T cells loss of Gata3 results in a substantial 
reduction in the generation of IL-4-, IL-5- and IL-13-producing cells11, 12. Gata3 binds to 
multiple sites within the 200 Kb Th2 cytokine locus in resting T cells; binding to the IL-5 
and IL-13 promoters increases upon T-cell activation. Introduction of Gata3 into in vitro-
cultured T cells generates Th2-specific DNAse I hypersensitive sites independent of 
Stat6, implicating Gata3 in the process of chromatin remodeling6. In activated Th2 cells 
Gata3, Stat6, c-Maf and the chromatin-remodeling enzyme Brg1 and RNA polymerase 
II are all bound across the Th2 locus, whereby densely looped, transcriptionally active 
chromatin is packaged by the special AT-rich sequence binding protein (Satb1)13. 
Furthermore, Gata3 activity is required during embryonic development14 and at multiple 
stages of thymocyte development, including the earliest double negative stages15, 16, 
β-selection17 and CD4+ cell development17-19.
In recent years, effector T cells distinct from the Th1 or Th2 subsets have been 
described, which produce IL-17 and are therefore termed Th17 cells20, 21. IL-17 is a pro-
inflammatory cytokine involved in the control of a wide range of infections at mucosal 
surfaces and has been implicated in the pathogenesis of autoimmune diseases, including 
experimental autoimmune encephalomyelitis (EAE), rheumatoid arthritis, autoimmune 
myocarditis and psoriasis (reviewed in22, 23). In mouse, transforming growth factor-β 
(TGF-β) and IL-6, an acute phase protein induced during inflammation, act together to 
induce Th17 differentiation24-26. Because TGF-β is also a critical factor for the generation 
of anti-inflammatory regulatory T (Treg) cells, there is a dichotomy in the generation of 
pathogenic Th17 T cells that induce autoimmunity and Tregs that inhibit autoimmune 
disease25, 26. The orphan nuclear receptor RORγt has been identified as a key regulator 
of the differentiation program of Th17 cells27. Th17 differentiation is regulated by several 
cytokines: IL-2 and IL-27 are strongly inhibitory, whereas IL-21 and IL-23 have been 
reported to promote IL-17 expression27-31.
As Th1, Th2, Th17 and Treg, appear to arise in a mutually exclusive fashion, 
various mechanisms of counter-regulation exist, at the level of cytokines as well as 
transcription factors. For example, TGF-β has the capacity to block Th2 development 
through inhibition of Gata3 expression32. In Th1 cells, T-bet essentially functions as a 
negative regulator of Gata3 expression10, 33. Gata3 suppresses the induction of T-bet 
by downregulating Stat4 and IL-12Rβ2 chain8-10. In CD8 cells, the Th2 cytokine locus 
is silenced by expression of repressor of Gata34. Yet, it is currently not known whether 
Gata3 activity inhibits or stimulates differentiation of Th17 cells. On the one hand, 
Gata3 induces IL-4, which has been shown to suppress Th17 development20, 21. But 
since IFN-γ is the main inhibitor of Th17 development, Gata3 activity may, on the other 
hand, promote Th17-cell generation because of its capacity to negatively regulate Th1 
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development and thus IFN-γ production8-10.
In this report, we investigated how Gata3 expression affects Th17 differentiation. 
We employed our previously characterized CD2-Gata3 transgenic mice, which have 
enforced Gata3 expression driven by the CD2 locus control region, resulting in enhanced 
Th2 differentiation of peripheral CD4+ T cells35. We isolated naïve primary CD4 T cells 
from CD2-Gata3 transgenic mice, activated them in vitro under culture conditions 
supporting Th17 differentiation, and found co-expression of Th2 cytokines in IL-17-
producing T-helper cells. Interestingly, we identified multiple stimulatory and inhibitory 
effects of Gata3 on Th17 differentiation in vitro. Although CD2-Gata3 transgenic mice 
contained normal numbers of IL-17+ cells in gut-draining lymphoid tissue, they were not 
susceptible to Th17-mediated EAE in vivo.
RESULTS
Transgenic Gata3 induces IL-4 and limits IL-2 production in T helper cells
To investigate how the presence of Gata3 affects differentiation of naïve T cells toward 
the Th17-cell lineage, we used CD2-Gata3 transgenic mice on a C57Bl/6 background. 
Their phenotype was essentially similar to CD2-Gata3 transgenic FVB mice described 
previously35, 36. These mice manifested a significant reduction of thymic cellularity, 
affecting most stages of thymic development (see Supplementary Fig. 1), and 
contained reduced numbers of CD4 T cells and particularly CD8 T cells in spleen and 
lymph nodes (see Supplementary Fig. 1). Peripheral T cells manifested an increased 
surface expression of the CD3/TCR-αβ-complex and a small but consistent decrease 
in CD5, which is a negative regulator of TCR signalling (Supplementary Fig. 1). 
We previously found that when total peripheral CD4 T-cell fractions from CD2-Gata3 
transgenic FVB mice were cultured under Th1 conditions, Th2 cytokine production was 
increased and IFN-γ production was hampered35. In these experiments, the presence 
of antigen-experienced Th2-committed cells might have contributed to the observed 
increased Th2 differentiation.
Because both IL-4 and IFN-γ are negative regulators of Th17 differentiation20, 21, 
24, 37, we first aimed to investigate the effect of Gata3 on Th17 differentiation, independent 
of its effects on IL-4 and IFN-γ production. To this end, we activated sorted splenic naïve 
CD62L+CD4+ T cells from wild-type (WT) and CD2-Gata3 transgenic C57BL/6 mice with 
plate-bound anti-CD3/anti-CD28 under Th17 conditions, i.e. in the presence of TGF-β, 
IL-6, anti-IFN-γ and anti-IL-4 for 7 days. We also cultured CD62L+CD4+ T cells under 
Th0 (no additional cytokines or mAb), Th1 (with IL-12 and anti-IL-4) and Th2 (with IL-4, 
anti-IFN-γ and anti-IL-12) polarizing conditions to confirm that the CD2-Gata3 transgene 
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Figure 1. The CD2-Gata3 transgene induces IL-4 and limits IL-2 production in Th1, Th2 and 
Th17 cells. (A) Quantitative RT-PCR analysis of Gata3 and T-bet expression in different T effector 
cells from wild-type (WT, white bars) and CD2-Gata3 transgenic mice (black bars), cultured for 
7 days. Expression was normalized to Gapdh and expression levels of Gata3 in WT Th2 cells 
and T-bet in WT Th1 cells were set to 1. Mean values and SEM are given for 5–7 mice per group 
(**P<0.01; ***P<0.001; t-test). (B) Flow cytometric analysis for intracellular expression of IL-4 and 
IFN-γ in gated CD4+ T cells from day 7 cultures. Numbers indicate percentages of total cells 
within the quadrants. (C) and (D) Flow cytometric analysis for intracellular IL-2 expression (C), 
CD25 and CD69 expression, Annexin and carboxy-fluorescein succinimidyl ester (CFSE) (D) in 
the indicated WT (gray filled histogram) and CD2-Gata3 transgenic (black line) T-cell cultures. 
Cells were cultured for 3 days. Numbers indicate the percentage of total cells (C) or the mean 
fluorescence intensity (D) from WT (gray numbers) or CD2-Gata3 transgenic (black numbers) Th0 
cell cultures. (E), Cell cycle distribution by PI (propidium iodide) staining of Th0 cells cultured for 3 
days. Numbers indicate the proportions of cells in S/G2/M. (B–D) Data shown are representatives 
of four mice analyzed per group.
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had the capacity to induce IL-4 and to limit IFN-γ production during differentiation of 
naïve T cells in vitro.
In all T-cell cultures from CD2-Gata3 transgenic mice, Gata3 expression levels 
reached values that were up to a factor of ~2–3 higher than those in WT Th2 cultures 
(Fig. 1A), irrespective of polarization conditions. Enforced Gata3 expression did not 
significantly affect the expression levels of T-bet in Th0, Th1 and Th2 cultures, but 
in CD2-Gata3 transgenic Th17 cultures the levels of T-bet were reduced (Fig. 1A). 
Whereas WT Th0 cultures contained detectable fractions of IFN-γ-producing cells, 
CD2-Gata3 transgenic Th0 cultures contained significant proportions of IL-4+ cells, as 
determined by intracellular flow cytometry (Fig. 1B). Under Th1 polarizing conditions, 
a large majority of WT T cells produced IFN-γ. In CD2-Gata3 transgenic Th1 cultures, 
IFN-γ was produced by a significant proportion (~43%) of the cells, a large fraction 
of which co-expressed IL-4. Under Th2 conditions, the presence of the CD2-Gata3 
transgene resulted in significantly increased proportions of IL-4+ cells. In WT Th17 
cultures, IL-4+ or IFN-γ+ cells were not detected, but in CD2-Gata3 transgenic Th17 
cultures ~16% of cells produced IL-4 (Fig. 1B). 
CD2-Gata3 transgenic Th cultures showed decreased production of IL-2, when 
compared with WT (Fig. 1C), irrespective of polarization conditions. This reduction in 
IL-2 appeared (at least partially) independent of Gata3-induced IL-4, as it was also 
seen under Th1 or Th17 conditions in the presence of anti-IL-4 antibodies. Reduced 
IL-2 production did not reflect impaired activation of CD2-Gata3 transgenic T cells, 
as at day 3 expression levels of the activation markers CD25/IL-2R and CD69 were 
upregulated. CD25 expression was even slightly higher in CD2-Gata3 transgenic T 
cells, when compared with WT (Fig. 1D). Nevertheless, CD2-Gata3 transgenic T-cell 
cultures showed increased apoptosis, as determined by Annexin V staining, and reduced 
proportions of cells in the S/G2/M phase of the cell cycle, but remaining cells showed a 
normal capacity to go through sequential cell divisions detected by carboxy-fluorescein 
succinimidyl ester-labeling (Fig. 1D and E).
Collectively, these data show that enforced Gata3 expression is sufficient to 
induce IL-4 expression and to reduce IL-2 production in all culture conditions. As a 
result, Th1 cultures contained many IL-4/IFN-γ double positive cells and Th17 cultures 
contained IL-4+ cells, even in the presence of anti-IL-4 antibodies during cell culture.
Enforced Gata3 expression allows Th17 differentiation in vitro
Interestingly, Th17 cultures from WT mice and CD2-Gata3 transgenic mice contained 
equal proportions of IL-17-expressing cells at day 7 (Fig. 2A), but the CD2-Gata3 
transgenic IL-17-producing cells co-expressed IL-4 and IL-13 (Fig. 2B). The proportions 
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of IL-13+ cells in CD2-Gata3 transgenic Th17 cultures were in the same ranges as those 
in CD2-Gata3 transgenic Th0, Th1 and Th2 cultures (Supplementary Fig. 2). Gata3 
also has the capacity to induce the immunosuppressive cytokine IL-1035, which was 
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Figure 2. Enforced Gata3 expression induces Th17 cells with Th2 characteristics. (A) Flow 
cytometric analysis of IL-17 production of wild-type (WT, white bar) and CD2-Gata3 transgenic 
(black bar) Th17 cells. Mean values and SEM are from 17 mice per group. (B) Intracellular flow 
cytometric analysis of the indicated cytokines in WT and CD2-Gata3 transgenic T-cell cultures at 
day 7. Numbers indicate the percentages of total cells within the quadrants. (C) Flow cytometric 
analysis for intracellular IL-10 in WT (gray filled histogram) and CD2-Gata3 transgenic (black line) 
T-cell cultures. Numbers indicate the percentages of IL-10+ cells. Data are representatives of 4–6 
mice per group. (D) Quantification of flow cytometric analysis for intracellular IL-10 in gated CD4+ 
T cells from WT (white bars) and CD2-Gata3 transgenic mice (black bars). Mean values and SEM 
are from 4 to 6 mice per group (**P<0.01; t-test). (E) Quantitative RT-PCR analysis of cytokine 
expression in the indicated T-cell cultures. Expression was normalized to Gapdh and expression 
levels of Il5 and Il6 in WT Th2 and expression levels of Tnfα, Il21 and Il22 in WT Th17 cells, were 
set to 1. Mean values and SEM are for 5–7 mice per group (*P<0.05;***P<0.001; t-test).
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originally described as a product of Th2 cells but is produced by many other cell types. 
We found a significant induction of IL-10+ cells in CD2-Gata3 transgenic Th0 cells (Fig. 
2C and D). In the presence of the CD2-Gata3 transgene the proportions of IL-10+ cells 
were generally increased in Th1 and Th2 cultures. We found only a modest increase 
in CD2-Gata3 transgenic Th17 cultures, when compared with WT cultures (Fig. 2C 
and D). The presence of Gata3-induced expression of IL-5, irrespective of polarization 
conditions (Supplementary Fig. 2 and Fig. 2E). IL-6, which is also associated with 
Th2 differentiation1, 2, 23 was induced in Th0, Th1 and Th2 but not in Th17 cultures, as 
determined by quantitative RT-PCR analyses (Fig. 2E). 
The ability of enforced Gata3 expression to induce Th2 cytokines and to 
suppress IL-2 production was not unique to T helper cells, as similar observations were 
made in cultured CD8+ T cells (without additional cytokines or mAb) and Treg cells (in 
the presence of TGF-β, anti-IFN-γ and anti-IL-4) for 7 days (Supplementary Fig. 3).
To further examine the properties of the effector T cells that developed in the 
CD2-Gata3 transgenic Th17 cultures, we determined expression of cytokines known to 
be produced by Th17 cells using quantitative RT-PCR. Consistent with the observed 
presence of IL-17+ cells in the CD2-Gata3 transgenic Th17 cultures, we found that 
they expressed IL-21 and TNF-α, albeit at lower levels when compared with WT Th17 
cultures (Fig. 2E). Enforced Gata3 expression allowed normal IL-22 production in Th17 
cells.
Taken together, these experiments demonstrate that – in the presence of anti-
IL-4 and anti-IFN-γ antibodies – enforced Gata3 expression does not significantly affect 
the generation of IL-17-producing cells in vitro. The CD2-Gata3 transgenic cells cultured 
in the presence of TGF-β and IL-6 had characteristics of both Th17 cells (production 
of IL-17, IL-21 and IL-22, low IL-6 expression) and Th2 cells (production of the Th2 
cytokines IL-4, IL-5 and IL-13, low levels of IL-2).
Transgenic Gata3 affects transcription of various regulators of Th17 cells
In our Th17 culture system, in the presence of anti-IFN-γ and anti-IL-4 antibodies, 
the proportions of IL-17-producing cells in WT and CD2-Gata3 transgenic cultures 
were similar at day 7 (see Fig. 2B), probably reflecting an equilibrium of stimulatory 
and inhibitory effects of Gata3. This enabled us to analyze the effect of Gata3 on the 
expression of individual factors involved in regulation of Th17 differentiation in cell 
populations that contained equal proportions of IL-17+ cells. Day 7 WT and CD2-Gata3 
transgenic Th17 cultures were activated by anti-CD3/anti-CD28 stimulation for 4h and 
mRNA expression levels were analyzed by quantitative RT-PCR and compared with 
those in Th0, Th1, Th2, Treg and CD8 cultures (Fig. 3 and Supplementary Fig. 4).
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Expression of the CD2-Gata3 transgene resulted in reduced transcription levels 
of RORγt, which is essential for Th17-cell generation. Also transcription of Nfatc2, which 
stimulates expression of IL-17 in human38, was reduced. Growth factor independent-1 
(Gfi-1) is a Stat6-dependent transcriptional repressor that is induced by IL-4 in activated 
CD4 T cells and increases Th2 cell expansion by promoting proliferation and preventing 
apoptosis39. Enforced Gata3 expression did not result in significantly increased 
Gfi-1 levels in Th17 cultures, but was associated with a substantial increase of Gfi-1 
expression in Treg cultures (Supplementary Fig. 4). Gata3 expression did not have 
detectable effects on the expression levels of Nfatc1 or Irf4, which was recently shown 
to be essential for Th17 differentiation40 (Supplementary Fig. 4).
Jak-Stat (signal transducer and activator of transcription) signalling is crucially 
involved in pathways integrating cytokine signals into T-cell differentiation programs: 
Stat1 and Stat4 in Th1 cells, Stat5a and Stat6 in Th2 cells and Stat3 and Stat4 in 
Th17 cells. In agreement with previous findings in Th1/Th2 polarization8, 9, we found 
that Gata3 is capable of downregulating Stat4 in Th17 cultures (Fig. 3). As Stat4 was 
recently shown to direct Th17 cells41, 42, this finding indicates that Gata3 might be a 
negative regulator of Th17 differentiation by Stat4 downregulation.
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Figure 3. Enforced Gata3 expression affects factors involved in Th17 differentiation. Quantitative 
RT-PCR analysis of expression of the indicated genes in wild-type (WT, white bars) and CD2-
Gata3 transgenic (black bars) Th17 cultures at day 7. Expression levels were normalized for 
Gapdh and values in Th17 cultures from WT mice were set to 1. Mean values and SEM are given 
for 6–11 mice analyzed per group (*P<0.05; **P<0.01; ***P<0.001; t-test).
Claudia Thesis_2.indd   193 17/10/2010   21:19:01
194 Chapter 6
Enforced Gata3 expression was also associated with reduced expression of 
Stat1, specifically in Th17 and Th0 cells, and Stat3, specifically in Th17 cells (Fig. 3 and 
Supplementary Fig. 4). The latter finding would implicate Gata3 as a negative regulator 
of IL-17 differentiation, because Stat3 directly binds to the IL-17A and IL-17F promoters43. 
No significant effects of Gata3 on Stat5a or Stat6 were observed (Supplementary Fig. 
4). IL-23-mediated phosphorylation of Stat3, and thus Th17 generation, is negatively 
regulated by the cytokine-inducible inhibitor Socs3 (suppressor of cytokine signalling)43. 
We found that the presence of enforced Gata3 expression is associated with significantly 
reduced levels of Socs3 transcripts (Fig. 3). 
Taken together, these RT-PCR analyses show that enforced Gata3 expression is 
associated with significant changes in the expression levels of critical regulators of Th17 
development. Gata3 has the capacity to stimulate Th17-cell generation by decreasing 
expression of Stat1 and Socs3 and to inhibit Th17 differentiation by limiting expression 
of RORγt, Stat3, Stat4 and Nfatc2.
Effects of Gata3, IL-2 and IL-4 on Th17 differentiation
As enforced Gata3 expression resulted in increased IL-4 and reduced IL-2 expression, 
both of which are negative regulators of Th17 differentiation24, 28, 37, we explored the 
effects of Gata3, IL-2 and IL-4 on Th17-cell generation in more detail.
To this end, we stimulated primary CD62L+CD4+ T cells with plate-bound anti-
CD3/anti-CD28 and cultured them with TGF-β/IL-6 and anti-IFN-γ in the presence or 
absence of exogenous IL-2 or IL-4 or antibodies against these cytokines, for 3 days. 
In these experiments, cells were re-stimulated with PMA/ionomycin for 4h before 
intracellular cytokine staining, which yielded higher proportions of IL-17+ cells, when 
compared with anti-CD3 re-stimulation (compare Fig. 2A with Fig. 4). Hereby, clearance 
of IL-4 had only marginal effects on the generation of IL-17+ cells in WT cells, probably 
due to the limited IL-4 expression of differentiating Th17 cells in the presence of TGF-β 
and IL-6. At day 3, the CD2-Gata3 transgenic Th17 cultures contained significantly 
reduced proportions of IL-17+ T cells: ~12% in the absence and ~22% in the presence 
of anti-IL-4 (Fig. 4A and B). Although addition of external IL-4 reduced the proportions 
of IL-17+ cells expression in WT Th17 cultures, it had only marginal effects on IL-17 
expression in CD2-Gata3 transgenic cultures, probably due to substantial transgenic 
IL-4 production of differentiating Gata3-expressing Th17 cells (Fig. 4A and B). 
Addition of anti-IL-2 mAb, next to anti-IL-4, significantly increased IL-17 production 
in differentiating WT and CD2-Gata3 transgenic Th17 cells (Fig. 4C). Consistent with 
this finding, IL-17 production was low in CD2-Gata3 transgenic Th17 cultures when 
exogenous IL-2 was added, irrespective of the addition of anti-IL-4 mAb. Thus, at day3 
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CD2-Gata3 transgenic Th17 cultures contained fewer IL-17-producing cells than WT 
cultures, even in the presence of anti-IL-4 mAb and independent of clearance of IL-2 or 
addition of IL-2 (Fig. 4C).
To further explore whether the negative effect of Gata3 on IL-2 production in 
Th17 cells is regulated via IL-4, we investigated IL-2 production in 3-day Th17 cultures 
in the absence or presence of anti-IL-4 mAb or exogenous IL-4. IL-2 was expressed 
in ~22–26% of the WT cells, irrespective of clearance of IL-4 (Fig. 4D). Expression 
of IL-2 in CD2-Gata3 transgenic Th17 cultures was very low (~6% of cells), and the 
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Figure 4. Enforced Gata3 expression affects Th17 differentiation via IL-4 and IL-2. (A) to (C) IL-
17/IFN-γ expression profiles of CD4+ T cells in Th17 cultures from the indicated mice. Cells were 
cultured for 3 days with the indicated antibodies or cytokines. Numbers indicate percentages of 
total cells within the quadrants (A, C) or mean values and SEM of the percentage of IL-17+ cells 
are given (*P<0.05; **P<0.01; ***P<0.001; t-test) (B). Data shown are representatives of 5–11 mice 
per group. (D) Flow cytometric analysis of intracellular IL-2 expression in wild-type (WT, gray filled 
histogram) and CD2-Gata3 transgenic (black line) Th17 cells, which were cultured for 3 days 
with or without αIL-4 or IL-4. Numbers indicate the percentages of IL-2+ cells. Data shown are 
representatives of 2–10 mice per group. (E) Flow cytometric analysis of intracellular IL-2 in Th17 
cultures from the indicated mice. Cells were cultured for 3 days and stimulated with indicated 
concentrations of plate-bound anti-CD3. Mean and individual data points are displayed, indicating 
the percentage of IL-2+ cells.
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proportion of IL-2-producing cells only moderately increased in the presence of anti-
IL-4. Thus, low IL-2 expression in the presence of the CD2-Gata3 transgene is partially 
IL-4-dependent and partially IL-4-independent. The capacity of IL-4 to reduce IL-2 
production in Th17 cells was confirmed by the finding of reduced IL-2 expression in WT 
Th17 cells that were cultured in the presence of IL-4 for 3 days (Fig. 4D). Consistent 
with the reported TCR signal strength-dependency of IL-2 production, and the inverse 
correlation between Gata3 induction and IL-2 expression in naïve T cells44, we found 
that in differentiating Th17 cells IL-2 production increased when cells were stimulated 
with higher doses of anti-CD3 and that in CD2-Gata3 transgenic T cells increasing the 
anti-CD3 concentration had limited effect (in the presence of anti-CD28 mAb; Fig. 4E).
Taken together, we found that enforced Gata3 expression in 3-day Th17 
cultures resulted in reduced proportions of IL-17-expressing cells under all conditions 
analyzed. Gata3 (i) stimulates IL-17 production via IL-2 downregulation, (ii) inhibits IL-
17 production via induction of IL-4 and (iii) additionally constrains IL-17 production in an 
IL-4-independent way.
Downregulation of Stat3/4, Socs3, Nfatc2 and RORγt by Gata3 is IL-4-
independent
Our finding that Gata3 has the capacity to limit expression of Stat3, Stat4, Socs3, Nfatc2 
and RORγt in Th17 cultures in the presence of antibodies to IL-4 and IFN-γ (Fig. 3) 
suggested that these inhibitory effects of Gata3 were IL-4-independent. To analyze this 
IL-4 independence directly, we performed Th17 cultures in the presence or absence 
of anti-IL-4 antibodies or exogenous IL-4 and analyzed the expression of Stat3, Stat4, 
Socs3, Nfatc2 and RORγt at day 7 by RT-PCR. We found that the capacity of Gata3 
to reduce transcription of these factors was indeed independent of IL-4 addition or 
clearance (Supplementary Fig. 5A). The presence of the Gata3 transgene did not 
significantly affect the in vitro proliferative capacity of Th17 cultures, excluding the 
possibility that the observed effects of Gata3 on gene transcription were unspecific 
(Supplementary Fig. 5B).
We therefore conclude that the observed inhibitory effect of Gata3 on Stat3, 
Stat4, Socs3, Nfatc2 and RORγt transcription is independent of IL-4.
IL-17-producing T cells are present in vivo in CD2-Gata3 transgenic mice
Next, we investigated whether enforced Gata3 expression would allow the differentiation 
of Th17 cells in vivo. Since Th17 cells have been associated with the mucosal lymphoid 
system27, we analyzed IL-17 expression in gut-draining lymphoid tissue, including 
Peyer’s patches, mesenteric and iliacal lymph nodes. In these tissues we found that in 
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the presence of the Gata3 transgene the populations of IL-17-producing T cells were 
maintained (Fig. 5A), but also IL-4 production was induced (Fig. 5B). Thus, enforced 
Gata3 expression allowed differentiation of Th17 cells in vivo. 
Transgenic Gata3 allows in vivo Th17 differentiation but protects against EAE
Although our analyses in gut-draining lymphoid tissues showed that enforced Gata3 
expression allowed differentiation of IL-17+ T cells in vivo, the various stimulatory and 
inhibitory effects of Gata3 on Th17 differentiation identified prompted us to investigate 
the effect of the CD2-Gata3 transgene on development of EAE, which has been reported 
to be highly dependent on Th17 cells22, 23, 29. After MOG peptide/CFA immunization, five 
out of eight WT mice developed EAE. In contrast, no clinical disease symptoms were 
found in ten CD2-Gata3 transgenic mice (Fig. 6A). We determined the presence of IL-
17-producing cells in a pool of axillary, brachial and inguinal lymph nodes after MOG 
peptide injection. Importantly, we found similar proportions of IL-17-producing CD4+ T 
cells in WT and in CD2-Gata3 transgenic mice (Fig. 6B), although the values in CD2-
Gata3 transgenic mice were slightly higher at day 14, and slightly lower at day 28, 
as compared with WT mice. Importantly, at day 14 CD2-Gata3 transgenic mice had 
significant numbers of IL-4 and IL-10- producing CD4+ T cells in their lymph nodes (~2.0 
and ~2.5%, n=5, respectively), in contrast to WT mice (both proportions were <0.2%) 
(Fig. 6C).
Next, we sorted T helper cells with the CD62L−CD4+ activated/memory 
phenotype from spleens from WT and CD2-Gata3 transgenic mice at day 14 after MOG 
peptide injection. Quantitative RT-PCR analyses revealed that increased expression 
of Gata3 was associated with reduced transcription of RORγt, Stat1, Stat3, Stat4 and 
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Figure 5. IL-17-producing cells in CD2-Gata3 transgenic mice in vivo. (A) Flow cytometric 
analysis for intracellular IL-17 and IFN-γ expression in gated CD4+ T cells from mesenteric lymph 
nodes (MLN), iliacal lymph nodes (ILN) and Peyer’s patches (PP) from wild-type (WT) and CD2-
Gata3 transgenic mice. Numbers indicate the percentage of cells within the quadrants. Data are 
representatives of six mice analyzed per group. (B) Quantification of flow cytometric analysis 
for intracellular IL-4 in gated CD4+ T cells from the indicated tissues from WT (white bars) and 
CD2-Gata3 transgenic mice (black bars). Mean values and SEM are from four mice per group 
(*P<0.05; **P<0.01; t-test).
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Socs3 (Fig. 6D), in agreement with our findings in in vitro Th17 cultures (Fig. 3). In 
addition, we found that T-bet and TNF-α expression were unaffected by the presence of 
the CD2-Gata3 transgene in vivo.
We therefore conclude that enforced Gata3 expression exerts a marginal effect 
on the generation of IL-17-producing cells in EAE. Nevertheless, CD2-Gata3 transgenic 
mice are not susceptible to in vivo EAE induction, possibly because concomitant 
production of IL-4 and the induction of IL-10 may restrain Th17-mediated pathology.
DISCUSSION
In this report, we studied the molecular mechanisms of counter-regulation by which the 
key regulator of Th2 differentiation, transcription factor Gata3, affects Th17 differentiation. 
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Figure 6. CD2-Gata3 transgenic mice are not susceptible to EAE induction. (A) Induction of 
EAE by immunization with MOG35–55 peptide. Mean clinical scores and weight are given for 8–10 
mice per group. (B) Flow cytometric analysis of intracellular IL-17 expression in gated LN CD4+ 
T cells from wild-type (WT) and CD2-Gata3 transgenic mice 14 and 28 days after EAE induction. 
Mean and individual data points are displayed, indicating the percentage of IL-17+ cells. (C) Flow 
cytometric analysis for the indicated cytokines in gated LN CD4+ T cells from WT mice and CD2-
Gata3 transgenic mice 14 days after EAE induction. Numbers indicate the percentage of cells 
within the quadrants. Data shown are representatives of 3–5 mice per group. (D) Quantitative 
RT-PCR analysis of expression of the indicated genes in sorted activated/memory CD4+CD62L− 
T cells from WT (white bars) and CD2-Gata3 transgenic (black bars) mice 14 days after EAE 
induction. Expression levels were normalized for Gapdh and values of WT mice were set to 1. 
Mean values and SEM are given for three mice analyzed per group (*P<0.05; **P<0.01; t-test).
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We show that enforced expression of Gata3 from a T-cell-specific transgene essentially 
induces Th2 cytokine production and hampers IL-2 cytokine production in various in 
vitro differentiating effector T-cell populations, including Th17 cells. The induction of 
the Th2 cytokine IL-4, by Gata3, had a negative effect on TGF-β/IL-6-induced Th17 
differentiation, but this was partially compensated by the capacity of Gata3 to limit IL-2 
production, which functions as a negative regulator of Th17 differentiation28. However, the 
Gata3-induced stimulation of IL-4 production alone could not fully explain the inhibitory 
effect of Gata3 on Th17 differentiation: also in the presence of anti-IL-4 antibodies CD2-
Gata3 transgenic Th17 cultures contained fewer IL-17+ cells, when compared with WT 
cultures, at day 3. Therefore, we conclude that Gata3 additionally constrained Th17 
differentiation through IL-4-independent mechanisms. Our RT-PCR analyses showed 
that Gata3 may stimulate Th17-cell differentiation by decreasing expression of Stat1 and 
Socs3 and may inhibit this process by limiting expression of RORγt, Stat3, Stat4 and 
Nfatc2. As in CD2-Gata3 transgenic mice IL-17-producing cells were present in normal 
numbers in vivo, both in gut-draining tissue and in lymph nodes during EAE induction, 
we conclude that the final consequences of the various stimulatory and inhibitory effects 
of Gata3 were that in vivo the presence of enforced Gata3 expression still allows for 
differentiation of IL-17-producing cells. However, because CD2-Gata3 transgenic mice 
were not susceptible to EAE, it appears that Gata3 mainly acts as an inhibitor of Th17-
mediated pathology, possibly by driving IL-4 and IL-10 production.
In single CD2-Gata3 transgenic T cells, Th2 cytokines were co-expressed 
together with cytokines that signify differentiation to other subsets, such as IL-17 (in Th17 
cells) or IFN-γ (in Th1 cells). Therefore, these findings indicate that Gata3 expression 
is sufficient to induce Th2 cytokine production, irrespective of the presence of critical 
transcription factors such as RORγt and T-bet in Th17 or Th1 cultures, respectively. 
Also CD8+ T-cell cultures contained substantial proportions of cells producing Th2 
cytokines or IL-10 at levels, similar to those found in WT Th2 cell cultures. Thus, in CD8 
T-cells transgenic Gata3 could counteract the repression of Th2 cytokine production by 
repressor of Gata. This finding is in apparent conflict with the report by Omori et al.34, 
who found that ectopic expression of Gata3 in cytotoxic type 2 cells resulted only in 
a limited generation of IL-4-producing cells. This discrepancy might be explained by 
the fact that in our study Gata3 is already overexpressed in naïve CD8+ T cells in vivo, 
whereas in their retrovirus gene introduction system Gata3 expression is induced during 
cell culture.
The finding that Gata3 had the capacity to inhibit IL-2 expression, even in Th1 
or Th17 cultures in the presence of anti-IL-4 antibodies, indicates that Gata3 directly 
regulates IL-2, through an IL-4-independent mechanism. Gata3 expression is sufficient 
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to induce IL-6 in Th0 or Th1 cells, but not in Th17 cells, suggesting that this capacity 
of Gata3 is either specifically inhibited in Th17 cells or dependent on a co-factor 
that is not present in Th17 cells. It has been shown that IL-4 suppresses Th17-cell 
development in vitro and that Th2 cytokines are important for preventing or ameliorating 
EAE; conversely, loss of IL-25 results in accelerated EAE pathology, associated with an 
increased number of IL-17-producing T cells that invade the central nervous system20, 
29, 45, 46. The prevention of EAE in CD2-Gata3 transgenic mice is consistent with our 
findings of (i) significant IL-4 production in lymph nodes from CD2-Gata3 transgenic 
mice during EAE induction in vivo and (ii) limited Th17 differentiation of cells from 
CD2-Gata3 transgenic mice, cultured for 3 days in Th17 conditions in the absence 
of neutralizing anti-IL-4 antibodies (Fig. 5A). Also, the observed induction of IL-10 by 
transgenic Gata3 might well contribute to the resistance of CD2-Gata3 transgenic mice 
to EAE. In this context, it was very recently found that TGF-β and IL-6 do not only 
drive Th17 commitment, but they also act together to restrain the pathogenic potential 
of Th17 cells, by inducing the production of IL-10, which is an important factor in the 
downmodulation of immune responses and EAE47-50. In fact, evidence was provided 
for the existence of Th17 subsets with effector or regulatory functions that correlate 
in part with their ability to produce IL-10. Although Gata3 has been shown to directly 
remodel the IL-10 locus in CD4+ T cells independently of IL-451, the observed significant 
proportions of IL-10+ CD4 T cells during in vivo EAE induction in CD2-Gata3 transgenic 
mice (Fig. 6C) do not necessarily point to a direct role of Gata3 in upregulating IL-10 
production in Th17 cells. On the contrary, we found that transgenic expression of Gata3 
had only a modest effect on IL-10 production by Th17 cells generated in vitro (Fig. 2C). 
Therefore, it is more likely that the induction of IL-10+ T cells in vivo is largely indirect, 
e.g. through tolerogenic dendritic cells47. Further experiments are required to determine 
whether prevention of EAE induction by enforced Gata3 expression is indeed dependent 
on the induction of IL-4, IL-10 or both, or whether other molecules are involved. In this 
context, we found that in the presence of neutralizing antibodies to IL-10 (from day 0 to 
day 8), EAE can be induced in CD2-Gata3 transgenic mice, albeit with an incidence and 
severity that is lower than in WT mice (JP van Hamburg, unpublished data). Therefore, 
these preliminary experiments indicate that IL-10 induction may contribute to the effects 
of transgenic Gata3, but does not completely explain the reduced susceptibility of CD2-
Gata3 transgenic mice.
Although in 3-day cultures transgenic Gata3 expression limited Th17 
differentiation, 7-day WT and CD2-Gata3 transgenic Th17 cultures contained similar 
proportions of IL-17-producing cells. Apparently at day 7 inhibitory and stimulatory 
effects of Gata3 are in balance, which made these cultures good tools to investigate the 
Claudia Thesis_2.indd   200 17/10/2010   21:19:03
Gata3 constrains Th17 differentiation 201
C
ha
pt
er
 6
effect of Gata3 activity on the expression of genes involved in Th17 differentiation. We 
found that enforced Gata3 is associated with reduced expression of RORγt, Stat3, Stat4 
and Nfatc2, but further experiments are required to establish whether these genes are 
direct Gata3 targets. Interestingly, Nfatc2, which is known to stimulate IL-17 in human 
T cells and IL-21 in Th2 cells, can be induced by IL-6 in Th2 cells38, 52, 53 and has the 
ability to interact with Irf454, which was recently shown to be critically involved in Th17 
differentiation. But, it is currently not known how Nfatc2 functions in Th17 differentiation. 
Furthermore, Gata3 expression resulted in downregulation of Stat1, known to suppress 
Th17 differentiation via IL-27 signalling55 and of Socs3, which is a negative regulator of 
Stat3 phosphorylation43. The effects of Gata3 on RORγt, Socs3, Stat3, Stat4 and Nfatc2 
were not influenced by the addition or clearance of IL-4, indicating that Gata3 regulates 
these factors in an IL-4-independent manner. This is quite remarkable for Socs3, since 
one of the mechanisms by which IL-4 suppresses Th17-cell development may be through 
induction of Socs3 expression through IL-4R signalling. This was shown to be the case 
in B cells by a p38 MAPK-mediated mechanism56. Finally, the in vivo development of 
significant numbers of IL-17+ effector cells in CD2-Gata3 transgenic mice could also 
partially be stimulated by the ability of Gata3 to limit IL-2 production and inhibit the 
generation of IFN-γ-producing cells, which suppress development of Th17 cells from 
naïve precursor cells20, 21. Taken together, Gata3 has various stimulatory and inhibitory 
effects on Th17 differentiation (see Fig. 7), whereby enforced Gata3 expression still 
allows the generation of IL-17-producing cells in vivo. 
It is not surprising that with the identification of two additional effector T-cell 
subsets, Th17 and Treg cells, the molecular mechanisms of the reciprocal interactions 
between T-cell subsets, involving counter-regulation at the level of transcription factors 
and cytokines, become more complex. For example, we found that in vitro generated 
Tregs (containing >95% CD25+Foxp3+ cells) expressed significant levels of Gata3 and 
RORγt (Supplementary Fig. 4), indicating that Gata3 is not Th2-specific and RORγt 
is not Th17-specific. As these cultured Treg cells express Foxp3, T-bet, Gata3 and 
RORγt, apparently without any tendency to develop into Th1, Th2 or Th17 cells, Treg 
differentiation seems critically dependent on the balance between these transcription 
factors and therefore a molecular mechanism should be present in these cells that keep 
transcription factors in check and prevents Th1, Th2 or Th17 development. Conversely, 
the presence of RORγt alone is not sufficient to induce commitment to the Th17 lineage. 
The simultaneous expression of Gata3, T-bet and RORγt in Treg cells are puzzling and 
in apparent conflict with molecular models in which key transcription factors are essential 
to stabilize active or silent states of cytokine loci by epigenetic modifications during 
polarized effector T-cell differentiation. Our findings in Gata3 transgenic mice show 
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that Gata3 has the capacity to constrain Th17 differentiation through IL-4-dependent 
and IL-4-independent pathways, but neither Gata3 expression, nor the consequential 
production of IL-4, IL-5, IL-13 or IL-10 inhibited the generation of IL-17-producing cells 
in vivo. In this context, these findings are consistent with population-based studies in 
man57-59 supporting the hypothesis that Th2-mediated diseases, such as asthma, do not 
necessarily protect from Th17-mediated autoimmune disorders.
METHODS
Mice. CD2-Gata3 transgenic mice36 were backcrossed on the C57BL/6 background 
for at least eight generations and genotyped by PCR. Gata3 primers were: 5′-
CAGCTCTGGACTCTTCCCAC-3′ and 5′-GTTCACACACTCCCTGCCTT-3′.
Flow cytometric analyses. Preparations of single-cell suspensions from thymus, spleen 
and lymph nodes, mAb incubations and four-color flow cytometry have been previously 
described60. Monoclonal antibodies were purchased from BD Biosciences, except PE-
conjugated anti-Granzyme B (GB12) and biotinylated anti-IL-13 (BAF413), which were 
from Caltag Laboratories (Burlingame, CA, USA) and R&D Systems (Minneapolis, 
MN, USA), respectively. For intracellular detection of cytokines, cells were stimulated 
with plate-bound anti-CD3 mAb (10 µg/mL in PBS) in the presence of GolgiStop™ (BD 
Biosciences) for 4h. Cells were harvested, extracellularly stained with anti-CD4 or anti-
CD8 mAbs, followed by standard intracellular staining using 2% paraformaldehyde 
and 0.5% saponin. Samples were acquired on a FACSCalibur™ flow cytometer and 
+ Th17
- Th17
IL-4 
IL-10
T-bet STAT4
STAT1
IFNγ
IL-2
SOCS3
STAT3
RORgtGATA3
NFATc2
Figure 7. Regulatory effects of Gata3 on Th17 differentiation. Model showing effects of Gata3 on 
Th17 differentiation. Gata3 has positive effects by limiting IFN-γ and IL-2 production and inhibiting 
expression of T-bet, Stat1, and the Th17 repressor protein Socs3. On the other hand, Gata3 
constrains Th17 differentiation by inhibiting expression of critical factors in Th17 differentiation, 
including RORγt, Stat3, Stat4 and Nfatc2, and limits Th17-mediated pathology by enhancing 
production of IL-4 and IL-10.
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analyzed using CELLQuest™ (Becton Dickinson, Sunnyvale, CA, USA) or FlowJo™ 
(Tree Star, Ashland, OR, USA) research software. Live events were collected based on 
forward and side scatter.
Purification of naïve or activated/memory T cells and in vitro T-cell cultures. Naïve 
CD62L+CD4+ or CD8+ T cells were purified from spleens obtained from 8-wk-old mice 
and activated/memory CD62L−CD4+ were purified from spleens from mice subjected 
to EAE induction. Cells were sorted, using an FACSVantage VE equipped with Diva 
Option and BD FACSDiva software (BD Bioscience). Purity of obtained fractions was 
typically >98%. CD62L+CD4+ or CD8+ T-cell fractions were cultured at concentrations 
of 1×106 cells/mL in Iscove’s modified Dulbecco’s medium (BioWhittaker, Walkersville, 
MD, USA), containing 10% heat-inactivated fetal calf serum (Sigma, St. Louis, MO, 
USA), 5×10−5 M β-mercapto-ethanol (Merck, Darmstadt, Germany), supplemented with 
various cytokines (R&D Systems), as described below. Plates were coated with anti-
CD3 and anti-CD28 (145-2C11; 37.51, BD Biosciences) at a concentration of 10 µg/
mL each in PBS at 4 °C overnight. For Th1 polarizing conditions, IL-12 (10 ng/mL) and 
anti-IL-4 (10 µg/mL; 11B11) were added. Th2 polarizing conditions included IL-4 (10 
ng/mL, R&D Systems), anti-IFN-γ (5 µg/mL; XMG1.2) and anti-IL-12/23 p40 (5 µg/mL; 
C17.8). Treg and Th17 polarizing conditions included TGF-β (3 ng/mL), anti-IL-4 and 
anti-IFN-γ. Th17 polarizing conditions additionally contained IL-6 (20 ng/mL), and in 
specified conditions also IL-4 (10 ng/mL), IL-2 (5 ng/mL) or anti IL-2 (10 µg/mL; JES6-
1A12, Southern Biotech Associates, Birmingham, AL, USA). For Th0 conditions or CD8 
T cells no cytokines or mAbs were added. On day 3 anti-CD3/CD28 activation was 
stopped and T-cell cultures were stained for intracellular cytokine detection or expanded 
in the presence of the indicated cytokines, supplemented with IL-2 (5 ng/mL) for up to 
7 days.
Quantitative PCR analyses. Total RNA was extracted using the GeneElute mammalian 
total RNA miniprep system (Sigma) and 1 µg was used as a template for cDNA 
synthesis, using Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA) 
and random hexamer primers. PCR primers spanning at least one intron–exon junction 
were designed manually or using ProbeFinder software (Roche Applied Science, 
Indianapolis, IN, USA) and probes were chosen from the universal probe library (Roche 
Applied Science) or designed manually and purchased from Eurogentec (Seraing, 
Belgium) (Supplementary Table 1). Quantitative real-time PCR was performed using 
the ABI Prism 7700 sequence detection system (Applied Biosystems, Foster City, CA, 
USA). To confirm the specificity of the amplification products, samples were analyzed 
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by standard agarose gel electrophoresis. Threshold levels were set and further analysis 
was performed using the SDS v1.9 software (Applied Biosystems). The obtained Ct 
values were normalized to those of glycereraldehyde-3-phosphate dehydrogenase 
(Gapdh).
EAE induction. EAE was induced in ~10-wk-old mice by subcutaneous injection of 200 
µg MOG35–55 peptide emulsified in complete Freund’s adjuvant (Difco), as described61. 
Mice were daily weighed and scored for clinical signs, as follows: 0, no disease; 0.5, 
partial tail paralysis; 1, complete tail paralysis; 1.5, limb weakness without tail paralysis; 
2, limb weakness and tail paralysis; 2.5, partial limb and tail paralysis; 3, complete hind 
or front limb paralysis; 3.5, paraplegia; 4, quadriplegia; 5, death due to EAE. Paralyzed 
mice with EAE scores above 2 were afforded easier access to food and water.
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Supplementary Figure 1. Characterization of CD2-Gata3 Tg mice on the C57BL/6 background. 
(A) Distribution of T cell populations in the thymus, spleen and mesenteric lymph node (MLN) of 
wild-type (WT) and CD2-Gata3 transgenic mice. Results are displayed as dot plots of CD4/CD8 
profiles. Percentages shown represent proportions of cells within a quadrant or gate. (B) Total 
cell numbers within the indicated cell populations in thymus and spleen. Mean values and SEM 
are given for eight mice analyzed per group (*, P<0.05; **, P<0.01; ***, P<0.001; t-test). (C) Cell 
size (FSC), surface expression of CD3 and CD5 in splenic CD4 and CD8 T cell populations. 
Results are displayed as histograms indicating WT mice (gray filled histograms) and CD2-Gata3 
transgenic mice (black lines). Data shown in (A) and (C) are representative for eight mice analyzed 
per group.
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Supplementary Figure 2. Induction of IL-5 and IL13 by Gata3. Flow cytometric analysis for 
intracellular expression of IL-5 and IL-13 in the indicated T cell cultures from WT and CD2-Gata3 
transgenic mice at day 7. CD4+ T cell populations were gated and dot plots are shown, whereby 
numbers indicate percentages of total cells within the quadrants. Data shown are representative 
for four mice analyzed per group.
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Supplementary Figure 3. Enforced Gata3 expression induces Th2 cytokines in CD8 T cells and 
Treg cells. (A) Quantitative RT-PCR analysis of Gata3 and T-bet expression in the indicated wild-
type (WT, white bars) and CD2-Gata3 transgenic (black bars) T effector cell cultures. Expression 
was normalized as indicated in the legend to Figure 1A. Mean values and SEM are given for four 
six mice per group (*, P<0.05; **, P<0.01; ***, P<0.001; t-test). (B) Flow cytometric analysis of 
intracellular expression of granzyme B and cytokines in WT and CD2-Gata3 transgenic CD8+ T 
cells, which were cultured for seven days. Numbers indicate the percent of total cells within the 
quadrants. Data shown are representative for four mice analyzed per group. (C) Flow cytometric 
analysis of IL-2 expression in WT and CD2-Gata3 transgenic CD8+ T cells, stimulated by plate-
bound anti-CD3/anti-CD28 and cultured for seven days (gray filled histogram) in comparison with 
cultures containing anti-IL-4 mAb (black line). Data shown are representative for 3-4 mice per 
group. (D) Quantitative RT-PCR of Gata3 and ROG expression in WT and CD2-Gata3 transgenic 
CD8 T cells, cultured under the indicated conditions. Expression was normalized to Gapdh and 
levels in WT CD8+ T cells were set to one. Mean values and SEM are given for 2-5 mice analyzed 
per group. (E) Flow cytometric analysis of intracellular expression of cytokines indicated and the 
Treg-specific transcription factor Foxp3. Numbers indicate the percentage of total cells within 
quadrants. (F) Flow cytometric analysis of intracellular IL-4 in WT (gray filled histogram) and 
CD2-Gata3 Tg (black line) Foxp3+ cells. Numbers indicate the percentage of IL-4+ cells within the 
Foxp3+ population. Data shown are representative of four mice analyzed per group.
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Supplementary Figure 4. Effect of enforced Gata3 expression on transcription levels of nuclear 
factors. Quantitative RT-PCR analysis of expression of the indicated nuclear factors in different 
T effector cell cultures. Expression levels were normalized for Gapdh and expression in Th17 
cultures from wild-type (WT) mice were set to one. Mean values and SEM are given for 5-11 mice 
analyzed per group (*, P<0.05; **, P<0.01; ***, P<0.001; t-test).
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Supplementary Figure 5. Enforced Gata3 expression affects critical factors in Th17 differentiation 
in an IL-4-independent manner. (A) Quantitative RT-PCR analysis of expression of the indicated 
genes in Th17 cultures. Cells were cultured for seven days with or without αIL-4 or IL-4. Expression 
was normalized for Gapdh and values in Th17 cultures from wild-type (WT) mice were set to one. 
Mean values and SEM are given for eight mice analyzed per group (*, P<0.05; **, P<0.01; ***, 
P<0.001; t-test). (B)  Fold expansion of WT and CD2-Gata3 transgenic Th0 and Th17 cells with or 
without αIL-4 or IL-4. Mean values and SEM are given for eight mice analyzed per group.
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Gene Forward primer Reverse primer Probe
Gapdh TTCACCACCATGGAGAAGGC GGCATGGACTGTGGTCATGA TGCATCCTGCACCACCAACTG
Gata3 CATTACCACCTATCCGCCCTATG CACACACTCCCTGCCTTCTGT CGAGGCCCAAGGCACGATCCAG
Gfi-1 TCCGAGTTCGAGGACTTTTG GAGCGGCACAGTGACTTCT CTTCTCCC
Il5  ACATTGACCGCCAAAAAGAG ATCCAGGAACTGCCTCGTC  GAGGAGAG
Il6 ATCAGGAAATTTGCCTATTGAAA CCAGGTAGCTATGGTACTCCAGA TTCCTCTG
Il21 CCATCAAACCCTGGAAACAA TCACAGGAAGGGCATTTAGC AGGAGGAG
Il22 GTGACGACCAGAACATCCAG TCCACTCTCTCCAAGCTTTTTC GGCTGAAG
Irf4 ACCCCATGACAGCACCTTAT GGGTGGCATCATGTAGTTATGA CAGCCAG
Nfatc1 TCCAAAGTCATTTTCGTGGA CTTTGCTTCCATCTCCCAGA GCTCCAGA
Nfatc2 CCTGCTGGTACCACCTACTTG CCGACTGATTGGAGAGTGG CAGCATCC
ROG GGCTTCCTCTAGCCCCACT CCAAGGGCTGAGGGTTTC CCAGGGCA
RORγt TTCACCCCACCTCCACTG TGCAAGGGATCACTTCAATTT TGCTGTCC
Socs3 ATTTCGCTTCGGGACTAGC AACTTGCTGTGGGTGACCAT CAGCCACC
Stat1 TTGTCAGATCGAACCTTCCTC TGTCGTTCTACCACGAAGGA CTTCCAGC
Stat3 CGTGGAGCTGTTCAGAAACTT AACTGGACACCAGTCTTGATGA TGGTGGAG
Stat4 CCTTAATTCAGAGCAGCTCAACA GGTGAGGTGACCATCATTGTAG TGGCAGAG
Stat5a TGAAGGCGACCATCATCAG GACGCAACAGTTGTTCAGGA CAGCAGGC
Stat6 TCTGAGAGAGGGAGAAGATAGCAG GGCCCCACAGAGACATGAT GGCTGCTG
T-bet TCAACCAGCACCAGACAGAG AAACATCCTGTAATGGCTTGTG GGCTGGAG
Tnfα CCACGTCGTAGCAAACCAC TTTGAGATCCATGCCGTTG TGGAGGAG
Supplementary Table 1. Primers and probes used for quantitative RT-PCR analysis for 
expression of the indicated genes.
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Lymphocyte development and differentiation into functional effector subsets is a 
complex and highly regulated process. The cellular mechanisms of lineage specification 
and commitment, proliferation and differentiation critically depend on developmentally 
regulated changes in gene expression patterns. This frequently involves coordinate 
binding of lineage-specific transcription factors to cis-regulatory elements located over 
considerable genomic distances. For instance, three-dimensional models of gene 
regulation have been recently illustrated by studies at antigen receptor and T helper 
cytokine gene loci. Direct evidence for CTCF-mediated higher-order chromatin structure 
has been reported at several developmentally regulated gene loci, including the mouse 
β-globin and H19/Igf2 loci and the human MHCII locus. More recently, genome-wide 
studies support a role for CTCF in the global organization of chromatin architecture. The 
main findings described in this thesis provide insight into the role of CTCF in lymphocyte 
proliferation, survival and differentiation, with particular emphasis on the regulation of Ig 
loci gene rearrangement and T helper cytokine gene expression. 
CTCF regulation of lymphocyte proliferation, survival and differentiation 
Previous studies have shown that CTCF levels markedly impact cellular functions as a 
consequence of the global and essential role for CTCF in regulating gene expression. 
Using a transgenic RNA interference (RNAi) approach, reduction of CTCF protein levels 
in oocytes prior to fertilization has been shown to disrupt normal progression to the 
blastocyst-stage embryos1. Further detailed analysis on the role of CTCF during early 
embryonic development identified misregulated transcription of hundreds of genes 
upon CTCF deletion2. Accordingly, in Chapter 3 we show that no homozygous Ctcf 
knockout mice were born from Ctcf+/- crosses. Furthermore, the ratio of wild-type to 
Ctcf+/- littermates is higher than expected on a Mendelian basis in crosses among Ctcf+/- 
mice and between wild-type and Ctcf+/- mice, which suggested that CTCF is required in 
a dose-dependent manner.
In order to characterize the in vivo function of CTCF during B- and T-cell 
development we crossed Ctcff/f mice with mice expressing Cre recombinase specifically 
in the early stages of B- and T-cell lineage - mb1-cre Ctcff/f and Lck-Cre Ctcff/f mice, 
respectively. We demonstrated in Chapter 2 that early B cell development is impaired 
in mb1-cre Ctcff/f mice due to markedly defective proliferation and differentiation of CD2- 
cytoplasmic Igµ+ pre-B cells. Likewise in Chapter 3 we found that deletion of CTCF in 
thymocytes from Lck-Cre Ctcff/f mice specifically hampers αβ T-cell development, namely 
the proliferation of β-selected cells (DN4 and ISP cells) and their differentiation from ISP 
to DP cells. Interestingly, both analyses show that CTCF is essential at early stages of 
lymphocyte development for the cellular proliferation and differentiation events occurring 
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after the first step of antigen receptor loci rearrangements – pre-BCR checkpoint after Igh 
rearrangement in B-cells and pre-TCR checkpoint after Tcrβ rearrangement in T-cells. 
Although a striking parallel between CTCF role in early B- and T-cell development can 
be drawn when comparing mb1-cre Ctcff/f and Lck-Cre Ctcff/f mice, it is important to note 
that the developmental arrest observed during T-cell development is apparently less 
complete and appears to occur later. Pre B-cells from mb1-cre Ctcff/f mice show reduced 
cell size, impaired proliferation and a complete developmental arrest (Chapter 2). In 
contrast, in Lck-Cre Ctcff/f mice, TCRβ+ DN3 cells have the capacity to increase their cell 
size and proliferate at the developmental progression of TCRβ- DN3E to TCRβ+ DN3L 
cells (Chapter 3). However, from the DN3L-to-ISP stage, CTCF-deficient cells become 
smaller and less proliferative than wild-type cells, and although CTCF-deficient DP cells 
are observed in Lck-Cre Ctcff/f mice, differentiation from the ISP-to-DP stage is strongly 
impaired. This does not necessary reflect that CTCF plays and intrinsically different role 
during B- and T-cell development and can be simply due to different kinetics of Ctcf 
deletion or CTCF protein depletion in mb1-cre Ctcff/f and Lck-Cre Ctcff/f mice. In this 
context, Ctcf deletion was monitored in mb1-cre Ctcff/f and Lck-Cre Ctcff/f mice by analysis 
of LacZ expression, a reporter gene present in the Ctcff/f allele. In the B-cell lineage, 
deletion of Ctcff/f alleles by mb1-cre occurs earlier and is more complete (Chapter 2), 
when compared to Lck-Cre-mediated Ctcff/f deletion in the T-cell lineage (Chapter 3). 
Further elucidation on the role of CTCF in T-cell proliferation came from in vitro studies 
with peripheral CD4 and CD8 T cells from CD4-Cre Ctcff/f mice described in Chapter 
4. TCR-stimulation of CTCF-deleted peripheral T-cells with plate-bound anti-CD3 and 
anti-CD28 antibodies results in severely impaired cell size increase, proliferation and 
upregulation of the activation markers CD25 and CD69. Interestingly, these defects can 
be rescued to a great extent when TCR-proximal signalling is circumvented with PMA 
and ionomycin, although cell recovery is still reduced when compared with wild-type 
cultures. These results suggest that CTCF controls the expression of genes encoding 
for proteins involved in TCR-proximal signalling events required for full T-cell activation. 
Importantly, they show that CTCF is not absolutely required for T-cell proliferation. In line 
with this, in vitro proliferation of γδ T-cells is completely CTCF-independent (Chapter 
3).
Changes in the expression levels of several genes may contribute to the 
defects observed in CTCF-deleted cells. In Chapter 2 we performed genome-wide 
gene expression profiling of B-cell progenitors from mb1-cre Ctcff/f and wild-type mice, 
to more comprehensively analyze changes in gene activity regulated by CTCF. We 
identified around 200 genes with misregulated transcription in CTCF-deficient B-cell 
progenitors. Some of these genes code for proteins with biological functions such as 
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signal transduction, proliferation, survival or metabolism. Dysregulated expression of 
these genes may explain proliferation, survival and differentiation defects in CTCF-
deficient B- and T-lymphocytes. A remarkable example is the Gimap4 gene, which we 
also showed to be upregulated in Lck-Cre Ctcff/f DP cells by RQ-PCR (Chapter 3). 
Gimap4 is a member of a novel protein family of putative small GTPases called Gimap/
Ian (GTPase of the immunity associated protein family, also termed immune-associated 
nucleotide-binding proteins), previously implicated in thymocyte development, survival 
of T lymphocytes and T helper cell differentiation3. Gimap4 expression is detected upon 
pre-TCR signalling, TCR-mediated positive selection and in peripheral T- and B-cells4-6. 
Gimap4 is a lymphocyte signalling molecule, which GTPase activity is regulated by 
Calmodulin (Calcium modulated protein) binding and phosphorylation mediated by 
PKC5, 7. Gimap4 seems to be dispensable for T cell development but is associated 
with increased apoptosis in peripheral T-cells5, 8. Thus, upregulated Gimap4 expression 
could contribute to survival defects in CTCF-deficient B- and T-lymphocytes. Eight 
functional mouse Gimap genes cluster on chromosome 6 spanning a region of ~140 
Kbp9. Interestingly, we also detected upregulated expression of Gimap3 and Gimap6 in 
CTCF-deficient B-cell progenitors micro-array analysis described in Chapter 2. Gimap3 
expression is increased during the transition from DP into CD4+ or CD8+ SP thymocytes 
and was shown to support positive selection of SP CD4+ and CD8+ T cells8. In rats, 
Gimap6 expression is the highest in DP thymocytes but its role in T-cells remains to be 
investigated10. It would be of interest to study if CTCF is a direct regulator of Gimap gene 
cluster expression and the significance of upregulated Gimap4, Gimap3 and Gimap6 
expression in the phenotype observed in CTCF-deleted B- and T-cells. 
Cell-type-specific changes in gene expression may also explain the proliferation 
and differentiation defects observed in B- and T-cells deleted for CTCF. For example, 
β-selected cells from Lck-Cre Ctcff/f mice have highly increased expression of the cyclin-
CDK inhibitor encoding genes p21 and p27, while in CTCF-deficient mouse embryonic 
fibroblasts (MEFs) expression of p21, but not of p27, is increased (Chapter 3). In 
mb1-cre Ctcff/f B-cell progenitors we do not find misregulated expression of p21 or p27 
(Chapter 2). Previously it has also been shown that in WEHI 231 immature B-cells, 
reduction of CTCF levels decreased rather than increased the expression of p21 and 
p27 11. This suggests that CTCF function is context dependent. In fact, ISP cells are 
highly proliferating as a result of pre-TCR stimulation, whereas crosslinking of the BCR 
on WEHI 231 immature B-cells results in cell-cycle arrest and apoptosis, which could 
explain a different effect of CTCF in p21 and p27 gene expression. CTCF binds to two 
adjacent sites in the first intron of p21, but no correlation between CTCF binding and 
p21 expression is observed in T-cells (Chapter 3). Therefore, whether CTCF is a direct 
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transcriptional regulator of p21 and/or p27 remains to be seen. It is possible that CTCF 
cooperates with distinct transcription factors for positive or negative regulation of p21 
and/or p27 expression in different cell-types. Similarly, expression of genes required for 
cell differentiation might depend on the cooperation between CTCF and lineage-specific 
transcription factors. In line with this, ISP and DP cells from Lck-Cre Ctcff/f mice express 
low levels of TCRβ (Chapter 3) and CTCF binding at the Tcrβ and Tcrα/δ loci has 
been previously reported12-14. The T-cell transcription factor Gata3 binds to Tcr enhancer 
elements and plays an important role in the regulation of T-cell-specific expression of the 
Tcrβ and Tcrα/δ loci15, 16. In Chapter 5 we found that overexpression of Gata3 resulted in 
increased occupancy of Gata-3-binding sites in the Tcrα enhancer region and enhanced 
TCR expression. It would be interesting to investigate whether Gata3 regulates Tcrβ 
and Tcrα/δ loci expression in a CTCF-dependent fashion.
In conclusion, global role of CTCF in regulating gene expression causes 
difficulties to the identification of specific CTCF target genes underlying B- and 
T-lymphocyte proliferation and differentiation defects. Further complexity arises from 
the fact that some of these genes may be regulated in a cell-type-specific manner. 
A comparative analysis of genome-wide gene expression profiling studies in different 
CTCF-deleted cell populations might be elucidative. In this context, γδ T-cells are unique 
in the sense that CTCF is not required for their development or in vitro proliferation 
(Chapter 3), which makes this cell population a prime candidate for genome-wide gene 
expression analysis. 
CTCF regulation of Ig loci gene rearrangements 
It is well-established that antigen receptor loci undergo large-scale contraction by 
chromatin looping as part of the mechanisms regulating V(D)J recombination17-22. 
This ensures that the multiple antigen receptor gene segments scattered over a large 
genomic region encounter each other with the appropriate frequencies. Thus far, only 
a few molecular components have been identified that modulate antigen receptor loci 
topology. These include Pax5, YY1 and Ikaros, which have been shown to control 
Igh locus contraction and distal VH-to-DJH recombination
23-25. However, the precise 
mechanism by which these factors act to regulate chromatin structure remains elusive 
and other proteins certainly collaborate with them to modulate chromatin structure.
The Igh locus
In Chapter 2 we found that CD2- cytoplasmic Igµ+ pre-B cells generated in mb1-cre Ctcff/f 
mice have an apparently normal VH family repertoire and no obvious recombination 
bias to proximal VH gene segments. The question arises of whether CTCF protein is 
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completely absent when Igh recombination, in particular VH-to-DJH joining, is initiated 
at the pro-B cell stage20. Analysis of LacZ expression in B-cell lineage cells of mb1-cre 
Ctcff/f mice shows that Ctcf deletion is efficiently induced and almost complete at the 
pro B-cell stage (Chapter 2). As for CTCF protein levels, western blot analysis clearly 
demonstrates that CTCF is essentially undetectable in B220+CD19+CD2- cells (pro-/
pre-B cell fractions) from mb1-cre Ctcff/f mice (Chapter 2). Importantly, the analysis of 
CTCF protein levels in total pro-/pre-B cell fractions does not lead to an underestimation 
of the actual amounts of CTCF protein in pro-B cells since cytoplasmic Igµ+ pre-B cells 
only represent a minor fraction of B220+CD19+CD2- cells in mb1-cre Ctcff/f mice (~25%), 
probably due to strong proliferation and/or survival defects (Chapter 2). Moreover, mb1-
cre-mediated Yy1 gene deletion has previously provided evidence that YY1 is critical 
for Igh locus contraction and distal VH-to-DJH rearrangement at the pro-B cell stage
24. 
Based on these findings, we propose that CTCF is not essential for distal VH-to-DJH 
rearrangement at the pro-B cell stage, which is further supported by the binding pattern 
of CTCF in the Igh locus. A total of 53 CTCF binding sites span the entire VH region, 
although CTCF occupancy is mostly similar in pro-B and pre-B cells26 (Fig.1A). Thus, it 
is unlikely that CTCF alone accounts for changes in Igh locus topology that localize distal 
VH regions within close proximity of DJH elements occurring in pro-B cells
20. However, 
we cannot formally exclude a role for CTCF in Igh locus conformation. It is possible that 
CTCF determines the establishment of a higher-order chromatin structure at the Igh 
locus before CTCF deletion in mb1-cre Ctcff/f mice is complete. For example, CTCF could 
epigenetically mark the Igh locus at the pre-pro-B cell stage and thereby determine the 
recruitment of other proteins directly involved in changing Igh locus topology in pro-B 
cells.  In line with this, the recruitment of cohesin to CTCF binding sites at the Igh locus 
is largely pro-B cell specific26 and CTCF capacity to direct histone modification was 
previously observed at the mouse β-globin locus27. Further experiments are required to 
investigate if earlier deletion of CTCF affects Igh locus rearrangement. 
Other CTCF binding sites identified in the Igh locus locate in the VH-DH intergenic 
region and at the 3’ regulatory region (3’RR)26, 28. A recent study has demonstrated that 
CTCF binding sites in the VH-DH intergenic region have enhancer-blocking activity and 
mark a sharp decrease in Eμ-dependent antisense transcription over the DH-JH region
29. 
Therefore, it was proposed that CTCF binding to the VH-DH intergenic region prevents 
chromatin opening extending into the independently activated VH chromatin domain. 
Interestingly, fluorescence in situ hybridization (FISH) experiments suggest that 
CTCF binding sites in the VH-DH intergenic region and at the 3’RR are in close spatial 
proximity during the pre-pro-B cell stage, when DH-to-JH rearrangement occurs, thereby 
forming a DJH chromatin loop
20. Based on these findings it is tempting to speculate that 
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CTCF is implicated in the control of ordered V(D)J recombination at the Igh locus. It 
is generally accepted that VH-to-DJH rearrangement is the step that is regulated in the 
context of lineage-specificity and allelic exclusion. Accordingly, DH-to-JH but not VH-to-
DJH rearrangements can be detected in T cells
30 and DH-to-JH joining occurs on both 
Igh alleles in developing pro-B cells31. It would be interesting to investigate whether 
CTCF is involved in the regulation of lineage-specificity and allelic exclusion of the Igh 
locus V(D)J recombination process. Finally, CTCF binding sites at the 3’RR also show 
enhancer-blocking activity28 and within the 5’ flank of the Igh locus a binding motif for 
CTCF maps to a constitutive hypersensitive site, but CTCF occupancy or enhancer-
blocking activity has not been tested32. Interestingly, genome-wide gene expression 
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Figure 1. Schematic representation of CTCF binding sites in the mouse Igh and Igκ loci. 
CTCF binding in the Igh and Igκ loci have previously been described in different B-cell lineage 
subsets (pro-B and pre-B cells)26. Black arrows represent CTCF binding sites present in both 
pro-B and pre-B cells. Grey arrows represent CTCF binding sites present in: (A) only in pro-B 
cells or pre-B cells, (B) only in pre-B cells. CTCF binds to the VH-DH or Vκ-Jκ intergenic region and 
the 3’ and 5’ flanks of both the Igh and Igκ loci. The CTCF binding site indicated between the Igκ 
locus and the Rpia gene was not reported by Degner et al 26 but is detected by CTCF ChIP-Seq 
in mouse I11 erythroid cells (R. Stadhouders and E.Soler, personal communication). 
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profiling of B-cell progenitors from mb1-cre Ctcff/f mice show upregulated expression 
of genes located in the vicinity of the Igh locus – Vipr2, Pld4 and Crip2 (Chapter 2). 
Thus, CTCF binding sites flanking the Igh locus probably function to protect neighboring 
sequences from recombination events or accessibility changes associated with Igh 
locus recombination. 
The Igκ locus
Results described in Chapter 2 support a role for CTCF-mediated enhancer-blocking 
activity between the iEκ and 3’Eκ enhancers and the Vκ region or genomic regions 
outside the Igκ locus. In small pre-B cells from mb1-cre Ctcff/f VH81X transgenic mice 
we observe (i) increased proximal Vκ and reduced Jκ germline transcription (κ
00.8 
and κ01.1), (ii) increased recombination to proximal Vκ gene segments, although 
recombination to distal Vκ gene segments still occurred, and (iii) increased interactions 
of the iEκ and 3’Eκ enhancers with the proximal Vκ region and with genomic elements 
outside the Igκ locus, although iEκ and 3’Eκ enhancers interactions with distal Vκ gene 
segments also occurred. Nevertheless, one criticism we could consider in our findings 
is the fact that CTCF-deletion likely has an impact in pre-B cells viability, which can 
be critical if we take into account that the Igκ locus can undergo multiple rounds of 
Vκ-to-Jκ recombination. In this view, CTCF-deficient pre-B cells would get only one 
opportunity of Vκ-to-Jκ recombination and these primary rearrangements would favor 
proximal Vκ gene segments. In contrast, longer-lived wild-type pre-B cells may undergo 
several rounds of Vκ-to-Jκ recombination using progressively more distal Vκ to rearrange 
with more downstream Jκ gene segments. However, crosses of mb1-cre Ctcf
f/f VH81X 
transgenic mice with mice carrying the anti-apoptotic Eμ-Bcl2 transgene demonstrate 
that increased survival cannot restore pre-B cell numbers and thus, the developmental 
arrest observed at this stage cannot be explained by defective survival only (C.R.A., 
unpublished). Moreover, when analyzing Vκ-to-Jκ recombination data (Chapter 2) for 
joints using Jκ 1, by definition the Jκ gene segment used in primary recombination events, 
we still observe increased usage of proximal Vκ gene segments in small pre-B cells from 
mb1-cre Ctcff/f VH81X transgenic mice. Another major concern in our analysis is the use 
of RAG-sufficient mb1-cre Ctcff/f VH81X transgenic mice. Particularly, one could argue 
that increased interactions of proximal Vκ gene segments with iEκ and 3’Eκ enhancers 
observed in 3C assays (Chapter 2) simply results from their increased recombination 
to Jκ gene segments and subsequent genomic proximity to iEκ and 3’Eκ enhancers. 
This would however not be supported by the finding that interactions between the 3’Eκ 
enhancer and the Jκ gene segments is reduced to background levels in mb1-cre Ctcf
f/f 
VH81X transgenic small pre-B cells (Chapter 2). Further 3C experiments using mb1-
Claudia Thesis_2.indd   220 17/10/2010   21:19:11
General discussion 221
C
ha
pt
er
 7
cre Ctcff/f VH81X transgenic small pre-B cells on a RAG-deficient background should 
definitively elucidate on this.
In a striking parallel to the Igh locus, strong CTCF binding sites locate to the 
Vκ-Jκ intergenic region and flank the Igκ locus
26 (Fig. 1B). Based on our findings and the 
work by Featherstone et al29 we propose that CTCF binding sites in the Vκ-Jκ intergenic 
region contain enhancer-blocking activity that limit interactions between the iEκ and 3’Eκ 
enhancers and the promoters of proximal Vκ gene segments (Fig. 2). Similarly, CTCF 
binding sites flanking the Igκ locus likely prevent inappropriate communication between 
the iEκ and 3’Eκ enhancers and genomic regions outside the Igκ locus. A remarkable 
example is the neighboring Rpia gene, which transcriptional unit is contacted by both 
the iEκ and 3’Eκ enhancers in mb1-cre Ctcff/f VH81X transgenic small pre-B cells, 
consistent with upregulated Rpia expression found in genome-wide gene expression 
profiling of B-cell progenitors from mb1-cre Ctcff/f mice (Chapter 2).. Interestingly, CTCF 
binding sites in the Vκ-Jκ intergenic region locate to the recombination silencer Sis
26, 
which deletion results in reduced levels of κ00.8 and κ01.1 germline transcripts (Fig. 2), 
although transcription from germline proximal Vκ gene segments was not assessed
33. 
Sis has been demonstrated to recruit one Igκ allele to pericentromeric heterochromatin 
by association with Ikaros, a repressor protein that binds to heterochromatin33. It would 
be interesting to test if Sis-bound CTCF cooperates with Ikaros in the pericentromeric 
heterochromatin recruitment of Igκ alleles, for example by FISH experiments. Further 
experiments are required to investigate whether mutation of CTCF binding sites in the 
Vκ-Jκ intergenic region and/or flanking the Igκ locus mimic the phenotype observed for 
CTCF-deficient small pre-B cells.
V 3 GLT 
J  
iE   
Sis 
C  
M
A
R
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 0 0.8 
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J  
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M
A
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Figure 2. Model for CTCF function at the Igκ locus. CTCF binding at the Vκ-Jκ intergenic region 
and the 3’ flank of the Igκ locus prevent inappropriate communication between the Igκ enhancers 
and the proximal Vκ gene segments (Vκ3) or the juxtaposed house-keeping gene Rpia (left). In 
the absence of CTCF, increased interactions (dashed arrows) between Igκ enhancers and the 
proximal Vκ gene segments or the juxtaposed house-keeping gene Rpia are observed (right). This 
results in increased Vκ3 germline transcription (GLT) and Rpia expression, and reduced levels of 
κ01.1 and κ00.8 germline transcripts (grey arrows).
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Enhancer-blocking CTCF-driven insulation usually occurs through the formation 
of long-range chromatin interactions between CTCF-bound insulators34-36. In Chapter 
2 we hypothesized that (i) CTCF binding sites flanking the Igκ locus and in the Vκ-Jκ 
intergenic region partition off the locus into two main chromatin loop domains, separating 
the Vκ region from the Jκ-Cκ cluster containing the iEκ and 3’Eκ enhancers, and (ii) 
dynamic scanning of the Vκ region for recombination depends on further regulatory sub-
loops bringing Vκ gene segments into close spatial proximity with the Jκ-Cκ cluster. This 
model is strongly supported by a recent study where the in vivo binding pattern of RAG1 
and RAG2 proteins to antigen receptor loci was assessed37. This study demonstrates 
that binding of RAG proteins occurs at small regions of highly active chromatin 
encompassing J (and where present J-proximal D) gene segments of Igκ, Igh, Tcrα and 
Tcrβ loci, referred to as recombination centers. Recombination centers are formed in a 
lineage- and developmental stage-specific manner and are thought to coordinate V(D)
J recombination by providing a discrete site within which V gene segments compete for 
stable capture by RAG proteins. In Chapter 2 we found that recombination and iEκ and 
3’Eκ enhancers interactions to distal Vκ gene segments occur in the absence of CTCF, 
which suggests that CTCF is largely dispensable for distal Vκ gene segments to contact 
with the Jκ-Cκ cluster containing the iEκ and 3’Eκ enhancers (or recombination center). 
Only 11 CTCF binding sites were identified in the Vκ region and the majority appeared to 
be pre-B cell specific26. It is possible that CTCF cooperates in a redundant fashion with 
lineage-specific transcription factors bound to Vκ promoters (such as, Ebf1 or OcaB
38, 39) 
or to iEκ and/or 3’Eκ enhancers (for example, E2A, Pax5 or Irf440-52) for cell-type-specific 
regulation of chromatin looping in the Vκ region. In line with this, a recent study has 
demonstrated coordinate binding of E2A and CTCF to a small subset of cis-regulatory 
elements genome-wide, which raises the possibility that E2A and CTCF act in concert 
to modulate long-range chromatin structure53. Further experiments using 3C assays 
are required to identify CTCF-based chromatin contacts in the Igκ locus in rearranging 
small pre-B cells and non-Igκ-expressing cells. It would also be interesting to study 
in CTCF-deficient small pre-B cells the possible additional effects of lineage-specific 
transcription factors deletion or genetic disruption of their target sequences on the 
structural organization of the Igκ locus. Alternatively, CTCF can function to direct local 
histone modifications at the Igκ locus27, and thereby regulated RAG protein targeting in 
the Jκ region. ChIP experiments to determine patterns of histone modifications in the Igκ 
locus in CTCF-deficient small pre-B cells would be required to elucidate this. 
Taken together, our findings suggest that CTCF is not absolutely required for distal V-to-(D)
J rearrangements at Ig loci in rearranging B-cells. Therefore, large-scale reorganization 
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of the chromatin fiber that brings distal V gene segments into close proximity of (D)J 
elements might not be dependent on CTCF. CTCF may predominantly function as an 
enhancer-blocking protein that orchestrates proper functional communication between 
enhancers and promoters within the Ig loci, while limiting the actions of enhancers 
elsewhere in the genome. Enhancer-blocking activity mediated by CTCF possibly 
evolved to have distinct functions in the Igh and Igκ loci – control of ordered V(D)J 
rearrangement at the Igh locus and limit of proximal Vκ gene segment usage at the Igκ 
locus. Interestingly, proximal Vκ3 family members usage has previously been associated 
with the development of auto-reactive B1-cells54, while in the Igh locus proximal VH7183 
family members are frequently used55. 
CTCF regulation of T helper cytokine gene expression 
During T helper cell differentiation, coordinate regulation of cytokine gene expression 
depends on long-range chromatin loops bringing distal cis-regulatory elements into 
intimate contact with cytokine genes56-59. Both T helper cell lineage-specific transcription 
factors and Stat proteins have been implicated in the control of these intrachromosomal 
interactions56-59. However, our current understanding of the mechanisms underlying cell 
type-specific differences in higher-order chromatin structure at cytokine gene loci and 
their contribution to gene expression is far from complete.
The Ifng locus and Th1 lineage commitment
In Chapter 3 we found ~50% reduction in IFN-γ-producing cells when naïve CD4+ T 
cells from CD4-Cre Ctcff/f mice are cultured in Th1-polarized conditions. The mechanism 
for reduced IFN-γ production in the absence of CTCF has been illuminated by a recently 
reported study. This study demonstrates that T-bet promotes Ifng expression in part by 
facilitating CTCF binding and chromatin looping at the Ifng locus59. Particularly, CTCF 
acts to establish a Th1-cell specific Ifng locus architecture, which helps to drive the 
juxtaposition of T-bet-binding enhancers and the flanking CTCF-binding elements to Ifng 
and to promote Ifng expression (Fig. 3). Another study in human Th1 cells demonstrated 
that cohesins form the topological and mechanistic basis for CTCF-mediated chromatin 
looping at the IFNG locus60. Consistently, we also observed reduced IFN-γ production 
in CTCF-deficient CD8+ T-cell cultures (C.R.A., unpublished). Given that in CD8+ T-cells 
T-bet acts in concert with other, highly homologous, T-box transcription factor called 
Eomes to promote IFN-γ production61-63, it would be interesting to investigate if CTCF 
cooperates with T-bet and/or Eomes for Ifng locus architecture in CD8+ T-cells. 
 In all vertebrates except rodents, the IFNG gene is not clustered with other 
co-expressed cytokines and the nearest upstream genes are IL26 and IL22, which are 
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mainly expressed by Th17 cells. In rodents, complex structural rearrangements resulted 
in near complete deletion of IL26, except for a distal regulator element located ~70 
Kbp upstream of Ifng64. The mouse -70 Kbp region exhibits both barrier and enhancer-
blocking insulator activity and CTCF occupancy is detected in naïve, Th1 and Th2 CD4+ 
T-cells59. Interestingly, in Chapter 3 we observed a small population of IFN-γ+ cells in 
CTCF-deficient Th17 cultures suggesting that binding of CTCF to the -70 Kbp region 
insulate the Ifng locus from the neighboring Il22 gene. Expression of IFN-γ can result 
in impaired differentiation of Th17 cells65, 66, although in vitro this might be masked by 
the presence of IFN-γ neutralizing antibodies in Th17-polarizing culture conditions. It 
would be interesting to investigate whether differentiation of Th17 cells in CD4-Cre Ctcff/f 
mice is impaired in vivo, for example upon induction of Th17-mediated inflammatory 
or autoimmune disorders, such as inflammatory bowel disease (IBD), experimental 
autoimmune encephalomyelitis (EAE) or collagen induced arthritis (CIA). Similarly, 
whether Il22 expression is upregulated in CTCF-deficient Th1 cultures and impairs Th1 
polarization remains to be tested.
+1 
Ifng -22 
-34 
+18/20 
+29 
+66 
-70 
+1 
Ifng 
-22 
-34 
-70 +6
6 
Th1 cells 
CTCF 
T-bet 
+ T-cells 
Figure 3. Model for CTCF-mediated higher-order chromatin conformation of the Ifng locus. 
In naive CD4+ T-cells, CTCF is bound primarily at hypersensitive site (HS) -70 and T-bet is not 
bound. Upon Th1 cell differentiation, T-bet binds to the Ifng promoter and to the conserved non-
coding sequence (CNS) -34, CNS+18/20, and CNS+29 enhancers, and CTCF binds strongly at 
HS +1  (in intron 1 of Ifng) and at HS +66 in addition to HS -70. This binding contributes to and is 
required for the juxtaposition of each of these distal regulatory elements to Ifng and its promoter. 
In this active locus conformation, the CNS -34 enhancer is in close proximity to Ifng gene. Figure 
adapter from59. See Appendix for full-color figure.
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The Th2 cytokine locus and Th2 lineage commitment
Results described in Chapter 3 support a critical role for CTCF in the control of Th2 
cytokine gene expression. We found that transcription of Il4, Il5 and Il13 is strongly 
reduced when naïve CD4+ T cells from CD4-Cre Ctcff/f mice are cultured in Th2-polarizing 
conditions. Consistent with a Th2 cytokine defect, CD4-Cre Ctcff/f mice have reduced 
serum levels of the IL-4 dependent isotypes IgG1 and IgE. Importantly, in CTCF-deficient 
Th2 cultures, cells were polarized towards the Th2 lineage as substantiated by induction 
of the key transcriptional regulators Gata3 and Satb1 and low expression of T-bet and 
Stat4. Based on these findings we propose that CTCF is essential for Gata3- and Satb1-
dependent regulation of Th2 cytokine gene expression. However, the mechanisms by 
which CTCF might facilitate Th2 cytokine production remain largely elusive.
 We identified four constitutive CTCF binding sites (CBS) in the mouse Th2 
cytokine locus (Chapter 3): two sites upstream of Il5 (CBS-6 and CBS-7) and one 
downstream of Il4 within Kif3a (CBS-1) flanking the Th2 cytokine locus and one site in 
the intergenic region between Il13 and Il4 (CBS-3) located to the DNaseI hypersensitive 
site Hss3, which is of unknown function67. Previous studies have shown that both Gata3 
and Stat6 are required for the establishment and/or maintenance of a “poised” chromatin 
configuration in the Th2 cytokine locus, where cytokine gene promoters and the LCR 
come into close spatial proximity56, 57. Further changes to this conformation are induced 
upon expression of Satb1, which mediates the formation of a more densely looped, 
transcriptionally active chromatin structure at the Th2 cytokine locus58. One possible 
explanation for the Th2 cytokine expression defect observed in CTCF-deficient Th2 
cells is that in the absence of CTCF the recruitment of key transcription factors for Th2 
development, such as Gata3, Stat6, Satb1, c-Maf or Irf4, to the Th2 cytokine locus is 
impaired (Fig. 4). Indeed, one of the CTCF binding sites we identified (CBS-3) is located 
near to CNS-1, which has been shown to bind the C-terminal Zn-finger of Gata3 and to 
be critical for Th2 cytokine expression67, 68. Preliminary experiments using ChIP assay 
suggested that CTCF deficiency in Th2 cells does not result in decreased occupancy of 
Gata3 at the Th2 cytokine locus in several Gata3 binding sites (C.R.A., unpublished). 
Another possibility is that CTCF organizes higher-order chromatin conformation at the 
Th2 cytokine locus required for transcription of Il4, Il5 and Il13 genes. This hypothesis 
can be tested using 3C-type experiments to interrogate Th2 cytokine locus interactions 
in CTCF-deficient and wild-type naïve, Th1 and Th2 CD4+ T-cells. For instance, 
upstream and downstream CTCF-binding elements could cooperate with the CTCF-
binding element in the Il13-Il4 intergenic region to help approximate Th2 cytokine gene 
promoters and cis-regulatory elements (such as the LCR or interposed enhancers) 
during Th2 differentiation. In this context, it would be interesting to investigate if similarly 
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to the Ifng locus59, Th2 cell-specific CTCF binding and chromatin looping also occurs 
at the Th2 cytokine locus. It also remains to be tested whether CTCF has a role in 
the maintenance of a transcriptionally active chromatin structure at Th2 cytokine locus. 
Further experiments where CTCF is targeted in vitro once polarization to the Th2 lineage 
is complete (for example using RNAi or recombinant soluble Cre approaches) would 
elucidate this.
 During Th2 differentiation Gata3-mediated counter-regulatory mechanisms are 
required for the suppression of alternative T helper lineage fates. For example, Gata3 
suppresses Th1 differentiation by downregulation of Stat4 69, 70. Gata3 has also been 
shown to inhibit Foxp3 expression during iTreg polarization71. In Chapter 6 we found 
that enforced Gata3 expression counteracts Th17 differentiation via (i) induction of IL-4 
expression and (ii) downregulation of Stat3, Stat4, Nfatc2 and RORγt transcription in 
an IL-4-independent way. It is therefore conceivable that these transcription factors 
are direct Gata3 targets. One intriguing possibility to be tested is whether CTCF also 
cooperates with master transcription factors for the negative regulation of genes 
essential for alternative T helper lineage fates.
Taken together, our findings demonstrate that CTCF is required for coordinate regulation 
Figure 4. Schematic representation of the binding sites for CTCF and key Th2 transcription 
factors in the mouse Th2 cytokine locus. CTCF binding sites in the Th2 cytokine locus are 
interspersed with the binding sites for key Th2 transcription factors such as Gata3, Stat6, Satb1, 
c-Maf and Irf4. CTCF binding sites (CBS) upstream of Il5 (CBS-6 and CBS-7) and downstream 
of Il4 within Kif3a (CBS-1), flank the Th2 cytokine locus. CTCF binding in the intergenic region 
between Il13 and Il4 (CBS-3) locates to the DNaseI hypersensitive site Hss3 near to CNS-1. See 
Appendix for full-color figure.
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of Ifng and Th2 cytokine gene expression during Th1 and Th2 cell differentiation, 
respectively. In particular, studies at the Ifng locus show that T-bet-dependent CTCF 
occupancy is on the basis of a Th1-cell specific Ifng locus architecture and Ifng 
expression59. Importantly, these findings demonstrate a presumably widespread 
mechanism of cooperation between a ubiquitous architectural factor (CTCF) and a 
lineage-specific transcription factor (T-bet) in cell type-specific gene regulation. 
Concluding remarks
The study of lymphocyte development is important for understanding how lymphocytes 
acquire their antigen specificity and function, and at the same time constitute an 
excellent model system to study developmentally regulated gene expression. In this 
thesis we used a conditional gene targeting approach to study the in vivo function of 
CTCF in B- and T-lymphocytes. We provide evidence that CTCF is important for gene 
regulation in the lymphocyte lineage, particularly during Ig loci gene rearrangement and 
T helper cytokine gene expression. Similarly to the imprinted H19/Igf2 locus, CTCF may 
predominantly function at the Ig loci as an enhancer-blocking protein that orchestrates 
proper functional communication between enhancers and promoters (Fig. 5). As for the 
regulation of T helper cytokine gene expression, the role of CTCF at the Ifng locus is 
parallel to its role in the MHCII locus. In both loci CTCF cooperates with cell type-specific 
factors (T-bet or CIITA/RFX) for enhancer-promoter long-range interactions and gene 
expression. It remains to be established if at the Th2 cytokine locus CTCF operates 
in a similar manner for coordinate regulation of gene expression, involving e.g. Gata3 
and Satb1. An alternative view is that CTCF-based chromatin loops are required for the 
establishment and/or maintenance of a transcriptionally active chromatin structure at 
the Th2 cytokine locus. A similar mechanism has been predicted at the β-globin locus, 
although destabilization of CTCF contacts has no effect on gene expression. Taken 
together, these studies demonstrate that CTCF-mediated chromatin loops can facilitate 
communication between cis-regulatory elements but can also lead to the exclusion of 
interactions between them. The spatial positioning of CTCF binding sites with respect to 
genes and other regulatory elements and the affinity of long-range interactions dictates 
the types of CTCF-based chromatin loops formed and final outcome in terms of gene 
regulation.
Dissecting the molecular mechanisms underlying the generation of a wide 
repertoire of antigen receptors and the expression of effector cytokines may (i) facilitate 
the development of clinical strategies for the generation of a functional lymphoid 
compartment, able to fight a vast array of potential pathogens while maintaining 
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tolerance to self (for example, in the context of HSC transplantation) and, (ii) contribute 
to understand the etiology of Th2-mediated diseases (such as, asthma and allergy) and 
improve current therapies. Despite CTCF being a ubiquitously expressed transcription 
factor, the possibility of topical treatment with CTCF-inhibitors for pulmonary Th2 
diseases such as asthma is a realistic one, paralleling e.g. inhaled corticosteroids.
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Figure 5. Comparison between CTCF function at several developmentally regulated 
loci. CTCF-mediated chromatin loops can facilitate the communication between cis-regulatory 
elements such as enhancers and promoters. At the human MHCII and mouse Ifng loci CTCF 
has been shown to cooperate with cell-type specific transcription factors (CIITA/RFX and T-bet) 
for long-range interactions between distal cis-regulatory elements and gene expression. We 
speculate that a similar mechanism accounts for CTCF function at the Th2 cytokine locus. At 
the Igf2/H19 and Igκ loci, CTCF prevents inappropriate communication between enhancers and 
promoters, which might also depend on the collaboration between CTCF and cell type-specific 
transcription factors.
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SUMMARY
The adaptive arm of the immune system is responsible for highly effective immune 
responses against pathogens, due to the unique and virtually limitless capacity of B- 
and T-lymphocytes to specifically recognize antigens. This relies on the generation of 
a wide repertoire of antigen receptors – B-cell receptor (BCR) in B-lymphocytes and 
T-cell receptor (TCR) in T-lymphocytes – during lymphocyte development. Additionally, 
effective immune responses against pathogens depend on differentiation of naïve 
B- and T-lymphocytes into mature effector B- and T-cells, once they encounter their 
cognate antigen.
 Proper lymphocyte development and differentiation into functional effector 
subsets depends on the expression of lineage-associated genes, which is controlled 
by the combinatorial activity of multiple signalling pathways and transcription factors in 
a complex gene regulatory network. In addition, the formation of a diverse repertoire 
of antigen receptors during lymphocyte development is a tightly regulated process. 
During this process, which is refered to as V(D)J recombination, recombination takes 
place between large genomic loci, containing over hundred V gene segments. Similarly, 
coordinate regulation of cytokine gene loci underlies the function of effector T-cells, 
namely T helper cells. When inappropriate it can result in immune pathologies e.g. 
asthma or autoimmune diseases, including rheumatoid arthritis or multiple sclerosis. 
At these complex loci, regulation of gene expression involves the coordinate binding 
of lineage-specific transcription factors to cis-regulatory elements, such as promoters, 
enhancers, silencers or LCRs, located over considerable genomic distances. Emerging 
evidence suggests that long-range interactions between cis-regulatory elements, by 
looping of the intervening DNA fragment, are part of the mechanism of gene regulation 
at these developmentally regulated loci. 
The CCCTC-binding factor (CTCF) is a highly conserved and ubiquitously 
expressed DNA-binding protein among vertebrates, which is implicated in genome-wide 
organization of chromatin architecture and non-canonical gene regulatory functions. 
Direct evidence for CTCF-mediated higher-order chromatin structure has been reported 
at several developmentally regulated gene loci, including the mouse β-globin and H19/
Igf2 loci and the human MHCII locus. Cell-type-specific regulation of chromatin looping 
possibly arises through cooperation between the ubiquitous architectural factor CTCF 
and lineage-specific transcription factors. This thesis describes the results from studies 
aimed to unravel the function of CTCF throughout B- and T-lymphocyte development and 
effector T helper cell differentiation, while further exploring the role of the  transcription 
factor Gata3 in the T cell lineage. 
In Chapters 2 and 3 we studied the in vivo function of CTCF during B- and T-cell 
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development through conditional deletion of the Ctcf gene, using the Cre-loxP system. 
In Chapter 2 we found that CTCF is critical at the pre B-cell developmental checkpoint, 
probably as a regulator of genes involved in cellular proliferation and differentiation. 
Pre-B cells generated in mb1-cre Ctcff/f mice have apparently normal Ig heavy chain 
(Igh) gene recombination. In contrast, at the Igκ light chain locus we observed enhanced 
proximal Vκ germline transcription, while recombination to proximal Vκ gene segments 
is significantly increased. We demonstrated that CTCF limits interactions of the intronic 
(iEκ) and 3’Eκ enhancers with the proximal Vκ region and prevents inappropriate 
interactions between these enhancers and genomic elements outside the Igκ locus. 
Based on these findings we propose a predominant role for CTCF as an enhancer-
blocking protein at the Igκ locus. In Chapter 3 we found that CTCF is essential for αβ 
T-cell development, in particular for proper  proliferation of β-selected cells and their 
differentiation from immature single positive (ISP) to double-positive (DP) cells. In Lck-
Cre Ctcff/f mice, β-selected cells are arrested in the cell cycle due to highly increased 
expression of the cyclin-CDK inhibitors p21 and p27. Remarkably, in Lck-Cre Ctcff/f mice 
γδ T-cell development appeared to occur independently of CTCF.
In Chapter 4 we investigated the role of CTCF in T cell activation and cytokine 
gene expression upon polarization of CD4-cre Ctcff/f naïve CD4+ T-cells into different T 
helper cell subsets in vitro. We found that CTCF-deleted peripheral T-cells have impaired 
activation and proliferation upon anti-CD3/anti-CD28 stimulation in vitro. Interestingly, 
these defects could be rescued to a great extent when TCR-proximal signalling was 
circumvented with phorbol ester (PMA) and ionomycin, suggesting that CTCF controls 
the expression of genes encoding for proteins involved in TCR-proximal signalling 
events required for full T-cell activation. Rescue of signaling cascade downstream of the 
TCR by PMA and ionomycin stimulation allowed in vitro differentiation of CTCF-deleted 
naïve CD4+ T-cells into different T helper cell subsets. We found strongly reduced 
transcription of Il4, Il5, and Il13 in Th2 polarization cultures, despite normal induction of 
key Th2 cytokine transcriptional regulators, Gata3 and special AT-rich binding protein 1 
(Satb1). In contrast, IFN-γ production in Th1 cultures was only moderately reduced and 
IL-17 production in Th17 cultures was unaffected. Consistent with a Th2 cytokine defect, 
CD4-cre Ctcff/f mice had very low levels of IgG1 and IgE in their serum. Chromatin 
immunoprecipitation analysis revealed multiple CTCF binding sites in the Th2 cytokine 
locus. Taken together, these findings demonstrate that CTCF is essential for Gata3- and 
Satb1-dependent regulation of Th2 cytokine gene expression.
Gata3 expression is induced at the DP stage and has been implicated in 
positive selection towards the CD4 lineage. In Chapter 5, a comparison between 
gene expression profiles of DP cells from CD2-Gata3 transgenic and wild-type mice 
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revealed new putative Gata3 target genes that may clarify Gata3 function at the DP 
stage. Interestingly, overexpression of Gata3 resulted in increased occupancy of 
Gata-3-binding sites in the TCRα enhancer region and enhanced TCR expression. 
Differentiation towards Th2 lineage is critically dependent on Gata3, which has previously 
been shown to negatively regulate the differentiation of alternative lineage fates, such 
as Th1 or iTreg. In Chapter 6, naïve CD4+ T-cells with enforced Gata3 expression were 
differentiated into Th17 cells in vitro. Gata3 was shown to support Th17 differentiation 
by limiting IL-2 and IFN-γ production and constrain Th17 differentiation, both through 
IL-4 production and by IL-4-independent mechanisms. These detailed analyzes on the 
molecular mechanisms underlying the role of Gata3 in the T-cell lineage represent an 
important step for future studies on the possible cooperation between Gata3 and CTCF 
in the regulation of Gata3 target genes. In particular, because parallel studies in Th1 
cells have shown a presumably widespread mechanism of cooperation between CTCF 
and a lineage-specific transcription factor in cell type-specific gene regulation.
 Finally, in the Discussion we consider the implications of our findings for the 
knowledge on the role of CTCF in B- and T-lymphocytes proliferation, survival and 
differentiation, particularly on Ig loci gene rearrangement and T helper cytokine gene 
expression. We identified CTCF as a critical factor that influences the usage of Vκ gene 
segments for recombination, contributing to the mechanism that gives nearby and 
remote Vκ  regions equal opportunities to rearrange with Jκ  elements in the Igκ locus. 
Parallel to findings in Th1 cells, we demonstrate that CTCF is essential for Th2 cytokine 
gene expression. We speculate that CTCF might cooperate with key Th2 transcription 
factors such as Gata3, in the regulation of Th2 cytokine gene expression.
Importantly, these findings contribute to our understanding of the molecular 
mechanisms underlying the generation of a wide repertoire of antigen receptors and 
the expression of effector cytokines. In the future, our findings might have implications 
for the development of clinical strategies for the generation of a functional lymphoid 
compartment, for example in the context of hematopoietic stem cell (HSC) transplantation. 
Moreover, they can contribute to understanding the etiology of Th2-mediated diseases, 
such as asthma and allergy, and improve current therapies.
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SAMENVATTING
Het immuunsysteem bestaat uit twee delen, namelijk een deel dat is aangeboren en een 
deel dat zich aanpast aan de ziekteverwekker. Dit laatste deel van het immuunsysteem, 
het aanpassingsimmuunsysteem, bestaat uit B- en T-lymfocyten. Deze B- en 
T-lymfocyten hebben de unieke eigenschap dat ze virtueel elke ziekteverwekker, ook wel 
een antigen genoemd, kunnen herkennen. Hierdoor is dit deel van het immuunsysteem 
in staat om zeer effectieve afweerreacties tegen ziekteverwekkers uit te voeren. De 
B- en T-lymfocyten kunnen veel verschillende antigenen herkennen doordat elk B- en 
T-lymfocyt een receptor tot expressie brengt die specifiek gericht is tegen een uniek 
antigen. Op B-cellen (B-lymfocyt) heet deze receptor de B-cel receptor (BCR), op T-cellen 
heet deze receptor de T-cel receptor (TCR). Zodra B- of T-cellen hun antigen herkennen 
worden ze geactiveerd en differentiëren de nog naïeve B-of T-cellen respectievelijk in 
effector B- of T-cellen.
 De vorming en differentiatie van B- en T-lymfocyten wordt aangestuurd door 
middel van celtype specifieke genen die op hun beurt weer worden gereguleerd door 
een netwerk van signaleringscascades en transcriptie factoren. Ook de vorming van het 
brede repertoire van BCRs en TCRs tijdens respectievelijk de B- en T-cel ontwikkeling 
is nauwkeurig gereguleerd. Tijdens dit proces, dat V(D)J recombinatie wordt genoemd, 
vindt er recombinatie plaats tussen verschillende genomische gebieden waarin meer 
dan honderd V-gen segmenten liggen. Ook de regulatie en activatie van de cytokine 
genen en loci in de effector T-cellen wordt gereguleerd door een complex netwerk van 
factoren. Wanneer de activiteit van deze cytokine loci niet goed wordt gereguleerd 
kan dat leiden tot immunologische ziektes, zoals auto-immuunziekten (waaronder 
reumatische artritis en multiple sclerosis) en astma.
 De genen in de hierboven genoemde loci worden gereguleerd door middel 
van celtype specifieke transcriptie factoren die binden aan cis-regulatore elementen die 
over het genoom verspreid kunnen liggen. Voorbeelden van cis-regulatore elementen 
zijn promotoren, enhancers, silencers of locus control regions (LCR). Steeds meer 
waarnemingen laten zien dat de interacties tussen ver uit elkaar liggende cis-regulatore 
elementen essentieel zijn voor de juiste regulatie van deze genen en loci. Wanneer ver 
uit elkaar liggende cis-regulatore elementen een interactie/binding aangaan vormt het 
tussenliggende DNA een lus.
 De CCCTC-binding factor (CTCF) is een eiwit dat aan DNA bind. Het eiwit is 
zeer geconserveerd binnen de groep van gewervelde dieren. Het CTCF eiwit komt in 
eigenlijk elk celtype tot expressie. CTCF is genoom-breed betrokken bij het tot stand 
brengen of juist tegen gaan van interacties tussen cis-regulatore elementen. CTCF 
reguleert de expressie van vele genen door de vorming van DNA structuren en DNA 
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lussen te dirigeren. Zo hebben onderzoekers laten zien dat CTCF betrokken is bij de 
regulatie van meerdere loci, waaronder de β-globin en H19/Igf2 loci en het humane 
MHCII locus. Celtype specifieke regulatie van de vorming van DNA structuren en lussen 
is mogelijk door de samenwerking tussen de alomvertegenwoordigd CTCF factor en 
celtype specifieke transcriptie factoren. Dit proefschrift beschrijft de resultaten van 
studies die zijn uitgevoerd om uit te zoeken welke functie(s) CTCF uitvoert tijdens de 
B- en T-cel ontwikkel en gedurende de differentiatie van geactiveerde T-cellen. Tevens 
beschrijft dit proefschrift studies die zijn uitgevoerd om de rol van de transcriptie factor 
Gata3 in T-cellen verder op te helderen.
 In de Hoofstukken 2 en 3 hebben we bestudeerd welke in vivo functie CTCF 
tijdens de B- en T-cel ontwikkeling uitvoert. Dit hebben we gedaan door middel van 
een conditionele deletie van het Ctcf gen, door gebruik te maken van het Cre-loxP 
systeem. In Hoofdstuk 2 vonden we dat CTCF een essentiële rol vervult op het 
controle punt in de ontwikkeling van de precursor-B cel (pre-B cel). CTCF reguleert 
dit controle punt waarschijnlijk door genen te reguleren die de celdeling en differentie 
aansturen. Pre-B cellen in mb1-cre Ctcff/f muizen hebben een normale recombinatie van 
de immunoglobuline zware keten (Igh) genen. Tevens vonden we versterkte expressie 
van de proximale Vκ steriele transcripten en een significant verhoogde gebruik van de 
proximale Vκ genen. Wij hebben laten zien dat CTCF de interacties met de intronic 
(iEκ) en 3’Eκ enhancers met de proximale Vκ gebieden remt. Tevens laat onze data 
zien dat CTCT onjuiste interacties voorkomt tussen deze enhancers en genomische 
gebieden buiten het Igκ locus. Op basis van deze bevindingen stellen wij de theorie 
voor dat het CTCT eiwit een dominante rol speelt als enhancer-blokkerend eiwit op de 
Igκ locus. De studie die is beschreven in Hoofdstuk 3 heeft ons laten zien dat CTCF 
noodzakelijk is voor de αβ T-cel ontwikkeling. CTCF vervult namelijk een belangrijke 
rol in de celdeling van β-geselecteerde cellen en in hun differentiatie van immature 
enkel positieve in dubbel-positieve (DP) T-cellen. We vonden namelijk in Lck-Cre Ctcff/f 
muizen dat β-geselecteerde cellen geblokkeerd zijn in hun celdeling als gevolg van 
sterk verhoogde expressie van de cyclin-CDK remmers p21 en p27. Daarin tegen is de 
ontwikkeling van γδ T-cellen normaal in Lck-Cre Ctcff/f muizen wat suggereert dat de 
ontwikkeling van deze cellen onafhankelijk is van CTCF.
 In Hoofdstuk 4 hebben we onderzocht welke rol CTCT vervult tijdens de 
activatie van T-cellen. Daarnaast hebben we in T-helper cellen gekeken welke functie 
CTCF vervult in de expressie van de cytokine genen. Hiervoor hebben we T-helper 
cellen bestudeerd die in vitro werden gedifferentieerd vanuit CD4-Cre Ctcff/f naïve 
CD4+ T-cellen. We vonden dat perifere T-cellen die deficiënt waren voor CTCF een 
verminderde activatie en celdeling hadden wanneer deze cellen in vitro gestimuleerd 
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werden met anti-CD3/anti-CD28. Opmerkelijk is dat deze defecten grotendeels konden 
worden opgeheven wanneer de TCR-signaleringscascade werd omzeild door middel 
van stimulatie met phorbol ester (PMA) en ionomycin. Dit suggereert dat CTCF de 
expressie reguleert van eiwitten die noodzakelijk zijn voor het tot stand brengen van 
de signaleringscascade achter de TCR. Het herstel van de T-cel activatie doormiddel 
van PMA en ionomycin zorgde ervoor dat de CTCF-deficiënte CD4+ T-cellen in vitro 
wel konden differentiëren in verschillende T-helper (Th) subsets. Analyse van de 
transcipties van Il4, Il5 en Il13 cytokine genen in Th2 gepolariseerde kweken liet zien dat 
de expressie van deze cytokines sterk was verlaagd in CTCF-deficiënte Th2-cellen. Dit 
ondanks dat de inductie van eiwitten die essentieel zijn voor de regulatie en expressie 
van Th2-cytokine genen, zoals Gata3 en Satb1, normaal was in CTCF-deficiënte Th2-
helper cellen. Daarin tegen was the IFN-γ productie in Th1-kweken alleen ligt verlaagd 
en was de productie van IL-17 in gekweekte Th17-cellen normaal. In overeenstemming 
met het gevonden defect in de productie van Th2-cytokines hadden de CD4-Cre Ctcff/f 
muizen een verlaagde hoeveelheid IgG1 en IgE in hun serum. Immuno precipitatie 
van het chromatin van CTCF-deficiente CD4+ T-cellen liet zien dat er meerde CTCF 
bindingsposities aanwezig zijn in het Th2-cytokine locus. Al deze bevindingen bij elkaar 
laten zien CTCF essentieel is voor de Gata3- en Satb1-afhankelijke regulatie van de 
expressie van de Th2-cytokine genen.
 De expressie van transcriptie factor Gata3 wordt geïnduceerd op het DP 
stadium van de T-cel ontwikkeling. Gata3 is op het DP stadium betrokken bij de positieve 
selectie in de richting van de CD4+ T-cellen. Hoofdstuk 5 beschrijft de bevindingen van 
de vergelijking tussen de genexpressie patronen in DP cellen van CD2-Gata3 transgene 
en wild-type muizen. Deze genexpressie analyse heeft genen onthuld die mogelijk door 
Gata3 worden gereguleerd. Met deze data hopen we te begrijpen welke rol Gata3 
vervult op het DP-stadium. Zo vonden we dat overexpressie van Gata3 resulteerde 
in verhoogde bezetting van de Gata3-bindingsites in het TCRα enhancer gebied en in 
een verhoogde expressie van de TCR. Eerder onderzoek heeft laten zien dat Gata3 
een belangrijke factor is voor het ontstaan van T-helper subsets: het ontstaan van 
Th2-cellen is afhankelijk van Gata3 terwijl de vorming van Th1-en regulatore T-cellen 
wordt geremd door Gata3. In Hoofdstuk 6 hebben we gekeken hoe Gata3 expressie 
de differentiatie van Th17-cellen reguleert door in vitro CD4+ T-cellen met versterkte 
Gata3 expressie te differentiëren in Th17-cellen. De resultaten lieten zien dat Gata3 de 
Th17-differentiatie ondersteund door de productie van IL-2 en IFN-γ te verminderen en 
door Th17-differentiatie te remmen door middel van zowel de productie van IL-4 als ook 
door IL-4 onafhankelijke mechanismen. Deze data over de moleculaire rol van Gata3 
in de T-cel ontwikkeling vormt de basis voor toekomstige studies om te onderzoeken 
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hoe Gata3 en CTCF mogelijk samen de expressie van genen reguleren die voor hun 
expressie afhankelijk zijn van Gata3. Voor Th1-cellen zijn al mogelijke interacties 
tussen CTCF-en Th1-specifieke transcriptie factoren beschreven die samen the Th1-
differentiatie vormgeven. 
 Tot slot, in de Discussie overwegen en wegen wij de implicaties van onze 
bevindingen voor de kennis en de kijk op de rol van CTCF in de ontwikkeling, proliferatie, 
overleving en differentiatie van B-en T-cellen. Hierbij ligt het accent op de rol van CTCF 
in de recombinatie van de Ig loci genen en de expressie van de T-helper cytokine genen. 
We hebben ontdekt dat CTCF een kritische factor is die de recombinatie van de Vκ-gen 
segmenten stuurt waardoor zowel dichtbij als verliggende Vκ-gen segmenten een gelijke 
kans hebben om te recombineren met een Jκ-element in het Igκ locus. Daarnaast vonden 
we dat CTCF, net zoals in Th1-cellen, ook essentieel is voor de expressie van the Th2-
cytokine genen. We veronderstellen dat CTCF samen met essentiële Th2- transcriptie 
factoren, waaronder Gata3, de expressie van de Th2-cytokine genen reguleert.
 De bevindingen die staan beschreven in dit proefschrift dragen bij aan het 
begrijpen van de moleculaire mechanismen die de vorming van het brede repertoire van 
antigen receptor en de expressie van de cytokine genen reguleren. We spreken de hoop 
uit dat onze bevindingen in de nabije toekomst kunnen bijdragen aan de ontwikkeling 
van therapeutische methoden voor het maken van functionele lymfoïde populaties, 
bijvoorbeeld voor de transplantatie van hematopoëtische stamcellen. Daarnaast kunnen 
onze bevindingen bijdragen aan het verbeteren van de huidige therapieën en aan het 
begrijpen van de etiologie van ziektes die worden veroorzaakt Th2-cellen, zoals astma 
en allergieën.
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Chapter 1 - Figure 7. Differentiation of effector CD4+ T-cells subsets in the mouse. During 
activation in a particular cytokine milieu, naïve CD4+ T-cells may differentiate into one of several 
lineages of T helper (Th) cells, including Th1, Th2, Th17, and inducible regulatory T-cells (iTregs). 
Different differentiation programs triggered by TCR and cytokine signalling are mainly based on 
the activation of Stat proteins and induction of master transcription factors that collaborate in the 
regulation of unique patterns of cytokine production. However, cytokine production by Th cells 
might be more flexible than previously though and recently T follicular helper (Tfh), Th9 and Th22 
cells have been described. Whether these subsets represent distinct lineages remains to be 
elucidated. 
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Chapter 1 - Figure 10. Schematic representation of the mouse Igf2/H19 locus. The maternally 
expressed noncoding H19 gene (A) is located approximately 90 Kbp downstream from the gene 
encoding Insulin-like growth factor 2 (Igf2) that is expressed exclusively from the paternal allele 
(B). The imprinting control region (ICR) ~2 Kbp upstream of H19 contains four CTCF binding sites 
and is essential for the regulation of the entire locus. Differentially methylated regions (DMRs) 
such as DMR1 upstream of Igf2 promoters and DMR2 within Igf2 exon 6, act in concert to regulate 
reciprocal, allele-specific expression patterns from a shared set of downstream enhancers 
at 8 Kbp (Ee, endodermal tissue enhancer) and 25 Kbp (Em, mesodermal tissue enhancer) 
downstream of the H19 gene. Allele-specific patterns of CTCF binding, DNA methylation (–CH3) 
and chromatin looping account for parent-of-origin H19 and Igf2 gene expression patterns during 
development. Figure adapter from316. 
Chapter 1 - Figure 12. Schematic representation of the human MHCII  locus.
In the human major histocompatibility complex class II (MHCII) locus, CTCF binds to the XL9 
enhancer element between two coregulated genes, HLA-DRB1 and HLA-DQA1, driven by 
divergent promoters. Transcription factors RFX, CREB and NF-Y bind to regulatory sequences 
within the proximal promoter of MHCII genes when they are transcriptionally inactive. Interferon-γ 
(IFN-γ) treatment induces transcription in non-expressing cell types by upregulating the non-
DNA binding coactivator CIITA, which subsequently forms an heterodimer with RFX-CREB-NF-
Y-bound promoters and the CTCF-bound enhancer in parallel with HLA-DRB1 and HLA-DQA1 
gene activation. Figure adapter from316.
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Chapter 1 - Figure 11. Schematic representation of the mouse β-globin locus. (A) Four 
globin genes are embedded within a larger olfactory receptor (OR) gene cluster. Developmentally 
regulated globin expression (εy and βh1 in primitive erythroid cells; β-major (βmaj) and β-minor 
(βmin) in definitive erythroid cells) is regulated in part by a series of cis-regulatory elements 
surrounding the locus (indicated by arrows). An upstream locus control region (LCR) containing 
six DNaseI hypersensitive sites (HS) is required for high-level transcription. Three CTCF binding 
sites have been identified upstream (5’HS85, 5’HS62/60 and 5’HS5) and one 20 Kbp downstream 
(3’HS1) of globin genes. (B) Cell type-specific CTCF-mediated intrachromosomal interactions in 
the mouse β-globin locus. Although loops are illustrated by CTCF multimerization, it is not clear 
whether CTCF binds directly to each site or through interaction with other proteins that are not 
represented for simplicity. In definitive erythroid cells full expression of, for example, the βmaj 
gene depends on stable LCR-gene contacts. Figure adapter from316.
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Chapter 2 - Figure 2. Defective pre-B cell proliferation and differentiation in mb1-cre Ctcff/f mice. 
(A) Flow cytometric analysis of wild-type (WT) and mb1-cre Ctcff/f (CTCF KO) B220+CD19+ pro-B 
cells (CD2-intracellular Igμ-) and large pre-B cells (CD2- intracellular Igμ+) for cell size (FSC, forward 
side scatter) and IL-7Rα. Results are displayed as histogram overlays (4-6 mice per genotype). 
(B) Propidium iodide (PI) cell cycle analysis of B220+CD19+ pro-B cells (CD2- intracellular Igμ-) and 
large pre-B cells (CD2- intracellular Igμ+) purified from WT and mb1-cre Ctcff/f BM. Percentages of 
cells in cycle (S/G2/M; >2N DNA content) are shown (representative of 2 mice per genotype). (C) 
In vivo proliferation analysis of WT and mb1-cre Ctcf f/f B220+CD19+ pro-B cells (CD2- intracellular 
Igμ-) and large pre-B cells (CD2- intracellular Igμ+). Mice were i.p. injected with a single dose of 
BrdU and after 4 hr the percentages of BrdU+ cells were determined by flow cytometry (mean 
values and SD for 3-4 mice per genotype; *, P<0.001). (D) and (E) DNA microarray analysis of 
total mRNA from purified B220+CD19+CD2- pro-B/large pre-B cell fractions in WT and mb1-cre 
Ctcff/f mice. Genes differentially expressed between the two genotypes were subdivided into two 
groups: genes which expression did (D) or did not differ (E) between control Rag1-/- pro-B cell 
and VH81X Rag1
-/- pre-B cell fractions. Heatmaps for the 30 genes with highest fold change in 
expression between WT and mb1-cre Ctcff/f B cell progenitors are shown (for complete gene lists: 
see Supplementary Tables 1 and 2). Bottom, logarithmic quantitative scale for gene expression 
(3-4 pools of 3-7 mice per genotype). 
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Chapter 2 - Figure 7. Increased interactions between the iEκ/3’Eκ enhancers and the Vκ 
proximal region in the absence of CTCF. (A) to (C) 3C-Seq analysis of iEκ and 3’Eκ interactions 
in B220+CD19+CD2+IgM- small pre-B cell populations purified from VH81X and VH81X mb1-cre 
Ctcff/f (CTCF KO) BM and total fetal liver cells. Cross-linked and NlaIII-digested DNA fragments 
were ligated and subsequently digested by BglII followed by re-ligation. Primers on the fragment 
of interest (containing iEκ or 3’Eκ, viewpoint) and facing outwards were used on inverse PCR. 
PCR products representing the genomic environment of the fragment of interest were further 
characterized by high-throughput sequencing. (A) Number of reads per million in 0.2 Mbp intervals 
in the Igκ locus (shaded area) plus 3.8 Mbp upstream and 5 Mbp downstream genomic regions. 
The dashed line represents the viewpoint. 3C-Seq counts obtained for fragments adjacent to the 
viewpoints were not considered. (B) Number of reads per million obtained for each of the 190 BglII 
fragments that cover the proximal 0.5 Mbp Vκ region. In each panel the X-axis shows the location 
of various Vκ gene segments present in the proximal 0.5 Mbp Vκ region. Shaded lines highlight 
the BglII fragments containing the Vκ gene segments shown to be used in unproductive and 
productive alleles in Figure 6. (C) Total number of BglII fragments on chromosome 6 interacting 
with iEκ or 3’Eκ that were found both in VH81X and VH81X mb1-cre Ctcf
f/f small pre-B cells, unique 
for VH81X small pre B cells or unique for CTCF-deficient VH81X small pre-B cells. 
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Chapter 2 -  Supplementary Figure 10. Interactions between Igκ enhancers in B220+CD19+CD2+ 
IgM- small pre-B cell populations purified from VH81X and VH81X mb1-cre Ctcf
f/f (CTCF KO) BM 
and total fetal liver cells, obtained by 3C-Seq analysis. Data represent number of reads per million 
obtained for the BglII fragments that cover the Igκ enhancers region. Shaded areas indicate the 
fragments containing the iEκ (left) and 3’Eκ (right) (viewpoint, VP). 3C-Seq counts obtained for 
fragments adjacent to the viewpoint are not shown.  Bottom, schematic representation of the Igκ 
enhancers region showing the relative location of Sis, Jκ, MAR, iEκ, Cκ, 3’Eκ and dEκ. Data is from 
5-6 mice per genotype.
Chapter 2 - Supplementary Figure 11. Model for CTCF function at the Igκ locus. CTCF binding 
sites flanking the Igκ locus and in the Vκ-Jκ intergenic region (Degner et al, 2009) prevent 
inappropriate communication between the Igκ enhancers and the proximal Vκ gene segments or 
the juxtaposed house-keeping gene Rpia by positioning the Jκ-Cκ cluster containing the iEκ and 
3’Eκ enhancers in a separate chromatin loop domain. CTCF possibly cooperates in a redundant 
fashion with other proteins for further regulatory sub-loops within Vκ region, bringing into close 
spatial proximity Vκ and Jκ gene segments in recombination centers (Ji et al, 2010) (shaded area). 
The absence of CTCF (right) favors interactions between Igκ enhancers and proximal Vκ gene 
segments or the Rpia gene. 
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Chapter 3 - Supplementary Figure 6. CTCF deletion 
does not affect nucleolar organization in resting T cells. 
FISH analysis of nucleolar organization in FACS-sorted 
naive CD62L+ peripheral T cells from the indicated 
mice. Slides were hybridized with a DIG-labeled 
rDNA probe (green) containing non transcribed rDNA 
(Akhmanova et al, 2000). Cells were counterstained 
with DAPI (blue).
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Chapter 5 - Figure 3. Identification of specific gene expression signatures in DP cells as a result 
of enforced Gata3 expression. Gene expression profiles were generated from FACS-sorted DP 
cells from wild-type (WT), CD2-Gata3 transgenic (G3), DO11.10 TCR transgenic (DO) and CD2-
Gata3:DO11.10 double transgenic (G3:DO) mice. (A) Non-supervised hierarchical clustering of 
both genes (rows) and individual mice (columns). Gene expression profiles were analyzed for 3 
individual mice per group. (B) Non-supervised hierarchical clustering of both genes (rows) and 
grouped (n=3) mice of the indicated genotype. Dendograms above and on the left side of the 
matrixes indicate the average linkage clustering of respectively individual mice and genes. Green 
and red colors indicate the level of downregulation or upregulation of genes, when compared 
with a pool of DP cells obtained from WT mice (n=6). The color scale above the matrix correlates 
with gene expression and the given value numbers represent 2log values. (C) Differentially 
expressed genes in DP thymocytes from CD2-Gata3 and DO11.10 single transgenic and CD2-
Gata3:DO11.10 double transgenic mice, displayed in a Venn diagram. Genes are either up- or 
downregulated 1.4-fold (P<0.0001) and are not differentially expressed in WT mice. Numbers of 
differentially expressed genes per cluster are given.
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Chapter 7 - Figure 3. Model for CTCF-mediated higher-order chromatin conformation of 
the Ifng locus. In naive CD4+ T-cells, CTCF is bound primarily at hypersensitive site (HS) -70 
and T-bet is not bound. Upon Th1 cell differentiation, T-bet binds to the Ifng promoter and to the 
conserved non-coding sequence (CNS) -34, CNS+18/20, and CNS+29 enhancers, and CTCF 
binds strongly at  HS +1  (in intron 1 of Ifng) and at HS +66 in addition to HS -70. This binding 
contributes to and is required for the juxtaposition of each of these distal regulatory elements to 
Ifng and its promoter. In this active locus conformation, the CNS -34 enhancer is in close proximity 
to Ifng gene. Figure adapter from59.
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Chapter 7 - Figure 4. Schematic representation of the binding sites for CTCF and key Th2 
transcription factors in the mouse Th2 cytokine locus. CTCF binding sites in the Th2 cytokine 
locus are interspersed with the binding sites for key Th2 transcription factors such as Gata3, 
Stat6, Satb1, c-Maf and Irf4. CTCF binding sites (CBS) upstream of Il5 (CBS-6 and CBS-7) 
and downstream of Il4 within Kif3a (CBS-1), flank the Th2 cytokine locus. CTCF binding in the 
intergenic region between Il13 and Il4 (CBS-3) locates to the DNaseI hypersensitive site Hss3 
near to CNS-1.
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